New high: a future-oriented study of American drug policy by Bress, Jessica Marie
Calhoun: The NPS Institutional Archive
DSpace Repository
Theses and Dissertations 1. Thesis and Dissertation Collection, all items
2017-12
New high: a future-oriented study of American
drug policy
Bress, Jessica Marie
Monterey, California: Naval Postgraduate School
http://hdl.handle.net/10945/56869
Copyright is reserved by the copyright owner.






Approved for public release. Distribution is unlimited. 
NEW HIGH: A FUTURE-ORIENTED STUDY OF 
AMERICAN DRUG POLICY 
by 
Jessica Marie Bress 
December 2017 





THIS PAGE INTENTIONALLY LEFT BLANK 
 
i
REPORT DOCUMENTATION PAGE Form Approved OMB  
No. 0704–0188
Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing 
instruction, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection 
of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including 
suggestions for reducing this burden, to Washington headquarters Services, Directorate for Information Operations and Reports, 1215 
Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and to the Office of Management and Budget, Paperwork 
Reduction Project (0704-0188) Washington, DC 20503.




3. REPORT TYPE AND DATES COVERED
Master’s thesis 
4. TITLE AND SUBTITLE
NEW HIGH: A FUTURE-ORIENTED STUDY OF AMERICAN DRUG 
POLICY 
5. FUNDING NUMBERS
6. AUTHOR(S)  Jessica Marie Bress
7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES)
Naval Postgraduate School 
Monterey, CA 93943-5000 
8. PERFORMING
ORGANIZATION REPORT 
NUMBER     




MONITORING  AGENCY 
REPORT NUMBER 
11. SUPPLEMENTARY NOTES The views expressed in this thesis are those of the author and do not reflect the
official policy or position of the Department of Defense or the U.S. Government. IRB number ____N/A____. 
12a. DISTRIBUTION / AVAILABILITY STATEMENT  
Approved for public release. Distribution is unlimited. 
12b. DISTRIBUTION CODE 
A 
13. ABSTRACT (maximum 200 words)
Drug policy in the United States is reactive and unprepared for burgeoning phenomena related to the 
convergence of drugs and technology. In the twenty-first century, innovations are disrupting society with 
unconventional rules. This thesis investigated how emerging technologies and global megatrends might 
converge to affect the future of United States drug policy. Through a scenarios-based future studies 
methodology, global megatrends and other nascent variables intertwine in two fictional scenarios to 
highlight regulatory and ethical challenges. Thesis findings underscore how it is critical for the United 
States to remain adaptable and identify general long-term, cyclical forces. Subsequently, it is imperative to 
analyze how these forces might influence the environment of illicit drug use before current regulatory drug 
frameworks become obsolete. Thesis findings recommend that the U.S. government decriminalize illicit 
drugs and transition drug policy from the domain of law enforcement to a strengthened public and 
behavioral healthcare system. Finally, this thesis also recommends the creation of a national biotech ethics 
committee and an office of the future.  
14. SUBJECT TERMS
futures, megatrends, emerging technologies, drug policy, public health, war on drugs, 
forecasting, behavioral health, scenarios, trends, innovation, regulation, policy, artificial 
intelligence, brain-computer interface, neural stimulation, nootropics, marijuana, digital 
currency, synthetic drugs, globalization, urbanization, Internet of things, hyper-connected 




















NSN 7540–01-280-5500 Standard form 298 (Rev. 2–89)  
Prescribed by ANSI Std. 239–18 
 ii
THIS PAGE INTENTIONALLY LEFT BLANK 
  
iii
Approved for public release. Distribution is unlimited. 
NEW HIGH: A FUTURE-ORIENTED STUDY OF AMERICAN DRUG POLICY 
Jessica Marie Bress 
Policy Advisor, District of Columbia Department of Behavioral Health, Washington, DC 
B.A., College of the Holy Cross, 2009 
M.P.H., George Washington University, 2013 
Submitted in partial fulfillment of the 
requirements for the degree of 
MASTER OF ARTS IN SECURITY STUDIES 
(HOMELAND SECURITY AND DEFENSE) 
from the 
NAVAL POSTGRADUATE SCHOOL 
December 2017 
Approved by: Rodrigo Nieto-Gómez 
Thesis Advisor 
Glen Woodbury 
Second Reader  
Erik Dahl 
Associate Chair for Instruction  
Department of National Security Affairs 
 iv




Drug policy in the United States is reactive and unprepared for burgeoning 
phenomena related to the convergence of drugs and technology. In the twenty-first 
century, innovations are disrupting society with unconventional rules. This thesis 
investigated how emerging technologies and global megatrends might converge to affect 
the future of United States drug policy. Through a scenarios-based future studies 
methodology, global megatrends and other nascent variables intertwine in two fictional 
scenarios to highlight regulatory and ethical challenges. Thesis findings underscore how 
it is critical for the United States to remain adaptable and identify general long-term, 
cyclical forces. Subsequently, it is imperative to analyze how these forces might 
influence the environment of illicit drug use before current regulatory drug frameworks 
become obsolete. Thesis findings recommend that the U.S. government decriminalize 
illicit drugs and transition drug policy from the domain of law enforcement to a 
strengthened public and behavioral healthcare system. Finally, this thesis also 
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The United States’ war on drugs has become a war of innovation, as criminals 
adapt new technologies faster than the government can regulate them.1 Evaluative 
analysis of research and literature regarding the U.S. war on drugs indicates that the war 
is a systemic public policy failure.2 The problem with losing the war on drugs is twofold. 
First, the United States has an ineffective drug policy that is not evidence-based, thus 
producing harmful consequences rather than real benefit to Americans.3 The second 
problem is that it makes U.S. drug policy reactive and unprepared for emerging trends 
shaping the landscape of illicit drugs.  
Disruptive technologies ignore conventional societal rules.4 The history of illicit 
drug use in the United States is one of resilient adaptation and deviant innovation. A 
burgeoning technological revolution may change the landscape of the current policy 
environment with the introduction of such emerging technologies as embodied 
intelligence augmentation, synthetic biology, unmanned aerial vehicles, and the ability to 
use 3D printers to create new drugs. The literature on emergent trends and forces is rife 
with anticipation about how accelerating technological innovation could affect illicit 
criminal enterprises. It is critical that the United States identify long-term, cyclical forces, 
and analyze how these forces might influence the environment of illicit drug use in the 
country. 
This thesis answers the question how might emerging technologies and global 
megatrends converge to affect the future of United States drug policy? Society often 
portrays drug policy reform through a false dichotomy: prohibition or full legalization.  
 
———————————— 
1 Marc Goodman, Future Crimes (New York: Anchor Books, 2016), 429. 
2 Dan Baum, Smoke and Mirrors: The War on Drugs and the Politics of Failure (Boston, MA: Little, 
Brown and Company, 1996), vii. 
3 Fiona Godlee and Richard Hurley, “The War on Drugs Has Failed: Doctors Should Lead Calls for 
Drug Policy Reform,” BMJ 355 (November 2016): 1, doi: https://doi.org/10.1136/bmj.i6067.  
4 Clayton M. Christensen, The Innovator’s Dilemma: When New Technologies Cause Great Firms to 
Fail (Boston, MA: Harvard Business Review Press, 2013), 98. 
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Between these two policy extremes, it is possible to envision alternative and preferred 
futures. New technologies warrant changing behavioral norms and cultural values. If U.S. 
drug policy is not adaptable, emerging technologies could ultimately make the ability to 
regulate illicit drugs obsolete due to digital convergence.  
To capture the most relevant uncertainties and driving forces related to the 
landscape of illicit drug use, this thesis uses a future studies methodology. This 
methodology facilitates the exploration of present trends and potential systemic 
interconnections to identify forces that may influence the future. Occurring at the 
intersection of many trends, megatrends are large, transformative global forces in societal 
development expected to affect the probable future.5 The megatrends driving this thesis 
include globalization, urbanization, Internet of things/hyper-connected society, and 
exponential technological growth.  
This research uses a three-point Likert scale to classify emergent variables into 
three categories: likely (marijuana legalization, synthetic drugs), possible (nootropics, 
digital currency), and radical (artificial intelligence and brain-computer interfaces/neural 
stimulation). Combining megatrends with these emergent variables categories, two 
fictional scenarios underscore the challenges in defining a drug, governing its use, and 
incorporating ethical considerations into regulatory frameworks. The utility of scenarios 
is in their ability to highlight irreducible uncertainty and draw attention to the notion that 
the future is not predetermined.   
The future may not emerge as a linear extrapolation of the present. Findings from 
each scenario underscore a challenge for how society decides to define a “drug.” 
Furthermore, each scenario highlights the difficulty in regulating emergent forms of drug 
use, as well as potential ethical issues resulting from these nascent technologies. The 
United States needs a new social framework to incorporate rapidly growing technological 
innovations to change and modernize its drug policy. 
———————————— 
5 Sue L. T. McGregor, “A Look Inside Creating Home Economics Futures: The Next 100 Years,” 
International Journal of Home Economics 7, no. 1 (2014): 2. 
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The fictional thesis scenarios highlight countless interdiction challenges as the 
Internet has revolutionized an already lucrative transnational drug trade in a landscape of 
increasing global connectedness. Analysis of the fictional scenarios concludes that 
1) people use drugs, 2) innovation is outpacing drug policy, and 3) the United States must 
rethink its approach to drug policy. The country is living through an era of exponential 
technological growth. The speed at which neoteric technologies emerge is unprecedented 
and beyond the ability of regulators to govern under current policy frameworks.  
This research concludes that a national drug policy should reflect a deliberate 
system of doctrines leading to the intended outcome of reducing morbidity and mortality 
caused by drug use. To create a resilient, adaptable drug policy prepared for the future, 
the United States should decriminalize all drug use and move drug policy from the realm 
of law enforcement to public health. The federal government should also create an office 
of the future, as well as a national biotech ethics committee and strategy. Finally, a drug 
policy framework for the twenty-first century should actively promote expanded access 
to public and behavioral healthcare.  
 
 xviii
THIS PAGE INTENTIONALLY LEFT BLANK 
xix
ACKNOWLEDGMENTS 
I want to thank my fiancée, Sophia Tripoli, for endlessly supporting my 
participation in this program for the past 21 months. Your Greek food, tough love, and 
ability to help me use words to articulate concepts in my head were indispensable. Thank 
you to Deputy Fire Chief Rafael Sa’adah for seeing my potential and recommending that 
I consider this program. I am especially grateful to Chris Bellavita, whose intellectual 
sparkle and ability to question everything is unmatched. Thank you for handling my crisis 
of perception and convincing me that I belong in this program.  
For months, my thesis scenarios floated in perpetual beta. I am ever grateful to 
my outstandingly brilliant thesis advisor, Rodrigo Nieto-Gómez, for pushing my 
writing ability and patiently responding to my constant barrage of Slack messages. I 
also want to thank my second reader, Glen Woodbury, for providing unhesitating 
thumbs up and support for my nontraditional thesis. You both gave me the academic 
freedom to think the unthinkable with innovative urgency.  
I want to express sincere appreciation to the Center for Homeland Defense and 
Security at the Naval Postgraduate School for selecting me to participate in this rigorous 
program. It was unexpectedly challenging and subsequently rewarding. I am now highly 
cognizant of my own biases, heuristics, and frames. I continue to be humbled by my 
phenomenal classmates in Cohorts 1601 and 1602; thank you all for your contributions to 
the safety, security, and resilience of this country. I will miss our colorful debates at the 
Trident Room and our catawampus, elastic vernacular.  
Family is everything. My grandparents, Jerry and Lorraine Kienlen, teach by 
example with integrity, drive, and leadership. Jenny, Andrea, and Kat: I am so fortunate 
to have three sisters who share my unrelenting passion for social justice. Thank you for 
your foxy eclecticism. Last in order but first in scale, I am grateful for my parents, 
Douglas and Karla Bress, for all of the sacrifices they made for me over the past 30 years. 
They continue to instill the importance of family, education, and public service.  
 xx




After forty years, thousands killed, millions imprisoned, and $1 trillion 
spent…we are still no closer to controlling either the supply—or 
demand—side of the illicit drug trade.1 
A. RESEARCH QUESTION 
This thesis answers the question, “How might emerging technologies and global 
megatrends converge to affect the future of United States drug policy?”  
B. PROBLEM STATEMENT 
Conformity to old ideas is lethal; it is rebellion that is going to change the 
planet.2 
The United States has lost the war on drugs. Neuropsychopharmacologist Dr. 
David Nutt summarizes this claim with his assertion, “Anything that tries to measure or 
evaluate the success of the war on drugs inevitably finds that it has failed, so evaluation 
and measurement are either suppressed or not carried out in the first place.”3 Since 
President Richard Nixon infamously declared drug abuse “public enemy number one” in 
1971, the United States continues to spend billions of dollars on the war.4 Across the 
world, oil is the only industry larger than the illicit drug trade.5 Analysis of the efficacy 
of the war on drugs consistently concludes that the herculean effort is a failure, as 
outlined in Figure 1.6 According to Dr. Nutt, policies concentrated on decreasing the 
prevalence of illicit drug use are ineffective and “often cause more harm than good.”7 
This is a policy problem.  
                                                 
1 David Nutt, Drugs Without the Hot Air (Cambridge, England: UIT Cambridge Ltd., 2012), 280.  
2 Joshua Cooper Ramo, The Age of the Unthinkable: Why the New World Disorder Constantly 
Surprises Us and What We Can Do about It (New York: Little, Brown and Company, 2009), 262.  
3 Nutt, Drugs without the Hot Air, 273.  
4 Evan Wood et al., “The War on Drugs: A Devastating Public-Policy Disaster,” The Lancet 373, no. 
9668 (2009): 989, doi: 10.1016/S0140-6736(09)60455-4.  
5 Nutt, Drugs without Hot Air, 276. 
6 Dan Baum, Smoke and Mirrors: The War on Drugs and the Politics of Failure (Boston, MA: Little, 
Brown and Company, 1996), vii.  
7 Ibid., 22.  
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Figure 1.  Perverse Effects Caused by the War on Drugs8 
Dr. Nutt, former chair of the Advisory Council on the Misuse of Drugs, 
outlines eight negative repercussions caused by the war on drugs: 
1. Increasing the spread of infectious disease.
2. Causing terminally ill people to die in agony.
3. Increasing instability and unaccountability in financial systems.
4. Holding back research on new medicines.
5. Increasing levels of drug-related violence and crime.
6. Increasing the number of users by forcing them to become dealers.
7. Bringing the law into dispute; allowing discriminatory policing.
8. Diverting attention away from the dangers of alcohol and tobacco.
For decades, illicit drug use is causing rising morbidity and mortality across the 
United States.9 According to the Substance Abuse and Mental Health Services 
Administration, in 2014, over 10 percent of Americans had used illicit drugs within the 
past month of the survey.10 With over 27 million citizens admitting to using illicit drugs 
within the past month in 2014, the incidence of misuse of alcohol, tobacco, marijuana, 
prescription drugs, and other substances continues to rise. This trend is not new; research 
examining rates of lifetime substance use disorder indicate a national increase among 
adults from 10.3 percent in 2002 to 15.6 percent in 2013.11 Additionally, the Centers for 
Disease Control and Prevention report that over 47 thousand citizens died from drug 
overdoses in 2014, indicating more than a doubling of the rate from 2000.12 According to 
8 Ibid., 274.  
9 Christopher S. Carpenter, Chandler B. McClellan, and Daniel I. Rees, “Economic Conditions, Illicit 
Drug Use, and Substance Use Disorders in the United States,” Journal of Health Economics 52 (March 
2017): 63, doi: 10.1016/j.jhealeco.2016.12.009. 63–73.  
10 Sarra L. Hedden et al., Behavioral Health Trends in the United States: Results from the 2014 
National Survey on Drug Use and Health (U.S. Health and Human Services Publication No. SMA 15-
4927) Rockville, MD: Center for Behavioral Health Statistics and Quality, 2015, 
https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf.  
11 Bridget F. Grant et al, “Epidemiology of DSM-5 Drug Use Disorder: Results from the National 
Epidemiologic Survey on Alcohol and Related Conditions–III,” JAMA Psychiatry 73, no. 1 (2016): 40, doi: 
10.1001/jamapsychiatry.2015.2132.  
12 “Drug Overdose Deaths Hit Record Numbers in 2014,” press release, Centers for Disease Control 
and Prevention, December 18, 2015, https://www.cdc.gov/media/releases/2015/p1218-drug-overdose.html.  
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the U.S. Government Accountability Office in 2017, illicit drug overdose is now the 
leading cause of death by injury in the United States.13  
Illicit drug use is a homeland security problem. In 2007, the Department of 
Justice’s National Drug Intelligence Center estimated that illicit drug use costs the United 
States over $193 billion dollars per year.14 In fiscal year 2016, the U.S. government spent 
$30.6 billion on drug control alone.15 Aside from the staggering economic impact, the 
high prevalence of illicit drug use affects other domains tangential to the homeland 
security enterprise. For example, according to the U.S. Government Accountability 
Office in 2016–2017, evidence demonstrates high rates of drug abuse among veterans.16 
The Federal Bureau of Prisons claims that approximately half of the federal prison 
population is serving sentences for crimes related to drugs.17 Similarly, the U.S. Drug 
Enforcement Administration (DEA) spends considerable resources tracking more than 
33,000 domestic gangs involved in drug trafficking and distribution.18 The threat posed 
by illicit drug use is transnational.  
The problem with losing the war on drugs is twofold. First, the United States has 
an ineffective drug policy that is not evidence-based, thus producing no real benefit to 
Americans.19 The second problem is that it makes U.S. drug policy reactive and 
unprepared for emerging trends shaping the landscape of illicit drugs. This is important 
                                                 
13 “Illicit Drug Use,” U.S. Government Accountability Office, accessed June 4, 2017, 
https://www.gao.gov/key_issues/illicit_drug_use/issue_summary.  
14 Economic impact cost estimate includes fiscal impact of healthcare, crime, and lost productivity; 
Sam Taxy, Julie Samuels, and William Adams, Drug Offenders in Federal Prison: Estimates of 
Characteristics Based on Linked Data (NCJ 248648) (Washington, DC: U.S. Department of Justice, 
Bureau of Justice Statistics, 2015).  
15 Statement of Diana C. Maurer, Office of National Drug Control Policy: Progress toward Some 
National Drug Control Strategy Goals, but None Have Been Fully Achieved (GAO-16-660T) (Washington, 
DC: U.S. Government Accountability Office, 2016), http://www.gao.gov/assets/680/677235.pdf, 1.  
16 “Illicit Drug Use,” U.S. Government Accountability Office.  
17 Ibid.  
18 Mary Ellis, “Street Gangs: A National Security Threat,” The Journal of Law Enforcement 5, no. 2 
(2016): 1, 2.  
19 Fiona Godlee and Richard Hurley, “The War on Drugs Has Failed: Doctors Should Lead Calls for 
Drug Policy Reform,” BMJ 355 (November 2016): 1, doi: https://doi.org/10.1136/bmj.i6067.  
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because trends may emerge as a string of random unconnected dots on the fringe that 
eventually materialize into the mainstream.20 
Since 1970, the Controlled Substances Act (CSA) has governed U.S. drug policy. 
The act established a federal drug policy regarding the manufacture, importation, 
possession, use, and distribution of certain substances falling under five schedules in 
accordance with such criteria as potential for abuse and currently accepted medical use.21 
In this categorization, schedule I drugs are the most highly regulated while Schedule V 
drugs are considered the least dangerous are less regulated. Schedule I drugs have a high 
potential for abuse, no currently accepted medical value, and a lack of accepted safety for 
use of the drug.22 Examples of drugs in this category include heroin, ecstasy, and 
marijuana.23 
A snapshot of marijuana use in America today provides evidence of how the war 
on drugs is failing to keep pace with a societal shift for legal access to the drug. While 
marijuana remains federally illegal as of 2017, 29 states and the District of Columbia 
have approved the use of marijuana for medicinal purposes. Further ignoring federal law, 
nine states and the District of Columbia have approved legislation for the legal 
recreational use of marijuana.24 
Critics claim that politics—rather than evidence—formed the basis for the 
decision to classify cannabis as a schedule one drug.25 To support their point, they point 
to research studies highlighting the medicinal benefits of using marijuana for treating a 
number of conditions including glaucoma, seizure disorders, chronic pain, muscle and 
                                                 
20 Amy Webb, The Signals Are Talking: Why Today’s Fringe is Tomorrow’s Mainstream (New York: 
Public Affairs, 2016), 48.  
21 Controlled Substances Act, 21 C.F.R. §812 (1970). 
22 David J. Nutt, Leslie A. King, and David E. Nichols, “Effects of Schedule I Drug Laws on 
Neuroscience Research and Treatment Innovation,” Nature Reviews 14, no. 8 (2013): 577.  
23 Controlled Substances Act, 21 C.F.R. §812 (1970).  
24 The following jurisdictions have legalized the recreational use of marijuana: Alaska, California, 
Colorado, District of Columbia, Maine, Massachusetts, Nevada, Oregon, and Washington. NORML, 
“Legalization,” accessed February 4, 2017, http://norml.org/legal/legalization.  
25 Stanley J. Watson, John A. Benson, and Janet E. Joy, “Marijuana and Medicine: Assessing the 
Science Base: A Summary of the 1999 Institute of Medicine Report,” Archives of General Psychiatry57, 
no. 6 (2000): 547–552.  
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spasticity as well as helping patients with nausea due to chemotherapy.26 To critics of the 
war on drugs, it appears incongruent to declare marijuana as more hazardous than 
cocaine, oxycodone, or methamphetamine—all of which fall into a lower Schedule II 
classification. This juxtaposition indicates the politicization of the scheduling of 
controlled substances. Furthermore, it highlights how conflicting information undermines 
public confidence as individuals look beyond government documents for sources of 
information.27 
In contrast to findings in evidence-based and peer-reviewed literature, the United 
States continues to push forward with ineffective supply reduction strategies. According 
to the Office of National Drug Control Policy, domestic supply reduction measures 
include regulation, enforcing anti-drug laws, eradicating marijuana plants, controlling the 
supply of precursor chemicals, screening prisons for drugs, creating drug-free school 
zones, and the implementation of screening procedures at customs.28 Internationally, 
supply reduction strategies include global accords, initiatives to prevent money 
laundering, drug-crop eradication, controlling precursor chemicals, and other means. As a 
strategy, supply reduction is not working.29 
1. A War of Innovation 
The war on drugs has become a war of innovation, as criminals adapt new 
technologies faster than the government can regulate them.30 Illicit use of the Internet’s 
dark web provides an example of deviant innovation. In 2017, illicit drugs are available 
                                                 
26 Kevin P. Hill, “Medical Marijuana for Treatment of Chronic Pain and Other Medical and 
Psychiatric Problems: A Clinical Review,” Journal of the American Medical Association 313, no. 24 
(2015): 2474–2483.  
27 Nutt, Drugs without the Hot Air, 31. 
28 “IV. A Comprehensive Approach,” Office of the National Drug Control Policy, accessed February 
22, 2017, https://www.ncjrs.gov/ondcppubs/publications/policy/99ndcs/iv-g.html.  
29 U.S.-Mexico border expert, Dr. Tony Payan, summarizes the failure of supply reduction strategies: 
“A frontal attack on a particular group providing an illegalized good may reduce the supply temporarily, 
but the demand does not go away and the supply is fairly elastic. Thus drug traffickers simply shift 
strategies to continue supplying drugs.” Tony Payan, The Three US-Mexico Border Wars: Drugs, 
Immigration, and Homeland Security: 2nd ed. (Santa Barbara, CA: ABC-CLIO, 2016), 33–34.  
30 Marc Goodman, Future Crimes (New York: Anchor Books, 2016), 429.  
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for purchase online using technologies, like bitcoin and Tor, which make sales and 
purchases nearly impossible to track.31 
The presence of pharmaceutical drugs continues to challenge federal, state, and 
local efforts to prevent illicit drug use. For instance, after federal and state governments 
strictly regulated abuse of prescription painkillers, the United States has developed an 
opioid epidemic.32 The epidemic has claimed the lives of more than 33,000 Americans 
due to overdose in 2015 alone, as people substituted prescription opioids with heroin and 
other opiates like the drug fentanyl.33 In 2017, pharmaceutical companies continue to 
produce more performance-enhancing drugs with strong, legal, direct-to-consumer 
marketing.34  
Despite popular perception, illicit drug use extends beyond the realm of criminals 
and lower income populations. The World Chess Federation reports that players often test 
positive for the use of modafinil and Ritalin to enhance performance during chess 
matches.35 Likewise, college students colloquially refer to Adderall, a drug frequently 
used to treat attention deficit hyperactivity disorder, as “Ivy league crack.”36 These 
“smart drugs” positively augment cognitive function, and researchers anticipate the 
development of even more effective compounds in the future.37 Given their legal 
pharmaceutical status, current drug prohibition efforts make controlling illicit use a 
                                                 
31 James Martin, “Lost on the Silk Road: Online Drug Distribution and the ‘Cryptomarket,’” 
Criminology and Criminal Justice 14, no. 3 (2014): 351–367.  
32 Robert L. DuPont et al., “Are Prescription Opioids Creating a New Type of Heroin User?” Journal 
of Global Drug Policy and Practice 11, no. 1 (2017): 18–24.  
33 Donald S. Burke, “Forecasting the Opioid Epidemic,” Science 354, no. 6312 (2016): 529, doi: 
10.1126/science.aal2943.  
34 Henry Greely et al., “Towards Responsible Use of Cognitive-Enhancing Drugs by the Healthy,” 
Nature 456, no. 7223 (2008): 702–705.  
35 Andreas G. Franke et al., “Methylphenidate, Modafinil, and Caffeine for Cognitive Enhancement in 
Chess: A Double-Blind, Randomised Controlled Trial,” European Neuropsychopharmacology 27, no. 3 
(2017): 248–260.  
36 “The Drug Adderall, Also Known as ‘Ivy League Crack,’ Is Not What It’s Cracked Up to Be,” Wet 
Bin, December 10, 2017, https://wetbin.com/the-drug-adderall-also-known-as-ivy-league-crack-is-not-
what-its-cracked-up-to-be/.  
37 Vince Cakic, “Smart Drugs for Cognitive Enhancement: Ethical and Pragmatic Considerations in 
the Era of Cosmetic Neurology,” Journal of Medical Ethics 35, no. 10 (2009): 611–615.  
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daunting challenge that will only become more difficult as new pharmaceutical drugs 
enter the market. 
A burgeoning technological revolution may change the landscape of the current 
policy environment with the introduction of such emerging technologies as embodied 
intelligence augmentation, synthetic biology, unmanned aerial vehicles, and the ability to 
use 3D printers to create new drugs. It is critical that the United States identify long-term, 
cyclical forces, and analyze how these forces might influence the environment of illicit 
drug use in the country. 
2. Future Scenarios for Drug Policy Reform  
This thesis operates under the premise that the war on drugs is a policy failure. A 
significant amount of literature on drug policy deliberates the ideological and moral 
foundation of certain drug laws. Other discourse focuses on the manipulation of drug 
policy for political convenience.38 While this examination of drug policy is 
indispensable, there is a current knowledge gap regarding how emerging technology and 
global megatrends could influence the future of U.S. drug policy. New technologies 
warrant changing behavioral norms and cultural values. They also facilitate a 
confrontation of established beliefs based on outdated technology. At the core of social 
change are new technologies innovatively disrupting society with unconventional rules. If 
U.S. drug policy is not adaptable, emerging technologies could ultimately make the 
ability to regulate illicit drugs obsolete.  
Forecasting visions of potential future drug use form the foundation for present 
action pertaining to policy.39 Solutions proposed in literature on the war on drugs 
typically call for drug policy reform. For instance, the Global Commission on Drug 
Policy concluded that society must transform the international prohibitionist approach to 
illicit drugs with the creation of a policy regime grounded in science, health, and human 
                                                 
38 13th, directed by Ava DuVernay (Netflix, 2016), DVD.  
39 James Allen Dator, Advancing Futures: Future Studies in Higher Education (West Port, CT: 
Greenwood Publishing Group, 2002), 8.  
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rights.40 Society often portrays drug policy reform through a false dichotomy: prohibition 
or full legalization. Between these two policy extremes, it is possible to envision, 
identify, and invent alternative and corresponding preferred futures.41 
Using future studies research methodology, this thesis aims to explore present 
technological trends, global megatrends, and potential systemic interconnections to 
identify how these forces may influence the future of U.S. drug policy. The intersection 
of multiple forces shape important effects; scenarios aim to capture relevant uncertainties 
and driving factors to highlight different plausible futures.  
C. LITERATURE REVIEW 
There is no reason for any individual to have a computer in their home. 
—Ken Olsen, Founder of Digital Equipment Corporation, 197742 
1. Futures and Megatrends 
Reality is infinitely complex, and humans have a compulsive explanatory urge to 
interpret and understand personal experiences.43 The future is both predictable and 
unpredictable, although these categories are not mutually exclusive. According to futurist 
Amy Webb, a trend is “a new manifestation of sustained change within an industry, the 
public sector, or society, or in a way that we behave toward one another.”44 Trends do not 
occur in a vacuum; compounding acceleration from changes in emergent technology 
influences how trends move from the fringe to the mainstream.45 
                                                 
40 Global Commission on Drug Policy, War on Drugs: Report of the Global Commission on Drug 
Policy (Geneva: Global Commission on Drug Policy, 2011).  
41 Jim Dator, What Futures Studies Is, and Is Not (Honolulu: University of Hawaii, 2007), 
www.futures.hawaii.edu/publications/futures-studies/WhatFSis1995.pdf.  
42 Niels Pinkwart, “Another 25 Years of AIED? Challenges and Opportunities for Intelligent 
Educational Technologies of the Future,” International Journal of Artificial Intelligence in Education 26, 
no. 2 (2016): 771–783.  
43 Philip E. Tetlock and Dan Gardner, Superforecasting: The Art and Science of Prediction (New 
York: Broadway Books, 2015), 37. 
44 Webb, The Signals Are Talking, 47.  
45 Ibid., 57.  
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Occurring at the intersection of many trends, megatrends are large, transformative 
global forces in societal development expected to affect the probable future.46 Occurring 
in the present, megatrends indicate a world in motion.47 To forecast and envision 
plausible futures, it is important to first identify and investigate these long-term forces. 
Subsequently, understanding the interaction between overlapping trends is equally 
important. Seeking answers to epistemic uncertainty, megatrends research comprises 
broad trend analysis research, which evaluates social, economic, and political conditions 
forecast to change the environment in the near future. This research methodology does 
not present deterministic, succinct narratives of the future. Rather, megatrends research 
describes probable futures, recognizing that there are many possible futures. Moreover, 
there is always the chance of an unlikely wildcard event, such as 9/11, that can create 
counter-forces to established trends. For example, State Secretary Joergen Ørstrøm 
Møeller in the Danish Ministry of Foreign Affairs argues that the United Kingdom’s 
2016 decision to succeed from the European Union was partially due to a backlash 
against globalization.48  
Literature on megatrends research primarily comprises reports, scholarly articles, 
books, and systematic reviews. In dealing with probable, possible, and preferred futures, 
the tone of existing literature varies on a spectrum from optimistic to pessimistic. Many 
articles have a tone of peril, warning readers of the threats of what could happen if 
society fails to act. Other articles focus on the potential of technological developments 
promising to improve the human condition. Reports differ based on the intended target 
audience. For instance, some research is specific to manufacturing industries. Other 
research is jurisdiction-specific, such as CSIRO Futures research, which focuses on how 
                                                 
46 Sue L. T. McGregor, “A Look Inside Creating Home Economics Futures: The Next 100 Years,” 
International Journal of Home Economics 7, no. 1 (2014): 67.  
47 EY, Megatrends 2015: Making Sense of a World in Motion, EY, 2015, http://www.ey.com/ 
Publication/vwLUAssets/ey-megatrends-report-2015/$FILE/ey-megatrends-report-2015.pdf.  
48 Joergen Oerstroem Moeller, “Trump and Brexit: Some Lessons for Southeast Asia,” ISEAS 
Perspective 2017, no. 11 (2017): 1–6.  
 10
global trends will affect Australia explicitly.49 Timeframes of megatrends literature 
generally remain within a 10–20 year time span. For instance, some reports contain 10-
year projections, while other sources focus on megatrends expected to affect the next 15–
20 years.  
Researchers identify megatrends with a fair degree of consistency. Given labels 
for megatrends are variable, but many of the chosen classification schemes nonetheless 
appear to fall into the same category. For example, a megatrend focused on an increasing 
influence of technology is described across the literature with such diverse titles as 
“technological convergence,” “technological breakthrough,” “technological singularity,” 
and “disruptive technology.” Some publications also identify megatrends that are outliers, 
such as “multipolar geopolitics,” which stand unique when contrasted with most other 
research in the field. Each source of information on megatrends varies in the number of 
identified megatrends, although most sources identified for this literature review 
comprised, on average, six to 10 distinct trends. 
Despite variance in labeling and identification, common themes emerge across the 
literature on megatrends, which allows for the aggregation of perspectives. Globalization 
is taking place, and it is strongly expected to increase in the future.50 The world economy 
is shifting west to east, with an anticipated surge in middle class growth and increasing 
urbanization.51 Megatrends research forecasts demographic change as the world faces an 
aging population, increased discretionary spending power, class ascendancy, 
individualism, and surging opportunities for entrepreneurialism. Megatrends researchers 
anticipate exponential growth and a hyper-connected, digital world of prosperity, 
complexity, and acceleration wherein data is the raw material of the information age.52 
                                                 
49 Stefan Hajkowicz, Hannah Cook, and Anna Littleboy, Our Future World: Global Megatrends that 
Will Change the Way We Live. The 2012 Revision (Brisbane, Australia: CSIRO, 2012), doi: 
https://doi.org/10.4225/08/584ee9706689b.  
50 Claire Kramsch, “Teaching Foreign Languages in an Era of Globalization: Introduction,” The 
Modern Language Journal 98, no. 1 (2014): 296–311.  
51 Stefan Hajkowicz, Global Megatrends: Seven Patterns of Change Shaping Our Future (Brisbane, 
Australia: CSIRO Publishing, 2015), 7.  
52 Alec Ross, The Industries of the Future (New York: Simon and Schuster Paperbacks, 2016), 182.  
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Interpretations of established megatrends vary. For example, there is a consensus 
that digital connectedness is leading to a change in social behaviors, but there is no clear 
agreement about how to elucidate this shift. Viewing this shift as positive or negative 
depends on the author’s interpretation, as some reports focus on how people are moving 
away from corporations and toward the individual, while other reports focus on how 
digital connectedness is leading to an increased demand for personalized services and 
experiences. Evaluation of any trend can be portrayed in either a positive or a negative 
light. As concluded by research on megatrends, the most important factor is that society 
remains open and adaptable rather than working to oppose the force of change.53 This 
requires an intellectual flexibility to reconcile probable futures with irreducible 
uncertainty. 
Even with an abundance of research on megatrends, flaws and gaps in the 
literature remain. Forecasting methods often lack objective, scientific monitoring or 
evaluation to determine the accuracy of predictions. Methodologies across studies also 
differ as researchers use a wide range of techniques, including predictive modeling, 
foresight studies, scenarios, and analysis of trends databases. From these varied 
techniques, it is unclear how researchers rank the significance of megatrends in their 
analysis. This leads to inconsistent results, as some studies list urbanization, for example, 
as one of the top three megatrends likely to influence the future, while other authors rate 
urbanization lower on the list.54 Literature on megatrends research appear to maintain a 
high degree of internal validity, though the accuracy of claims made in conclusions 
remain unknown for years. Additionally, megatrends research leaves certain areas 
unexplored. For instance, even if the megatrends occur as forecasted, it is unknown how 
societies will react to the forces. Moreover, it is unknown how these broad global 
megatrends may affect specific fields like drug policy. 
                                                 
53 Richard Dobbs, James Manyika, and Jonathan Woetzel, No Ordinary Disruption: The Four Global 
Forces Breaking All the Trends (New York: Public Affairs, 2015), 174.  
54 Urbanization is listed as the number one megatrend likely to affect the future: Sarwant Singh, “Top 
20 Global Megatrends and their Impact on Business, Cultures and Society,” Frost & Sullivan, March 10, 
2014. In this source, published the same year, urbanization is only listed at number four: Matthew Burrows, 
The Future, Declassified: Megatrends That Will Undo the World Unless We Take Action (New York: 
Palgrave Macmillan, 2014), 89.  
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2. Trends and Forces Shaping the War on Drugs 
In the same way that megatrends are transforming the global landscape, smaller 
trends are shaping the United States’ war on drugs. As of 2017, social attitudes favor 
deregulation and call for reform of drug policy at the national level. Aside from this shift 
in social perception, as previously stated the United States is in the heart of an opiate 
epidemic claiming the lives of tens of thousands of Americans due to overdose.55 
Upcoming trends are visibly influencing the illicit drug ecosystem in ways that should 
not be surprising. This review focuses on the literature surrounding the forces shaping the 
war on drugs to inform an analysis to forecast future trajectories using currently available 
information. 
Literature pertaining to drug policy and shifting dynamics comprises books, 
documentaries, studies, and peer-reviewed publications. Abundant news media and 
material supplied by advocacy organizations aim to reform U.S. drug policy.56 Heavy 
bias plagues the majority of non-academic literature, typically calling for specific actions 
such as the recreational legalization of drugs. In writing for the purposes of achieving an 
agenda, these publications have a tendency to emphasize specific aspects of reform rather 
than taking an objective, wide-lens perspective to analyze critically how larger forces 
may be influencing the drug policy environment.  
The most salient resources for understanding the trends affecting the current 
landscape of illicit drugs come from the application of trend analysis research. Four 
trends emerge from this literature review research: 1) criminals are early adopters of 
technology; 2) the creation of drugs outside of the law; 3) emerging technologies beyond 
the horizon; and 4) a shift in drug trafficking from land to air and sea. 
Criminals and cartels are perpetual early adopters of new technologies and use 
them to their advantage, often before the government agencies prosecuting them do.57 
This is not a new trend. For instance, drug dealers adopted pagers before police officers, 
                                                 
55 Burke, “Forecasting the Opioid Epidemic,” 529. 
56 NORML, “Legalization.”  
57 Goodman, Future Crimes, 223.  
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and they use Square technology to sell drugs in cities like San Francisco.58 Literature on 
drug cartels support the notion that this trend is continuing, and there is evidence that 
cartels use their own encrypted cellular radio telecommunications systems and divert 
significant resources to focus on cyberspace research.59 At a time when the United States 
government is using Palantir to track drug cartels, narcotics organizations are already 
using social media to assemble their own intelligence on law enforcement.60 Drug 
traffickers have exploited the digital underground through Tor, a software allowing for 
anonymous communication.61 As law enforcement continually attempts to keep up with 
drug dealing organizations, they have already implemented broad sophisticated 
counterintelligence operations.62 
A second trend appearing throughout the literature is a growing challenge to stay 
abreast of interdiction. There is a growing presence of drugs existing outside of the law as 
it is currently written. The format of the Internet scrambles the ties of drug trafficking 
organizations to geography as dealers are turning to the dark web on sites, such as the 
now shut down Silk Road to sell illegal items.63 Moreover, the creation of new synthetic 
drugs such as “Spice,” “K2,” and “Scooby Snax” appear on the streets faster than they 
can be added to the CSA, the statute establishing federal drug policy.64 
While dark web drug sales and unclassified synthetic drugs fall into the realm of 
illicit drug use, literature on the field of drug policy also covers an emerging field of legal 
smart drugs for cognitive enhancement. Also called “nootropics,” these pharmaceutical 
compounds aim to augment cognitive function positively in areas such as focus, memory, 
                                                 
58 Michael Arrington, “Square: The Perfect Solution for Tricky Drug and Prostitution Transactions,” 
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59 Goodman, Future Crimes, 2.  
60 Ross, Industries of the Future, 173.  
61 Goodman, Future Crimes, 245–246.  
62 Ibid., 127.  
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creativity, and/or motivation.65 Peer-reviewed articles on this subject often equivocate 
over the ethical and pragmatic implications for the use of smart drugs. Researchers 
anticipate the future development of more of these types of compounds and predict that 
future formulations will be even more effective.66 Researchers also debate the practicality 
of prohibition and relate the use of nootropics to using drugs for performance 
enhancement in sports. Literature on nootropics has not arrived at a consensus on the 
intrinsic ethics of using pharmacological substances to enhance mental function.  
The third element across the literature on trends affecting drug policy focuses on 
the potential misuse of such emerging technologies as synthetic biology, 3D printing, 
robots, and artificial intelligence (AI). Synthetic biology, also known as “synbio,” has the 
potential to disrupt drug trafficking as it creates economic incentives to engineer new 
pathways of producing illicit drugs without having to cultivate fields of real plants.67 
Already, researchers have genetically engineered THC from E. Coli bacteria and turned 
baking yeast into lysergic acid diethylamide (LSD) and opium.68 The potential radical 
disruption of synbio may cancel the mediating role of existing players in the narcotics 
trade. This same set of issues related to supply chain simplification applies to the 
potential misuse of 3D printing as devices can be hacked to produce illicit drugs instead 
of the intended pharmaceutical compounds. Concern over the potential misuse of 
emerging technologies also extends to robots and AI. Literature on these subjects 
discusses the use of robots for surveillance and the ability to kill law enforcement officers 
or rival drug gang members.69 Likewise, the cognitive abilities of AI present potential for 
the role of developing or selling drugs. 
Finally, the fourth trend across the literature indicates that narcotraffickers are 
shifting distribution tactics from ground to air and sea. Researchers tracking drug 
trafficking illustrate the trajectory of the emerging use of drones and unmanned 
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submarine technologies.70 Narcosyndicates in Latin America and Mexico are already 
using drones and reinvesting some of their funding into research and development for 
new technologically-based strategies, such as launching their own satellite systems for 
communication.71 
Literature on the trends and forces shaping the war on drugs is rife with 
anticipation about how accelerating technological innovation could affect the illicit drug 
enterprise. However, what remains unknown is the social response to these changes, and 
whether they will influence perceptions of illicit drug behavior. For instance, society may 
be increasingly accepting the fallibility of humans as indelible data preserves people’s’ 
collective indiscretions.72 In the future, society may need a new social framework to 
incorporate rapidly growing innovations.  
3. The Failure of the War on Drugs 
Evaluative analysis of research and literature regarding the United States’ war on 
drugs indicates that the war is a systemic public policy failure as summarized in the 
problem statement above.73 National and international shifts in language around this 
subject indicate a movement toward a paradigm of drug policy reform. An accumulation 
of contradictions surrounding the war indicates that the existing system is neither 
working nor matching the reality of citizens. Evidence conclusively points to the notion 
that targeting people who use drugs with criminal sanctions fails to reduce demand for 
illicit drugs.74 Literature suggests the war has failed at decreasing both supply and 
demand at the same time that it infringes on civil and human rights, and politicians 
militarized the war instead of taking a public health approach. 
Economists conclude that after over four decades of fighting, the United States 
has spent over one trillion dollars on the war on drugs, yet it has not decreased supply or 
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demand.75 Rather, supply reduction measures have led to unintended consequences, such 
as fueling a criminal black market.76 Trend analysis research provides evidence that 
despite strong supply reduction efforts, access to illicit drugs is increasing as is drug 
purity.77 Meta-analysis studies and systematic reviews conclude that disrupting drug 
markets actually increases violence and that prohibition has not succeeded in decreasing 
demand.78 
Most literature on the subject of U.S. drug policy concludes that the U.S. war on 
drugs has led to mass incarceration, and millions of Americans in prison for nonviolent 
offenses.79 The prison-industrial complex is fast growing; since 1980, the number of 
incarcerated Americans has increased by more than 450 percent.80 Strict sentencing laws, 
such as mandatory minimum sentencing and “three strikes,” have created an 
unprecedented growth in the number of people imprisoned in the United States. Mass 
incarceration has profound social and economic effects.81 Because of strict drug laws, 
first time nonviolent offenders can receive de facto life sentences if the court prosecutes 
multiple trafficking convictions together.82 Judges argue that mandatory minimum 
sentencing shifts the power of sentencing from judges to prosecutors.83 Criminal justice 
experts argue that a system of mass incarceration leads to additional societal burden as 
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individuals exiting the criminal system face difficulties in employment, housing, and 
other areas such as the burden on families deprived of a person’s income.84 
Substantial discourse regarding the war on drugs focuses on the civil and human 
rights violations of the war. For instance, a body of research and literature provide 
evidence that the war on drugs disproportionately affects communities of color in the 
United States. Policy research supports the notion that U.S. drug policy leads to disparate 
criminal sentencing, wherein three quarters of state prisoners incarcerated for drug 
conviction are people of color, despite quantitative evidence that black and white citizens 
use drugs at approximately the same rates.85 In an erosion of civil rights, law 
enforcement officers may confiscate property before a judge declares an individual is 
guilty; getting these items back is difficult even if the person is found innocent or not 
charged.86 Furthermore, the war has led to expanded search and wiretap authorities.87 
Privacy advocates and experts in the field of civil rights challenge these policies 
pertaining to the drug war.88 
The literature discusses the militarization of the war and the greater effort focused 
on criminalization rather than on treatment for addiction. Rather than following a public 
health approach to drug use, the United States concentrates most of its effort on law 
enforcement.89 A zero-tolerance drug policy impedes public health approaches, 
subsequently marginalizing and stigmatizing those who suffer from the disease of 
addiction.90 Researchers in healthcare fields claim that zero tolerance dismisses evidence-
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based harm reduction strategies, such as syringe exchange programs.91 These types of 
counterintuitive policies affect students as well as hundreds of thousands of students are 
ineligible for federal financial aid due to laws prohibiting students convicted of illegally 
possessing a controlled substance from taking out student loans.92 Without an education, 
individuals remain limited in the realm of job prospects for the rest of their lives.  
While the majority of research on the war on drugs concludes that it is a public 
policy failure, there is often a discrepancy in proposed solutions for reform. Frequently, 
solutions across the literature pose a false dichotomy wherein the country either legalizes 
illicit drugs entirely or continues with prohibition.93 Literature on U.S. drug policy 
contains a noticeable abundance of research with built-in bias or advocacy. 
Many experts conclude that the United States should spend less on law 
enforcement and more on prevention, education, and/or treatment.94 Limiting this notion, 
these solutions assume a stable trajectory in the status of illicit drug use. However, future 
trends will likely affect illicit drug usage. The scope of this thesis is not to contribute to 
the literature assessing whether or not the war on drugs is a failure; the objective is to 
identify megatrends influencing the future of drug policy. Nevertheless, it is important to 
establish a baseline understanding on the discourse surrounding the war before moving 
forward to analyze how megatrends might influence the future of U.S. drug policy.  
This thesis comprises five chapters, as illustrated in Figure 2. The next chapter 
(Chapter II) describes methodology. Chapters III and IV present two alternative scenarios 
for the future. Finally, Chapter V contains analysis and policy recommendations arising 
from the two fictional scenarios.  
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II. METHODOLOGY 
If you don’t like change, you’re going to like irrelevance even less. 
Eric Shinseki, Chief of Staff, U.S. Army95 
To capture the most relevant uncertainties and driving forces related to the 
landscape of illicit drug use, this thesis uses a future studies methodology. The future is 
uncertain, but policymakers do not have to speculate “like blind men arguing over the 
colors of the rainbow.”96 Future studies, or “futures,” is “the study of postulating 
possible, probable, and preferable futures and the worldviews and myths that underlie 
them.”97 By its own merits, Google Trends data can help researchers predict the present, 
allowing for a new form of contemporaneous forecasting.98 This methodology facilitates 
the exploration of present trends and potential systemic interconnections to identify 
forces that may influence the future.  
Using a three-point Likert scale and the process described in this chapter, the 
approach of this thesis weaves together megatrends and technological variables to form 
hypothetical scenarios. The utility of scenarios is in their ability to highlight irreducible 
uncertainty and draw attention to the notion that the future is not predetermined. In this 
thesis, two fictional scenarios frame possibilities for how low-impact emerging 
technologies may intersect with global megatrends to move illicit drug use issues into the 
realm of high impact.  
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A. DATA COLLECTION 
This thesis presents an analysis of existing research to forecast future phenomena 
related to trends in illicit drug use.99 Understanding this topic involves researching two 
primary domains: 1) emerging technologies and 2) global megatrends. The scope of this 
study is on timely and current trends. Thus, this thesis uses literature published primarily 
within the last decade (2007 and later). With the exception of informing background 
contextual information, the analysis does not focus on the failure of the war on drugs. As 
reviewed in the literature review in Chapter I, a substantial body of research already 
exists on this topic. Data sources primarily comprise academic literature, nonfiction 
books, international publications, and internal reports and/or records. Research also 
included peer-reviewed journal articles identified by querying PubMed, Google Scholar, 
Dudley Knox Library’s Homeland Security Digital Library, and other relevant 
publications.   
B. PROCEDURE 
The procedure described in this section occurred after this researcher completed 
an extensive review of research on the topics of emerging technologies and megatrends. 
Future studies methodology incorporates systematic and pattern-based understanding to 
highlight trend analysis.100 Accordingly, this thesis uses a systematic and deductive 
approach to assess specific technological developments and subsequently to deduce 
specific insights as to how these technologies could relate to illicit drug use. As outlined 
in this chapter, the methodology utilizes a diverse range of models and methods, mostly 
normative and qualitative in nature. Qualitative methods inform an examination of social 
systems and accompanying ambiguities to extrapolate future possibilities.  
                                                 
99 Forecasting involves the use of “nowcasting,” a process of using current information to predict 
future trends to derive, subsequently, alternative future scenarios. Nieto-Gómez, “A Director of the 
Present?”  
100 Ziauddin Sardar, “The Namesake: Futures; Futures Studies; Futurology; Futuristic; Foresight—
What’s In a Name?,” Futures 42, no. 3 (2010): 177–184.  
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1. Step 1: Megatrends Research 
The researcher organized a compilation of megatrends literature sources from 
publications within the past decade into a table. Research on the subject of megatrends 
largely comprises reports listing and describing upcoming trends. Most publications 
postulated a range of around six to ten megatrends. Table 1 consolidates and organizes 
similar trends without changing the labels as written in individual publications. Due to 
the large number of sources reviewed, the Table 1 presents an example classification 
scheme in lieu of a lengthy appendix comprising all research materials. Double or triple 
“Xs” indicate reports listing multiple megatrends within a single consolidated box.  
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Despite variance in labeling and identification, common themes surface across the 
literature on megatrends, allowing for the aggregation of perspectives. Sources with the 
greatest number of Xs are considered thematic, due to the repetition of their existence 
across the literature. From this meta-analysis, four prominent megatrends emerged for the 
purpose of this thesis: 1) globalization, 2) urbanization, 3) Internet of things/hyper-
connected society, and) exponential technological growth. A description of each 
megatrend appears later in section C below.  
2. Step 2: Variables 
Myriad technologies and innovative disruptions contain potential to influence 
illicit drug use. The methodology for selecting key variables began with brainstorming a 
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list of emergent technology and topics mentioned frequently in literature covering 
emergent technology. A non-exhaustive version of this list appears in Figure 3.  






























For practical reasons, the list of potential variables was too long to incorporate 
into one analysis. Some literature sources already linked items, like virtual reality, with 
potential for illicit drug use. In other cases, the potential illicit drug nexus of items on the 
list is more readily discernable. The ultimate purpose of this thesis is to describe how 
megatrends and emerging technologies may converge in the future to challenge the 
ability to regulate illicit drug use. Thus, the actual variables selected are irrelevant as they 
only exist for structuring scenarios to highlight future policy implications.  
Next, this researcher developed a three-point Likert rating scale to categorize 
variables for the analysis within the following categorical parameters: radical, possible, 
and likely. The created Likert scale assigned a point-based rating for the nominal data.101 
The categorical labels indicated the plausible possibility of a variable changing the 
landscape of illicit drug use. As illustrated in Figure 4, the higher the plausible possibility 
of a variable, the higher the variable score.  
101 I. Elaine Allen and Christopher A. Seaman, “Likert Scales and Data Analyses,” Quality Progress 
40, no. 7 (2007): 64–65.  
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Figure 4.  Possibility Likert Scale 
Radical variables describe plausible extreme technologies that largely do not fully 
exist yet. These atypical gadgets and conceptual blueprints represent fringe signals of 
future technologies on the horizon. Possible variables designate uncommon and 
emerging phenomena. Most variables in this category are still in development, and their 
connection to illicit drug use may seem improbable as of 2017. Finally, likely variables 
define items appearing with frequency in public policy discourse. The high prevalence of 
their existence supports a strong likelihood that these variables will shape illicit drug use 
in the near future. Based on research assessing each variable individually, this researcher 
placed variables along the possibility scale as indicated in Figure 5. Discussion of 
individual variables in detail occurs later in this chapter.  
Figure 5.  Classification of Variables 
1 2 3 








3. Step 3: Scenario Creation
This thesis is grounded on a fundamental assumption that the future is not 
singular. Thus, the final product incorporates multiple alternative scenarios. The intention 
of the fictional narratives is not to predict a likely future. Rather, the intention is to first 
stimulate a conversation about the utility of current drug policy and, second, to 
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proactively nowcast the potential influence of upcoming technologies as they relate to the 
realm of illicit drug use.  
Megatrends paired with variables from all Likert classification categories create 
hypothetical, yet plausible, scenarios. The two-scenario format used in this thesis is based 
on an adaptation of the methodology used by Shell in its new lens scenarios.102 Figure 6 
outlines the structure of how megatrends and variables drive the two scenarios 
characterized in Chapters III and IV.  
Figure 6.  Megatrends and Variables for Thesis Scenarios 
4. Intended Output
Literature on emergent trends and forces is rife with anticipation about how 
accelerating technological innovation could affect illicit criminal enterprises. While most 
articles focus on a singular technology, this thesis presents possible effects to illicit drug 
use when numerous future technologies exist congruently. The United States needs a new 
social framework to incorporate rapidly growing technological innovations to change and 
102 See, for example: “New Lens Scenarios: A Shift in Perspective for a World in Transition,” Shell 
International BV, 2013, www.shell.com/energy-and-innovation/the-energy-future/scenarios/new-lenses-on-
the-future.html. Shell creates two scenarios for the future by combining global trends and emergent issues 
related to the energy sector. Observing trends and trajectories, the scenarios highlight implications for 
public policy.  
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modernize its drug policy. Extrapolations from the analysis of emergent technological 
innovations suggest a new framework for conceptualizing domestic drug policy.  
This thesis includes a definition and brief description of emerging technological 
phenomena and concludes with as a set of actionable policy recommendations. After 
presenting and analyzing relevant data, Chapter V includes recommended policy 
solutions for addressing future trends. The consequences and outcomes of each solution 
appear within the context of homeland security. 
C. DESCRIPTION OF KEY MEGATRENDS 
The following section provides a brief overview of the megatrends driving this 
thesis. As previously mentioned, these are 1) globalization, 2) urbanization, 3) Internet of 
things/hyper-connected society, and) exponential technological growth.  
1. Globalization 
Globalization refers to the dynamic movement of increasing connectedness across 
the world and between nations.103 This connectedness is evident in the accelerating flows 
of capital, people, finance, and information. In a highly interconnected and growing 
global system, shifts in one region can stimulate unanticipated volatility in another 
region.104 Amid this swirling, furious energy, a global marketplace of economic 
integration and democratization usher in increased opportunities for transnational 
organized crime.105 Globalization occurs through multiple complex processes rather than 
through a single linear process.106 In academia, globalization is often broken down into 
economic, cultural, and political categories, although it also exists under other lens such 
                                                 
103 W. Neil Adger, Hallie Eakin, and Alexandra Winkels, “Nested and Teleconnected Vulnerabilities 
to Environmental Change,” Frontiers in Ecology and the Environment 7, no. 3 (2009): 150–157.  
104 Dobbs, Manyika, and Woetzel, No Ordinary Disruption, 72.  
105 Harold Trinkunas, The Network Effect: Trafficking in Illicit Drugs, Money, and People in Latin 
America (Washington, DC: Brookings, 2015), https://www.brookings.edu/blog/order-from-
chaos/2015/12/03/the-network-effect-trafficking-in-illicit-drugs-money-and-people-in-latin-america/.  
106 Colin Hay and David Marsh, eds., Demystifying Globalization (London: Palgrave Macmillan UK, 
2000), 3.  
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as military or environmental globalization.107 Globalization helps fuel an international 
cross-country illicit drug trade, making interdiction by law enforcement increasingly 
challenging.108  
2. Internet of Things/ Hyper-Connected Society 
Where globalization refers to cross-border flows, hyper-connected society refers 
to the skyrocketing digital flows of data and information in a converging, digitized 
society.109 In the digital future, instant access to information will be omnipresent.110 
Fueled by social network organizing, ubiquitous mobile connectivity, and cloud 
computing, a quickly increasing number of devices are joining the “Internet of Things 
(IoT).”111 More and more objects, such as household coffee makers, are transforming 
into digitized technologies. Digitization enables easy communication and for the 
collection of enormous amounts of data. As more devices join the IoT, cybersecurity 
threats become increasingly salient as all devices are becoming connected and 
dependent.112 Criminals are perpetual adopters of new technology.113 The same hyper-
connectedness that benefits society is also benefitting drug cartels and powering a digital 
underground where illegal items are readily available for purchase on the dark web. 
Society’s collective vulnerability to hacking is driving societal discussions on the values 
of privacy, transparency, and security.  
                                                 
107 Salvatore Barbones, Studying Globalization: Methodological Issues (Oxford: Blackwell 
Publishers, 2007), 146.  
108 Cláudia Costa Storti and Paul De Grauwe, “Globalization and the Price Decline of Illicit Drugs,” 
International Journal of Drug Policy 20, no. 1 (2009): 48–61.  
109 Ovidiu Vermesan and Peter Friess, eds. Building the Hyperconnected Society: Internet of Things 
Research and Innovation Value Chains, Ecosystems and Markets, Vol. 43 (Gistrup, Denmark: River 
Publishers, 2015), xv.  
110 Ibid., 226.  
111 Ibid., 32, 45.  
112 Ibid., 147.  
113 Goodman, Future Crimes, 223.  
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3. Exponential Technological Growth 
Exponential technological growth is transforming the world with disruptive 
technology. This change is taking place rapidly and in accordance with Moore’s law, an 
empirical observational theory postulating that computer technology constantly doubles 
in the performance ratio of power versus price.114 This means that breakthrough 
technology is developing expeditiously and affordably for consumers. The shift toward 
democratization of technology is accelerating, especially as different technologies merge 
into technological convergence. These technologies require diligent oversight; such 
technologies as additive manufacturing, synthetic biology, and robotics hold immense 
potential for misuse by criminal syndicates. Following the trend of innovation, the future 
of crime will be exponential, automated, and three-dimensional.115  
4. Urbanization 
Urbanization is occurring rapidly across the globe. An anticipated 67 percent of 
the planet will live in cities before the year 2050.116 This trend generates a boost in social 
and economic opportunities for residents. Along with urbanization, however, arise policy 
challenges to make cities both sustainable and resilient. The rural-urban migration 
movement toward cities necessitates planning and investment in effective infrastructure. 
Living in cities exposes citizens to the stresses of urban life and creates enabling 
conditions for illicit drug use. As an indicator for modernization, urbanization is highly 
correlated with drug abuse.117 While the proximity of healthcare providers and addiction 
treatment resources may help mitigate this increased risk, cities create conditions and 
opportunities allowing criminal enterprises to thrive, thus fueling illegal drug markets.  
                                                 
114 Scott E. Thompson and Srivatsan Parthasarathy, “Moore’s Law: The Future of Si 
Microelectronics,” Materials Today 9, no.6 (2005): 21, doi: 10.1016/S1369-7021(06)71539-5.  
115 Goodman, Future Crimes, 506.  
116 Gerhard K. Heilig, World Urbanization Prospects: The 2011 Revision (New York: United Nations, 
Department of Economic and Social Affairs, 2012), 
http://www.un.org/en/development/desa/population/publications/pdf/urbanization/WUP2011_Report.pdf, 
4.  
117 United Nations Office on Drugs and Crime, World Drug Report 2004, Vol. 1 (New York: United 
Nations 2004), http://www.unodc.org/pdf/WDR_2004/volume_1.pdf, 28.  
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D. DESCRIPTION OF KEY VARIABLES 
Disruptive technologies ignore conventional societal rules.118 Embracing inherent 
unpredictability, innovation eventually produces social change. This section presents an 
overview of the key variables driving this thesis. Further analysis of each unique 
technology takes place in the following chapters.  
1. Likely Variables 
As mentioned earlier in this chapter, likely variables frequently appear in public 
policy discourse. The high prevalence of discussions regarding marijuana legalization 
and synthetic drugs indicate a high possibility that these variables will influence future 
drug policy.   
a. Marijuana Legalization 
The 1970 CSA governs U.S. drug policy. The act established a federal drug policy 
regarding the manufacture, importation, possession, use, and distribution of certain 
substances falling under five schedules according to such criteria as:  
(1) Its actual or relative potential for abuse. (2) Scientific evidence of its 
pharmacological effect, if known. (3) The state of current scientific knowledge 
regarding the drug or other substance. (4) Its history and current pattern of abuse. 
(5) The scope, duration, and significance of abuse. (6) What, if any, risk there is 
to the public health. (7) Its psychic or physiological dependence liability. (8) 
Whether the substance is an immediate precursor of a substance already 
controlled under this subchapter.119 
Despite this classification, there is a multifaceted movement in the country to 
legalize marijuana.120 As of 2017, nine states have taken unprecedented action to legalize 
the recreational use of marijuana.121 Moreover, 29 states and the District of Columbia 
                                                 
118 Clayton M. Christensen, The Innovator’s Dilemma: When New Technologies Cause Great Firms 
to Fail (Boston, MA: Harvard Business Review Press, 2013), 98.  
119 Controlled Substances Act, 21 C.F.R. §811(c) (1970).  
120 Jonathan P. Caulkins et al., Considering Marijuana Legalization (Santa Monica, CA: RAND, 
2015), 2.  
121 Legalization of recreational marijuana use is adopted in nine jurisdictions: Colorado (2012), 
Washington (2012), Alaska (2014), Oregon (2014), California (2016), Maine (2016), Massachusetts 
(2016), Nevada (2016), and the District of Columbia (2014). NORML, “Legalization.”  
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have legalized the use of marijuana for medicinal purposes.122 Change is a contagious 
force, and marijuana is a controversial topic hanging in legal purgatory. In the context of 
underscoring the research question of this thesis, it is important to address the national 
trend toward marijuana legalization as well as to question the implications that arise from 
states taking authority to ignore federal law.  
b. Synthetic Drugs 
First formulated in the 1920s and known by such nicknames as “bath salts,” 
“spice,” “plant food,” and “synthetic marijuana,” synthetic drug use has been on the rise 
in the United States since 2009.123 From 2009 to 2014, the DEA identified approximately 
200 to 300 new designer drugs around the country.124 One factor contributing to the 
popularity of synthetic cathinones is the myth that these dangerous substances circumvent 
drug laws.125 Seeking a “legal high” that will not be detected by a drug test, users report 
that synthetic drugs produce stimulant effects similar to cocaine or other 
amphetamines.126 In response, legislators ban the precursor chemicals used to produce 
these drugs. Subsequently, manufacturers of synthetic cathinones rapidly replace these 
specific molecules to create newer versions of drugs.127 This lack of consistency among 
synthetic drugs only furthers the danger to citizens who use them. The rising presence of 
synthetic drugs in the recreational drug market is engendering international 
apprehension.128 The rising incidence of synthetic drug use signals a trend toward the 
                                                 
122 Ibid.  
123 M. Coppola and R. Mondola, “Synthetic Cathinones: Chemistry, Pharmacology and Toxicology of 
a New Class of Designer Drugs of Abuse Marketed as ‘Bath Salts’ or ‘Plant Food,’” Toxicology Letters 
211, no. 2 (2012): 145, 147, doi: 10.1016/j.toxlet.2012.03.009.   
124 “DEA News: Huge Synthetic Drug Takedown,” U.S. Drug Enforcement Administration, May 7, 
2014, www.dea.gov/divisions/hq/2014/hq050714.shtml.  
125 John P. Kelly, “Cathinone Derivatives: A Review of their Chemistry, Pharmacology and 
Toxicology,” Drug Testing and Analysis 3, no. 7–8 (2011): 439, doi: 10.1002/dta.313.  
126 Laurent Karila and Michel Reynaud, “GHB and Synthetic Cathinones: Clinical Effects and 
Potential Consequences,” Drug Testing and Analysis 3, no. 9 (2011): 552, doi: 10.1002/dta.210.  
127 Susannah Davies et al., “Purchasing ‘Legal Highs’ on the Internet: Is There Consistency in What 
You Get?” QJM 103, no. 7 (2010): 493, doi: 10.1093/qjmed/hcq056.  
128 Henry A. Spiller et al., “Clinical Experience with and Analytical Confirmation of ‘Bath Salts’ and 
‘Legal Highs’ (Synthetic Cathinones) in the United States,” Clinical Toxicology 49, no. 6 (2011): 499, doi: 
10.3109/15563650.2011.590812.  
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consumption of drugs constructed from manufactured chemicals, regardless of their 
toxicity.  
2. Possible Variables 
Possible variables refer to technologies on the horizon that may influence drug 
policy in the future. These emerging phenomena are largely still in development and their 
potential association with illicit drug use may seem improbable in 2017.  
a. Nootropics 
Nootropics are pharmaceutical compounds that positively augment cognitive 
functioning in such areas as focus, memory, creativity, and/or motivation. While caffeine 
is an exemplar and culturally endorsed nootropic, peer-reviewed articles on this subject 
often equivocate over the ethical and pragmatic implications for the use of smart drugs. 
Researchers anticipate the future development of more of these types of compounds.129 
Widespread abuse of nootropics, such as Adderall and Ritalin, is already pervasive on 
college campuses.130 As these “smart drugs” enhance cognitive function, researchers 
anticipate the development of stronger and more effective compounds in the future.131 
Compounding the development of performance-enhancing drugs, pharmaceutical 
companies engage in strong, legal, direct-to-consumer marketing. Given their legal 
pharmaceutical status, current drug prohibition efforts make controlling illicit 
pharmaceutical use a daunting challenge that will only become more difficult as new 
pharmaceutical drugs enter the market.  
b. Digital Currency 
Digital currency refers to electronic currency that operates in a manner similar to 
physical currency, such as the Euro or the U.S. dollar. Using this form of currency, 
transactions are instantaneous. Historically, government-run currency had a monopoly 
                                                 
129 Cakic, Smart Drugs for Cognitive Enhancement, 611.  
130 Christine T. Sweeney et al., “Nonmedical Use of Prescription ADHD Stimulants and Preexisting 
Patterns of Drug Abuse,” Journal of Addictive Diseases 32, no. 1 (2013): 1, 
doi:10.1080/10550887.2012.759858.  
131 Cakic, Smart Drugs for Cognitive Enhancement, 611.  
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over traditional money because there was not a reliable alternative.132 In 2017, there are 
countless alternative virtual currencies. Cryptocurrencies, like Bitcoin, are a form of 
digital currency that use cryptography to secure transactions.133 Bitcoin is partially 
anonymous and decentralized instead of having backing from a government or similar 
state actor.134 Digital currencies, relying on peer-to-peer networking, are often vulnerable 
to fluctuating volatility in worth.135  
3. Radical Variables 
Lastly, radical variables describe fringe technologies that are extreme yet 
plausible. Although these technologies are still under development, they signal future 
possibilities.  
a. Artificial Intelligence 
AI refers to intelligence demonstrated by machines, often mimicking cognitive 
functions of humans like learning and reasoning. Technological advances employing 
deep neural networks already allow artificial intelligence to solve such complex pattern 
detection problems as speech recognition and word prediction.136 Experts predict that AI 
will most likely reach general human capability before the year 2050.137 Surpassing 
human abilities, the development of superintelligence refers to cognitive performance 
beyond human potential.138 Highly functioning AI poses an existential threat to humanity 
                                                 
132 Nikolei Kaplanov, “Nerdy Money: Bitcoin, the Private Digital Currency, and the Case against Its 
Regulation,” Loyola Consumer Law Review 25, no.1 (2012): 111–174.  
133 William J. Luther, “Cryptocurrencies, Network Effects, and Switching Costs,” Contemporary 
Economic Policy 34, no. 3 (2016): 553–571.  
134 Reuben Grinberg, “Bitcoin: An Innovative Alternative Digital Currency,” Hastings Science and 
Technology Law Journal 4 (2012): 159.  
135 Nicole D. Swartz, “Bursting the Bitcoin Bubble: The Case to Regulate Digital Currency as a 
Security or Commodity,” Tulane Journal of Technology and Intellectual Property 17 (2014): 319.  
136 Zoubin Ghahramani, “Probabilistic Machine Learning and Artificial Intelligence,” Nature 521, no. 
7553 (2015): 453, doi: 10.1038/nature14541.  
137 Vincent C. Müller and Nick Bostrom, “Future Progress in Artificial Intelligence: A Survey of 
Expert Opinion,” in Fundamental Issues of Artificial Intelligence, ed. Vincent C. Müller (Synthese Library; 
Berlin: Springer International Publishing, 2016), 567.  
138 Nick Bostrom, Superintelligence: Paths, Dangers, Strategies (Oxford: Oxford University Press, 
2014), 26. 
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as described by technological singularity. This hypothesis posits that accelerating growth 
in disruptive technologies may trigger an unfathomable phase that will radically change 
human civilization.139 Looming anticipation surrounds potential future usage of AI. Law 
enforcement officers anticipate the use of AI to investigate criminals and drug dealers. 
The pharmaceutical industry anticipates the use of deep learning to accelerate the 
discovery and development of future drugs. At the same time, AI could provide the 
ability to develop formulations for new illicit drugs or even to sell them.140 
b. Brain-Computer and Neural Interfaces  
Brain-computer interface (BCI) refers to direct communication between a brain 
and an external device such as a computer. Using internal implants or external wires, 
researchers typically use this technology to research and map brain functions so as to 
augment or rehabilitate cognitive functions.141 BCIs are a conduit for scientists to interact 
innovatively with the nervous system. For example, BCI research has produced 
neuroprosthetics applications to help restore impaired senses through cochlear or retinal 
implants. Motor neuroprosthetics restore movement in individuals with paralysis and 
deep brain stimulator implants assist individuals with Parkinson’s. This technology is still 
evolving, but in the future, BCIs will integrate with the body seamlessly, limited only by 
the brain’s plasticity.142 BCI may have potential use as a component of drug addiction 
treatment as it can provide a neurofeedback mechanism.143  
                                                 
139 Amnon H. Eden et al., “Singularity Hypotheses: An Overview,” in Singularity Hypotheses: A 
Scientific and Philosophical Assessment, ed. Amnon H. Eden et al. (Berlin: Springer-Verlag, 2012), 1. 
Disruptive technologies include artificial intelligence, robotics, genetic engineering, and nanotechnology, 
among others.  
140 Goodman, Future Crimes, 398, 413.  
141 Max O. Krucoff et al., “Enhancing Nervous System Recovery through Neurobiotics, Neural 
Interface Training, and Neurorehabilitation,” Frontiers in Neuroscience 10, no. 584 (2016): 2, doi: 
10.3389/fnins.2016.00584.   
142 Eric D. Chan, “The FDA and the Future of the Brain-Computer Interface: Adapting FDA Device 
Law to the Challenges of Human-Machine Enhancement,” John Marshall Journal of Computer and 
Information Law 25, no. 4 (2007): 118.  
143 Brent J. Lance et al., “Brain-Computer Interface Technologies in the Coming Decades,” 
Proceedings of the IEEE 100, Special Centennial Issue (May 2012): 1588.  
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Within the next two decades, experts anticipate BCI technology will allow 
computing fueled by brain signals, rather than a person having to say or touch a 
device.144 While this will increase the ease of computing, BCI also opens the door for 
hackers to detect or even manipulate the thoughts of others without their knowledge. This 
presents a noticeable security threat, as narcotrafficking organizations may have the 
ability to decipher the thoughts of enemies and/or hack the computer interface strategic 
plans and network of law enforcement.  
E. CONCLUSION  
Reality is infinitely complex, but forecasting possible future scenarios provides 
support in laying the foundation for present action. There is currently a gap in the use of 
futures methodologies in the field of homeland security. The value of the thesis is not 
only the content itself but in the adaptation of future studies for homeland security. 
Adaptability requires an intellectual flexibility to reconcile probable futures with 
irreducible uncertainty. The following two chapters present scenarios illustrating how 
trajectories of megatrends and the specific technological variables outlined above could 
intersect. These scenarios are not predictions; they merely present narratives of 
alternative environments that intentionally feel unnatural. This method captures relevant 
uncertainties and dynamic factors related to the contextual landscape of illicit drug use. In 
doing so, this thesis highlights risks as well as opportunities for consideration in 
strategizing future drug policy.  
 
 
                                                 
144 Harish Shah, “The New Security Threats in the Age of the Brain Computer Interface,” Futurista 
[blog], February 10, 2014, http://futuristablog.com/new-security-threats-age-brain-computer-interface/.  
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III. SCENARIO 1: CHEMICALLY ENHANCED 
Amid growing availability of high quality recreational drugs coming from 
Mexico and Canada, in this world, Americans legally regulate and 
augment their own cognitive functioning. 
In 2018, the United States federal government strictly cracks down on all state-
level recreational and medical marijuana legislation. Around the same time, international 
regulations and treaties on drugs collapse following the decisions from both Canada and 
Mexico to legalize recreational use of marijuana in 2017 and 2018, respectively. 
Following the economic success of marijuana legalization, in 2022, Canada decides to 
further decriminalize all recreational drugs. The decision by the United States to 
militarize the border and strictly enforce the nation’s CSA creates distinctive 
repercussions at a time when drugs from both border countries seep as through osmosis 
into the United States.  
In 2030, the United States finds itself beleaguered by a confusing, inconsistent 
drug policy, coupled with a rising prevalence of illicit drugs. On the other hand, use of 
legal nootropics—drugs for enhancing brain cognition—is ubiquitous. Despite America’s 
new isolationist stance and increased law enforcement efforts, recreational drugs from 
Mexico and Canada continue to appear throughout the United States. Following IBM 
Watson’s success in the medical field, the Pharmaceutical Research and Manufacturers of 
America trade group collaborate with IBM Watson Group to create artificially intelligent 
Wendy, a deep learning sister system focused exclusively on research and development 
in the pharmaceutical industry.145 This partnership proves lucrative, ushering in an era of 
enhanced human cognition with the help of legal pills. In this world, Americans sleep 
better, are more productive at work, and experience general emotional well-being. 
Widespread use of nootropics is seen as miraculous and imperative, the key to advancing 
humanity.  
                                                 
145 Deep learning refers to a process of applying artificial neural networks to learning tasks.  
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A. THE WORLD: 2030  
Americans live in a world of increasingly enigmatic drug policy. On one hand, 
Americans view nootropics as acceptable legal substances, no different from taking daily 
vitamins with breakfast in previous decades. On the other hand, recreational drugs 
legalized in Canada and Mexico increasingly appear on the black market, despite their 
illegal status in the United States. Although the federal government continues to spend 
more on border enforcement and security, illegal drugs such as marijuana and 
psychedelics are increasingly flooding the country.  
Pharmaceutical assistance improves almost any physical or mental ailment. 
Students take Memovirium for superior memory and focus, derisively remembering how 
people used to search for Adderall or Ritalin from friends lucky enough to get a 
prescription. Attorneys, politicians, and corporate businesspersons take Execumol for 
higher executive brain functioning. Permitted to by the International Olympic Committee, 
athletes take ViperEx for enhanced speed and muscle performance. Artists, musicians, 
and those who are creatively inclined take Partum for heightened creativity. As depicted 
in Figure 7, more than one-third of adults with full time occupations take Motus for 
boosted motivation and flexibility. The cognitive augmentation benefits from these 
substances appear limitless, enriching myriad facets of human life for those who can 
afford it.   
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Figure 7.  Advertisement for Motus 
Nootropics are for adults and children alike. Due to widespread use of Attentax 
among schoolchildren, the United States has risen to sixth among the world’s leading 
education systems. Harvard, Stanford, and the Massachusetts Institute of Technology 
have all pioneered new doctoral programs in neuroscience optimization.  
The landscape of competitive sports looks distorted.146 Athletes throw further, run 
faster, and lift heavier than at any other time in history. Athletes augment themselves 
146 Ryan M. Rodenberg and John T. Holden, “Cognition Enhancing Drugs (‘Nootropics’): Time to 
Include Coaches and Team Executives in Doping Tests?,” British Journal of Sports Medicine 51, no. 18 
(2016), doi: 10.1136/bjsports-2015-095474.  
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through powerful and potent nootropics, replacing the use of steroids, supplements, and 
other doping techniques of previous years. The field of competitive sports has yet to 
conclude how to regulate the use of these intense new drugs. The National Collegiate 
Athletic Association is in the midst of a highly controversial lawsuit for failing to drug 
test athletes for nootropics. Proponents of the lawsuit claim that the drugs are 
prohibitively expensive and give students the means to having an unfair advantage over 
their competitors. Critics of the lawsuit call it quixotic, claiming that nootropics are legal 
substances and point to the use and normalization of other legal nootropics like caffeine.  
Computer programmers and software engineers view the creation of IBM Watson 
as the breakthrough point for highlighting the societal benefits of using AI. Wendy, IBM 
Watson’s sister program, assists the pharmaceutical industry in researching and 
developing new cognitive enhancement drugs. In the same vein, Walter helps the 
agriculture industry by creating genetically modified organisms and synthetic substances. 
Similarly, Wiley analyzes biometric data and sorts through aggregate databases to help 
law enforcement jurisdictions prosecute crimes. Despite their specialized uses, all of the 
artificially intelligent programs exist in one centralized network, connecting the deep 
learning occurring within each individual system.  
The age of nootropics highlights a watershed moment in the field of public health. 
There are countless nootropics to enhance physical health, leading to a decrease in 
morbidity and mortality from obesity. Nootropics on pharmacy shelves combat hunger, 
low energy, and overeating. Other nootropics increase fat burning and even physical 
performance while exercising. By 2030, most Americans have forgotten the opioid 
epidemic that engrossed the country during the previous decade. New vendors appear to 
promote cognitive enhancement drugs every year at annual conferences of the American 
Public Health Association. Simultaneously, concern rises for an increasing number of 
people seeking treatment from combining multiple nootropics. While most see nootropics 
as indispensable, physicians fear a lack of longitudinal data on their safety and worry that 
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the drugs may deteriorate the brain’s delicate balance of neurotransmitter levels.147 Other 
critics cite philosophical opposition to the “loss of what it means to be human.” 
The pharmaceutical drug industry experiences soaring success. Capitalizing on 
uncertainty proves to be lucrative for the pharmaceutical industry; its aggressive lobbying 
efforts of the Food and Drug Administration (FDA) paved the way for the classification 
of nootropics as legal over-the-counter supplements. Successful lobbying has led to a 
furious rush to create and bring new cognitive enhancement drugs to the market. The 
federal government, lacking a national biology policy and focused on supporting 
corporate business interests, has shortened the clinical trial process for testing new drugs. 
The resulting surge in new drugs ushers in undeniable fiscal improvements to the 
American economy.  
The success of nootropics does not replace the existence of illegal drugs, as 
highlighted in Figure 8. Increasing numbers of Americans are in prison following 
incarceration for nonviolent offenses related to drug use. Prohibitive drug policies do not 
reduce demand.148 Not surprisingly, underground speakeasies provide access to 
marijuana and other psychoactive drugs. “Physical rooms” provide comfortable settings 
for people to relax with illicit drugs, and complex air filtration systems disguise the smell 
of cannabis to anyone who may be passing near the establishments. Individuals 
patronizing these establishments refer to 2030 as “Prohibition 2.0” or “the roaring 
twenties.”  
                                                 
147 Ruairidh M. Battleday and Anna Katharine Brem, “Modafinil for Cognitive Neuroenhancement in 
Healthy Non-sleep-deprived Subjects: A Systematic Review,” European Neuropsychopharmacology 25, 
no. 11 (2015): 1865–1881.  
148 Angus Bancroft, Drugs, Intoxication and Society (Cambridge, UK: Polity Press, 2009), 82.  
42
Figure 8.  Newspaper Column: Mirage Scenes and Product Greens 
In 2030, United States drug policy is in a state of pandemonium after withdrawing 
from the North American Free Trade Agreement. With America moving toward a more 
isolationist stance and an increase in law enforcement powers, further militarization of 
security makes illicit drugs harder to come by. In a search for legal (and affordable) 
alternatives, people welcome the development of nootropics. Their advent is an 
advertiser’s dream. The products sold themselves—at first, local pharmacies even 
struggled to keep the shelves stocked for customers. The rapid adoption of nootropics is 
comparable to the electronic cigarette, or “vaping,” phenomenon in the United States—
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which quickly gained traction among tobacco smokers.149 From 2011 to 2012, e-cigarette 
sales in the United States doubled from $250 to $500 million.150 Sales of nootropics 
mirror this exponential growth.  
Nootropics are domestic disrupters that bring a new type of inequality. The 
wealthy have access to new designer drugs first and can afford higher quality substances. 
Highlighted in Figure 9, urbanization accelerates this disparity. The gap between rural 
and urban populations increases as people living in cities have greater access to drugs and 
more discretionary income. The resulting social disparities slowly become apparent 
across multiple contexts, widening the gap between ends of the socioeconomic spectrum. 
This issue is especially prevalent in school systems and sports, wherein capabilities differ 
drastically between those who use and those who do not use enhancement substances. 
Debate over intentional cognitive augmentation creates rancor among politicians 
regarding the issue of equity.  
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Figure 9.  Zoo York Times Book Review 
Despite American isolationism, the rest of the world continues to move forward 
with globalization. In December 2030, 18 countries sign a free trade agreement, radically 
changing the landscape of international trade and policy. The United States, still 
recovering from its withdrawal from the North American Free Trade Agreement, does 
 45
not participate in the deal. Experts predict a geopolitical crisis as the United States slowly 
loses its predominance in the world economy.  
B. WHERE ARE WE IN 2017? 
The previous section presented a plausible scenario for the year 2030. Stories that 
cannot be rendered impossible through logical reasoning, plausible scenarios present a 
challenge to deeply held assumptions. The depiction presented a narrative interweaving 
nootropics, AI, globalization, urbanization, and marijuana legalization in Canada and 
Mexico. Is this scenario plausible? In 2017, the driving forces behind each of these 
factors are already self-evident.  
1. Nootropics  
Humans naturally pursue pleasure; the desire to intentionally augment or enhance 
one’s cognitive functioning is not new. Nootropics are substances taken to augment 
positively cognitive functioning. These types of substances are omnipresent throughout 
daily life. As previously states, caffeine is an exemplar and culturally endorsed nootropic. 
Additionally, nicotine positively affects cognitive processing through improved motor 
abilities, attention, and memory.151 The L-theanine found in green and black tea provides 
relaxation and mental alertness,152 and theobromine found in chocolate has memory 
enhancement properties.153  
Humanity’s evolutionary history points to a natural impulse to consume 
intentionally external substances to augment brain chemistry.154 For example, ancient 
Greek athletes consumed various plants and hallucinogens to improve speed and overall 
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Olympic performance as far back as the third century B.C.155 Similarly, Roman 
gladiators ingested stimulants to fight fatigue.156 Nineteenth century Austrian 
lumberjacks boosted their endurance by consuming significant quantities of arsenic.157 
For thousands of years, Indian Ayurvedic medicine employed forskolin extract, a plant 
derivative, to boost learning and memory formation.158 Neuropsychopharmacologist 
David Nutt highlights the role of drugs in human evolution by explaining, “Deliberately 
creating altered states of consciousness is one of the human universals.”159 Nootropics 
are not new, but their prevalence is slowly increasing in the societal consciousness.  
Hollywood films capture the prevailing zeitgeist surrounding cultural trends. 
Recent media framing surrounding nootropics demonstrates increasing acceptance, as 
popularized by such recent movies as Limitless in 2011 and Lucy in 2014. Limitless 
provoked scholarly debate over the use of nootropics for human enhancement. The main 
character in the film takes NZT-48, a fictional nootropic causing perfect memory recall 
and the ability to cross-correlate large quantities of information at a high speed.160 
Similarly, Lucy stimulated dialogue on nootropics following its portrayal of a woman 
who takes the fictional synthetic drug CPH4, leading to such psychokinetic abilities as 
telekinesis, enhanced mental capability, and the inability to feel pain.161 As debate on this 
topic continues, websites and groups continually move forward to promote smart drugs, 
as seen in Figure 10, a screenshot from the website smartdrugsmarts.com.162  
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Figure 10.  Screenshot from SmartDrugSmarts.com163  
Illegal use of nootropics is common in the United States. According to the 
National Survey on Drug Use and Health, in 2014, 1.2 percent of young adults ages 18–
25 self-reported that they abuse such prescription stimulants as Adderall or Ritalin.164 
One study analyzing abuse prevalence of individuals taking non-prescribed attention-
deficit/hyperactivity disorder (ADHD) medications reported abuse rates of 43 percent.165 
Abuse of ADHD medications is popular because the drugs enrich attention, motivation, 
and focus while decreasing fatigue.166 Likewise, many athletes abuse steroids, take 
growth hormones, or use other doping techniques to improve performance.167 Seeking 
163 “About Us,” Smart Drugs Smarts, accessed October 15, 2016, https://smartdrugsmarts.com/about/.  
164 Center for Behavioral Health Statistics and Quality, Behavioral Health Trends in the United 
States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication no. SMA 15-
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College Health 56, no.6 (2008): 601–606.  
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bursts of synthetic clarity, some high performing professionals on Wall Street and in 
Silicon Valley abuse prescriptions of Provigil (modafinil), a wakefulness agent originally 
created to treat sleep disorders like narcolepsy.168 This nootropic drug improves 
cognitive abilities through concentration, clarity, motivation, and focus, primarily by 
mediating an increase in adrenaline and dopamine release.169 Although not approved for 
sale in the United States, piracetam is a nootropic sold in Europe, Asia, and South 
America to improve memory as well as learning capacity.170 There are countless other 
drugs that people take off-label for nootropic abilities as well.171  
A considerable market for legal nootropics is also thriving. Backed by 
independent clinical results, a company known as Onnit sells Alpha BRAIN, a legal 
cognitive-enhancement drug promising to optimize memory, focus, and mental 
processing speed.172 Likewise, Neurohacker Collective sells Qualia, a product to “build a 
better brain” at the cognitive, psychoaffective, and physiological levels.173 The company 
Bulletproof sells Unfair Advantage for a burst of brain-enhancing energy, and KetoPrime 
for clarity via potent doses of the neuroprotective agent oxaloacetate. The marketing 
success of NeuroBrands provides evidence of demand for a culture of neural self-
augmentation.174 Seeking legal and natural products to enhance mental stimulation, some 
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individuals snort raw cacao powder. A company called Legal Lean even sells a snorting 
powder called Coco Loko comprising cacao, gingko biloba, taurine, and guarana.   
In what might sound like radical pop science, Americans are also taking initiative 
to combine genetic testing with nootropics.175 Individuals first obtain DNA analysis 
using saliva through a company like 23andMe.176 The kits are available online and 
through Best Buy, CVS, or Target for $100–$200. Next, several online companies like 
Nutrahacker or Promethease mine the individual’s genetic data and provide 
recommendations about supplements and nootropics that can enhance the mind and 
body.177 In case the list of recommendations is confusing, the site Nootropedia provides 
comprehensive information on every category of nootropics for self-optimization.178 The 
trend of hyper-personalized body hacking will likely continue to present a challenge to 
drug regulation.  
Compelling research on the medical utility of certain illicit drugs continues to 
challenge the CSA. The American Academy of Neurology published a report in 2014 
supporting the use of oral cannabis extract for such neurological conditions as muscle 
spasticity, pain, and urinary dysfunction.179 In 2013, researchers published longitudinal 
data demonstrating the lasting efficacy of using 3,4-methylenedioxymethamphetamine 
(ecstasy) within a clinical setting to treat patients suffering from chronic post-traumatic 
stress disorder.180 While some individuals report taking LSD as a nootropic for 
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enhancing creativity and empathy, scientists are exploring the use of LSD and/or 
psilocybin (mushrooms) to treat cluster headaches.181 
Humans have a long history with nootropics—and one displaying a propensity to 
creatively adapt plant products to alter brain functioning. The pervasive and increasing 
promulgation of nootropics indicates that humans naturally desire the ability to biohack 
their brains for improved performance. Biohacking refers to the process of exploiting or 
tinkering with genetic material of existing organisms.182 Nootropics are everywhere, and 
experts anticipate their use will only increase in the future.183 The timeless search for 
new means of cognitive enhancement presents an ethical issue regarding the types of 
nootropics that society aims to develop and how Americans intend to use them.  
2. Artificial Intelligence  
The hypothetical scenario of 2030 incorporated a brand extension from IBM’s 
deep learning computer system Watson for specialized uses in particular industries. 
Wendy assisted the pharmaceutical industry in creating new drugs, Walter aided the 
agriculture industry, and Wiley combed through aggregated data for law enforcement. 
Anchored in events already taking place in 2017, this scenario is plausible.  
IBM’s Watson already has an AI sister named Lucy working in Africa to tackle 
large-scale development projects across the continent.184 IBM also pitches this cognitive 
supercomputer to businesses wanting to utilize aggregate data to enhance marketing 
capabilities. Lucy specializes in marketing by researching extraordinarily large structured 
and unstructured data in fractions of a second. Like Watson, Lucy understands natural 
language processing, and after digesting over 250,000 articles a day, she has the capacity 
to provide insights and plan the next course of action.185  
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Aside from marketing, IBM has developed numerous applications for using AI in 
targeted industries.186 For instance, Watson Education is a global alliance to bring 
Watson’s cognitive abilities to bear to help educate citizens around the world. 
Additionally, Watson Talent assists human resource departments by aiding recruitment, 
providing talent insights, career coaching, and improving human resource operations, and 
Watson Financial Services assists the financial sector on a broad range of issues 
including customer demographics, risk management, regulatory compliance, and profit 
enhancement.  
In the scenario of 2030, Wendy is a supercomputer that helps pharmaceutical 
companies rapidly develop new cognitive enhancement drugs. In 2017, Watson for Drug 
Discovery uses the AI’s cognitive capabilities to help researchers identify novel drug 
targets and different uses for drugs already on the market. For example, Watson for Drug 
Discovery presently assists researchers at the Barrow Neurological Institute in their 
mission to discover new drug targets for treating amyotrophic lateral sclerosis In 
September 2017, over 250 AI and pharmaceutical representatives from leading biotech 
companies attended a London-based conference on the use of AI in drug development.187 
The company TwoXAR uses AI for drug discovery.188 Similarly, a startup company in 
San Francisco called AtomWise uses AI to scan over a million compounds in 24 hours, a 
process that typically requires months using traditional methodologies.189 The future use 
of AI across different business sectors and industries is not only possible...it is already 
happening.  
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3. Marijuana Legalization  
The scenario presented in this section involves the decision by Mexico and 
Canada to legalize marijuana and potentially other recreational drugs. In this scenario, 
Canada decided to decriminalize all drugs in 2022. The response by the United States is 
to enforce strictly the CSA, which drives the marijuana industry underground. This 
scenario highlights the unmaintainable discrepancy between federal and state marijuana 
laws.  
Following campaign promises, in March 2017, Prime Minister Justin Trudeau’s 
Liberal Party voted to legalize marijuana across Canada. By July 2018, infrastructure will 
be in place for legal marijuana sales across the country. This legislative decision 
ultimately affects Canadian diplomacy and the country’s involvement in international 
drug control treaties. As of 2017, Canada is a signatory of the United Nation’s 1961 
Single Convention on Narcotic Drugs, the 1971 Convention on Psychotropic Substances, 
and the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances.190 The geopolitical ramifications of deciding to break international law 
through marijuana legalization have yet to be determined.  
On the southern border of the United States, Mexican President Enrique Peña 
Nieto signed a law to legalize medical usage of marijuana in Mexico in June 2017.191 
Mexico’s Ministry of Health leads the implementation of regulating the medical use of 
cannabis and oversees a research program to study the impact of the drug policy. Given 
the shift from conservative drug laws to medical marijuana legalization, it is not 
improbable to anticipate full cannabis legalization in Mexico by 2030.  
The fictionalized decision by Canada to decriminalize all drugs in 2022 is both 
conceivable and grounded in a global momentum toward a more liberal drug policy. In 
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July 2001, Portugal decriminalized possession and use of all drugs for personal use.192 
Portugal’s Law 30/2000 decriminalized the use, possession, and acquisition of all drugs 
for personal use, defined as a 10-day supply.193 While it removed penal sanctions for 
drug crimes, this policy did not make drug use legal in Portugal. Rather, Portugal now 
treats drug use as an administrative violation that has the potential to receive punishment 
by either fines or community service.  
As of 2017, Mexico and Canada have taken the stance that the criminalization of 
drug use has been a failure and that society needs to approach drug use from a public 
health lens. The countries are just beginning to move forward in regulating the legal use 
of marijuana and creating the infrastructure to support this shift. This period of transition 
leaves the United States in a quagmire at a time when marijuana already is in a regulatory 
grey area.  
As Canada and Mexico scramble to set up infrastructure to regulate a new 
business industry, the United States is at a crossroads between action and the status quo. 
U.S. public policy surrounding marijuana is rife with inherent contradiction. The 
decisions by Mexico and Canada to legalize marijuana at various levels will have a 
profound impact on the United States. By maintaining the status quo in the United States, 
marijuana remains suspended in a paradoxical predicament, as any state legalizing 
marijuana in any form is inherently breaking federal law, yet 29 states and the District of 
Columbia have done so. Alternately, the United States could follow suit with sweeping 
decriminalization or move to enforce the CSA strictly. In the hypothetical scenario of 
2030, the U.S. federal government decided to strictly enforce the CSA’s zero tolerance 
policy toward marijuana, which eventually drove the relatively new marijuana industry 
underground, evoking a tribute to the popularity of speakeasies in the early 1920s and 
30s.  
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In 2017, there is no indication that the U.S. federal government intends to 
reschedule marijuana within the CSA or decriminalize its use. In February 2017, the 
White House warned the marijuana industry that “greater enforcement” of federal drug 
laws would be taking place.194 Strict enforcement of federal drug laws would upend an 
industry that had over $6.7 billion in marijuana sales in 2016.195 An environment of legal 
uncertainty is unsustainable. Legislative ambiguity impedes the full potential of the 
marijuana industry.196 Former Mexican President Vincente Fox cautioned that the 
decisions by Canada and Mexico to sell marijuana in various forms would lead to stiff 
competition for marijuana entrepreneurs in the United States. Both border countries aim 
to export marijuana to the United States; Fox claimed that Mexico intends to integrate 
cannabis into the North American Free Trade Agreement.197  
Strict enforcement of the CSA might lead to a shutdown of state and local 
marijuana dispensaries, cultivation centers, and all associated business industry. The 
criminal justice system might boost its effort to prosecute personal marijuana use, 
including all owners, state regulators, and law enforcement officers complicit in their 
involvement. Although this decision would be extreme, it is not without precedent. In 
2013, former Deputy Attorney General James Cole distributed a memorandum 
notoriously warning states that the Justice Department intended to enforce federal drug 
laws banning marijuana.198 The memo included a caveat that the department would likely 
overlook states with well-run programs, but it warned of federal intervention in states 
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lacking robust regulatory frameworks to control usage. Mounting friction between federal 
and state marijuana laws will eventually lead to a strategy of either prohibition or a move 
toward legalization.  
4. Globalization and Urbanization  
Innovation and globalization have created opportunity the likes of which 
has never before existed.199 
Across the literature on megatrends research, globalization, and urbanization are 
two of the most prominently reiterated movements. In the scenario presented in this 
chapter, the United States responds to globalization by moving to an isolationist stance 
after the country withdraws from the North American Free Trade Agreement. In 2030, 18 
countries sign a free trade deal without involvement from the United States. These 
changes lead to an amplification of border security control measures. At the same time, 
citizens continue the momentum of relocating to cities in search of employment. This 
scenario is plausible and highlights some of the issues occurring within the discursive 
framing surrounding transnational drug policy.  
Globalization is a megatrend describing the dynamic movement of increasing 
connectedness across the globe and among nations. This phenomenon has existed for 
decades and occurs through multiple complex processes rather than via a singular linear 
progression.200 Cultural and social trends strongly influence norms surrounding drug use. 
The decisions of Canada and Mexico to permit the recreational and medical use of 
marijuana reflect a cultural trend happening around the world.201 Currently, more than 25 
countries have shifted toward removing criminal sanctions for personal use of illicit 
drugs.202 For example, the Netherlands, Uruguay, and certain states within Australia have 
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removed criminal sanctions for the recreational use of marijuana.203 Moreover, social 
attitudes in the United States currently favor deregulation and widely call for reform of 
draconian drug policy at the national level.204 In 2011, the Global Commission on Drug 
Policy concluded that the United States should spend less on law enforcement and more 
on prevention, education, and treatment.205 
In the midst of globalization, a swelling anti-globalization current is rising to push 
back the megatrend of international connectedness. Fueled by populist movements and 
anti-terrorism rhetoric, some countries are taking steps to becoming closed systems. For 
example in 2016, the United Kingdom decided to withdrawal from the European Union. 
Within this contextual landscape, it is plausible to imagine a scenario wherein the United 
States transforms itself into a more isolationist state dealing exclusively in bilateral 
negotiations. In 2017, the United States withdrew from the Trans-Pacific Partnership held 
among 12 countries. The federal administration in place in 2017 also intends to 
renegotiate or withdrawal from the North American Free Trade Agreement with Canada 
and Mexico.206 In 2017, the United States withdrew itself from the list of 195 signatories 
of the Paris Agreement on climate change.207 This same year, Japan and the European 
Union signed a free trade agreement encompassing approximately one-third of the global 
economy and 40 percent of international trade.208  
Around the world, urbanization is transforming the landscape of population 
density maps. Economic and social opportunities accompany the migration from rural 
regions to cities. Concurrently, urbanization taxes infrastructure and drains local 
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resources. In the backdrop of a city, availability of illicit drugs permeates and conceals 
criminal enterprises. The correlation between drug abuse and urban living should inform 
U.S. strategy for regulating controlled substances. How can the Substance Abuse and 
Mental Health Services Administration effectively promote prevention of illicit drug use 
in an urban environment that enables an easy transfer of drugs?  
The future is transnational. Globalization and urbanization may increase 
ramifications to the stability of United States drug policy. Globalization helps drive an 
underground drug trade between countries. Thus, interdiction and prosecution by law 
enforcement will continue be challenging. In a highly interconnected global system, 
fluctuations in one region can inspire unanticipated volatility in another region.209 
Subsequently, the new marijuana policies of Canada and Mexico affect the United States 
and its place in a burgeoning North American marketplace of marijuana. Furthermore, the 
movement of many countries to decriminalize drugs will continue to challenge the 
existence and role of international drug treaties. Futurologist Alec Ross encapsulates that 
to flourish amid globalization, “a society must be open to exchange new ideas, conduct 
research free from political interference, and pursue creative projects.”210 The world is 
increasingly connected, and people are congregating in densely populated metropolises. 
The United States needs to determine its role among this momentum. The 2030 scenario 
may not come to fruition in the future, but nonetheless its plausibility should agitate 
greater questions about the utility and dexterity of the CSA within a rapidly changing 
world. 
C. INFLUENCING UNITED STATES DRUG POLICY 
This thesis asks how megatrends and emergent technologies may affect future 
United States drug policy. This first scenario described for 2030 underscores larger issues 
of strategic significance. The scenario highlights issues relating to neuroethics, the 
feasibility of regulating nootropics, marijuana policy failures, and the ethics of AI.  
                                                 
209 Dobbs, No Ordinary Disruption, 72.  
210 Ross, Industries of the Future, 204.  
 58
1. Neuroethics 
The drug landscape of the hypothetical 2030 highlights an underlying ethical 
challenge in framing national drug discourse. An examination of the rising prominence of 
nootropics elicits the following question: is there something intrinsically wrong with 
pharmacologically augmenting one’s own brain?211 In the early 1990s, psychologist Peter 
Kramer envisioned a medical realm of “cosmetic psychopharmacology” entailing the use 
of medications by healthy people to promote socially desirable personality traits.212 Since 
then, more and more people have sought to strengthen their neuroplasticity by biohacking 
their own minds.  
In the scenario, the ubiquity of cognitive enhancement substances raised conflict. 
This notion incites a discussion on social equality and how the government should 
regulate the use of nootropics, especially in such realms as schools and sports. 
Psychologist Vince Cakic likens the use of nootropics in schools to the use of illegal 
drugs in competitive sports.213 Cakic points out that prohibiting nootropics in any realm 
does not level the playing field because inequality is already omnipresent in the United 
States. From this perspective, a decision to fight educational inequality by banning 
cognitive enhancement drugs should be consistent and accompany a ban of private tutors 
or other items for which distribution of access is not equal among all students. Could 
intelligence augmentation lead to identity-based conflict or civil conflict based on 
transhumanist advantage? Highlighting the potential for alterity conflict, futurist Rodrigo 
Nieto-Gómez points to the current dissonance between those supporting transhumanist 
advantage and those maintaining a bioconservative ethic.214 
Analyzing the applied ethical issues arising from advancements in neuroscience is 
beyond the scope of this thesis. The intention of this scenario is to stimulate critical 
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discussions about how an emerging science of intentional cognitive amplification might 
affect current drug policy. In 2004, neurologist Anjan Chatterjee coined the term 
“cosmetic neurology” in reference to the idea of neurocognitive enhancement.215 
Chatterjee claims that humanity is now facing a historical inflection point as it hovers on 
the brink of a neuro-enhancement revolution.216 On the other side of this inflection point, 
the cognitive abilities of healthy individuals will be augmented using brain-enhancing 
drugs.217  
The intellectual movement of transhumanism embraces the use of new 
technologies to improve the human condition. With a limited mechanistic understanding 
of how the human brain functions, the incorporation of neuroethical discussions into 
National dialogue is imperative as newer onto-epistemological developments arise. For 
instance, in a capitalist society of naïve consumerism, what is the role of government in 
regulating direct-to-consumer marketing for cognitive enhancement drugs? Will 
employers one day require employees to consume certain substances for enhanced job 
performance? Will bioethical constructs within the neuroscience of free will change when 
it is conventional to alter one’s consciousness intentionally?  
2. Is Nootropic Regulation Possible?  
The 2030 scenario highlights the futility of regulating nootropics. The federal 
government modifies the CSA regularly to include newly discovered drugs. In 2017, the 
lag time between drug discovery and legislative change already borders on unattainable. 
The process for rescheduling the legal classification of drugs necessitates an intricate 
legal process involving either Congressional or administrative executive action. It is easy 
to classify certain drugs, such as marijuana or cocaine, but how might the federal 
government regulate substances like the Indian water plant bacopa monnieri, which 
                                                 
215 Anjan Chatterjee, “Cosmetic Neurology: The Controversy over Enhancing Movement, Mentation, 
and Mood,” Neurology 63, no. 6 (2004): 968–974.   
216 Anjan Chatterjee and Oshin Vartanian, “Neuroaesthetics,” Trends in Cognitive Sciences 18, no. 7 
(2014): 370–375.  
217 Jacob M. Appel, “When the Boss Turns Pusher: A Proposal for Employee Protections in the Age 
of Cosmetic Neurology,” Journal of Medical Ethics 34, no. 8 (2008): 616–618.  
 60
relieves stress and improves memory?218 At some point, regulators draw a line between 
illicit drugs and unregulated vitamins or supplements. Further confounding this issue, 
medical utility is one of the primary factors used to classify where to schedule illegal 
drugs. This presents a challenge when cognitive enhancement substances accompany 
solid evidence demonstrating their biological and/or medicinal value. How might the 
government regulate products like the snorting powder Coco Loko when all of the 
primary ingredients are available over the counter and occurring frequently in energy 
drinks? 
In this chapter’s scenario, the FDA shortens the clinical trial process to promote 
the proliferation of new drugs and its resulting fiscal boost to the economy. This idea is 
not outside the realm of possibility; research supports the notion that machine learning 
outperforms humans in drug design.219 Researchers studying translational paradigms in 
drug discovery claim that decisions in the field of pharmacology are increasingly based 
on aggregated, digitized groupthink in what has become a “positive-herding” 
phenomenon focused more on outcomes and less on the safety process.220 The cost of 
producing a new FDA-approved pharmacological drug is high and continues to rise. 
Eroom’s law states that the price of creating a new pharmaceutical drug doubles every 
nine years.221 In 2015, the FDA released a white paper regarding the administration’s aim 
to accelerate the development of new pharmaceutical therapies.222 To counter declining 
efficiency in research and development, the use of programs like IBM Watson could 
assist rapid succession in the discovery of new nootropics. As these new drugs enter the 
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market in unconscionable proportion, trying to regulate all new substances adequately 
becomes an unsustainable game of whack-a-mole.   
3. Marijuana Policy Failures  
The scenario presented in this chapter draws attention to the challenge of 
managing the impact of marijuana legalization in the border countries of Canada and 
Mexico. In a landscape of globalization and a burgeoning movement to decriminalize 
drugs in certain countries, it is reasonable to forecast increasing recreational drugs 
becoming legal in Mexico and Canada. Borders are porous. Moreover, a decision by 
Canada or Mexico to follow Portugal’s model to decriminalize all drugs would have 
widespread implications for the United States. Regulation would be subject to the usual 
vicissitudes of drug control efforts on the border—but on a substantially larger scale.  
In considering other recreational drugs, can the United States avoid the pitfalls 
and policy mistakes of marijuana regulation? In 2017, marijuana remains in a legal 
purgatory hovering between federal prohibition and asynchronous state laws that allow 
the drug in certain forms in certain contexts. A trend by Mexico, Canada, or other 
countries to legalize psychoactive substances beyond marijuana could further obfuscate 
the already complicated enforcement capability of United States drug policy. Escalating 
globalization further befuddles domestic drug control efforts amid international 
integration in the free movement of people and goods.  
In considering the ability of the United States to keep marijuana illegal despite 
widespread availability in its border countries, it is helpful to revisit the efficacy of 
alcohol prohibition during the early part of the nineteenth century. American-Mexican 
relations were altered following the prohibition of alcohol production and consumption in 
accordance with the 1919 Volstead Act.223 Literature on drug policy implementation 
supports the notion that enforcement does not reduce availability.224 Rather, zero 
tolerance policies merely drive illicit drug markets underground as the United States 
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experienced during Prohibition.225 During this period, Tijuana, as well as other Mexican 
cities, blossomed as havens for alcohol. Additionally, alcohol prohibition in the United 
States led to the formation of lucrative black markets. Mexico’s bootlegging role in 1910 
established drug trafficking routes that are still in existence in 2017.226 
While marijuana legalization has yet to go into effect in Mexico and Canada, the 
domestic policy environment is facing rapid change. In July 2017, Oregon presented 
House Bill 2355, legislation decriminalizing cocaine, heroin, ecstasy, and 
methamphetamine for residents without previous felony convictions or more than two 
previous drug arrests.227 Marijuana legalization in both border countries will further 
agitate domestic drug enforcement policies with a significant change.  
4. Ethics of Artificial Intelligence  
In the scenario outlined in this chapter, in 2030, the pharmaceutical industry 
capitalizes on AI to help create new cognitive enhancement drugs. At a time when 
autonomous robots are already performing soft-tissue surgery, the use of AI for drug 
discovery is underway and thus highly relevant.228 The scenario highlights the need to 
assess developing technologies proactively as society moves toward an increasingly 
symbiotic relationship between human and machine.  
Artificially intelligent robots are already in use in such fields as medicine, the 
military, transportation, and other industries. In October 2017, the first robot in the world 
was recognized with a nationality when Saudi Arabia official granted citizenship to 
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Sophia, an intelligent humanoid robot.229 Despite this progress, the field is still nascent 
and growing; we can anticipate that AI and machine learning will play a more 
comprehensive role in biomedical research in the future.230 Moore’s law stipulates that 
the number of transistors per square inch on integrated circuit boards will double every 
year.231 One consequence of this type of exponential growth is that technology 
simultaneously becomes cheaper and more advanced. Applying this theory to AI, what 
happens when AI and programs like IBM Watson are affordable for anyone? Could drug 
syndicates hack AI units to develop new illicit drugs or even use their cognitive abilities 
to sell drugs?232  
Technological singularity refers to the ability of AI to improve itself 
autonomously, ultimately surpassing human control or grasp. As of 2017, many experts 
predict that AI technology will reach human capability before the year 2045; some 
experts predict singularity will even occur before 2030.233 Pushing for regulation in July 
of 2017, Elon Musk warned the National Governors Association about the existential risk 
posed by AI.234 What happens to U.S. national drug policy when AI comes to the life 
sciences in a more mainstream capacity? The United States currently lacks a national 
biology policy. This is concerning, as the future of cyber-crime will likely be exponential, 
automated, and three-dimensional.235 The United States needs a proactive policy 
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infrastructure that can anticipate how future developments in emerging technologies 
could affect the nation.  
5. A Path Forward 
When it comes to American drug policy, are policymakers asking the right 
questions? National drug policy should reflect a deliberate system of doctrines leading to 
the intended outcome of reducing morbidity and mortality caused by drug use. 
Antidepressants, anesthetics, and plastic surgery were all initially considered fringe and 
bizarre bodily modifications before becoming ordinary.236 Absent an unpredictable 
wildcard event, linear extrapolation of current trends indicate that emerging technologies 
will undoubtedly affect the future landscape of drug use in America. It is important to 
assess not only what United States drug policy aims to accomplish, but also how it 
intends to do so. Does the CSA effectively realize this goal or does the country have a 
catawampus collective of unsustainable policy directives ready to be undermined by 
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IV. SCENARIO 2: WEARABLE ENHANCEMENT 
In this scenario, biohackers have discovered ways to trigger pleasure areas of the 
body to stimulate the brain via neural interface technology. In the hyper-connected world 
of 2030, Americans combine neural stimulation with illicit synthetic drugs and other 
technologies. Ubiquitous digital currency and exponential technological growth challenge 
interdiction efforts.  
Over 35 billion devices comprise the worldwide IoT. Mired in the inertia of 
exponential technological growth, digital disruption improves the quality of life for most 
Americans. Stores are fully automated using RFID technology.237 Robotic digital 
assistants assiduously take care of mundane tasks, challenging the orthodoxy of the 40-
hour work week. Banking systems use cloud-based digital currency with biometric 
scanning to verify identities. Due to the IoT and its interconnecting richness, the United 
States exists as a hyper-connected society. Human ingenuity produces a variegated mix 
of IoT-based toys and devices with a prevalent, if erroneous, belief that these new 
technologies are largely impervious to hacking.  
The year 2030 is a world full of newfangled gadgets altering perception through 
cybernetics—the scientific study of the synthesis between humans, animals, and 
machines through frames of information, control, and communication.238 Through 
amalgamating the organic and the mechanical, people have ascertained ways to use 
neural interface devices for recreational drug use. An array of neural stimulation devices 
appear on the market for public consumption. Many of the devices mimic illicit drugs in 
the human brain, despite their lack of a physical biochemical structure. Should United 
States drug policy concern itself with the development of non-biochemical devices that 
alter consciousness?  
                                                 
237 Radio-frequency identification n (RFID) uses electromagnetic fields to identify automatically and 
track tags attached to objects.  
238 Katherine N. Hayles, How We Became Posthuman: Virtual Bodies in Cybernetics, Literature, and 
Informatics (Chicago: University of Chicago Press, 2008), 8. 
 66
A. THE WORLD: 2030 
Americans live in a socio-technical world of human ingenuity and digital 
disruption. In this environment, there is greater tolerance for ambiguity. Digitized cities 
exist collectively on one national smart grid. Robust infrastructure improvements make 
the United States highly efficient, although critics point out how the unified grid 
essentially organizes the country into potential national instability. Over 99.5 percent of 
Americans are online and hyper-connected in a ubiquitous web of networked computing.  
With countless new technologies on the market, Americans generally possess a 
sanguine view of exponential technological growth. Subject to frequent topics of 
discussion in the news, biohackers discover innovative ways to stimulate the brain to 
release specific neurotransmitters through neural interfaces. With direct neural 
stimulation, individuals can subversively hack their own neurotransmitters to release 
natural opioids or specific neurotransmitters like dopamine without having to ingest 
noxious chemicals physically. Lacking a regulatory framework to oversee many of these 
products, the U.S. Patent and Trademark Office reported a 460 percent increase in the 
number of patents filed during the last fiscal year.  
A Japanese company called HaiRave sells neon, rainbow-colored hair wigs that 
cause hallucinations by the individual wearing the wig. The wigs operate by dramatically 
elevating dopamine levels in the brain. After appearing in a viral music video, the wigs 
became a staple feature at raves and music festivals. This year, the wigs were for sale by 
multiple vendors at Coachella.239 Carrying only beers and smart phones, festival-goers 
paid for the wigs seamlessly using ZaBux digital currency with the touch of their finger 
on the screen. Outside of the United States, the wigs are also popular across Europe and 
in parts of China and Japan. The theatrical antics of people wearing HaiRave wigs at 
music festivals belie the severity of the notion that humans are slowly merging with 
machines.  
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The landscape of competitive sports looks warped as new products, such as 
Vitaglass, spark heated debate. Vitaglass Products is a company producing neural 
stimulating eyeglasses for athletes. The glasses contain a transmitting node near the back 
of the ear to stimulate norepinephrine release to produce energy surges mimicking a 
fight-or-flight response. The company anticipates the release of a contact lens version of 
their product within the next five years. The glasses are especially prominent in sports, 
like sprinting, which require type II fast-twitch muscle fibers.240 Athletes wearing 
Vitaglass consistently outperform, at statistically significant levels, when compared with 
athletes not wearing the eyeglasses. Proponents of Vitaglass point to the fact that sports 
associations do not ban the wearing of eyeglasses. Moreover, the sheer variety of frames 
produced by Vitaglass Products makes it nearly impossible to determine who is wearing 
Vitaglass as opposed to ordinary eyeglasses. Critics of Vitaglass claim the wearables give 
athletes an unfair advantage over their opponents. Physicians and scientists are concerned 
with the unknown and potential long-term risks associated with manipulating 
norepinephrine levels in the brain. Already, abuse of Vitaglass is associated with causing 
a flat affect, an apathetic mindset, and general fatigue. A recent article in The Atlantic 
profiles four professional athletes known for openly using Vitaglass. The exposé 
highlights the danger of this new technology as all four athletes reported miserable 
feelings of anxiousness, hyperactivity, and hypervigilance in the 24-hour period 
following a major sporting event in which Vitaglass technology was used repeatedly. In 
spite of this negative news coverage, Vitaglass Products reported a steep increase in sales 
of glasses in the quarter following the article’s publication.  
The utility of neural interface products extends beyond therapeutic use. Mellow 
Melon is a helmet stimulating serotonin receptors of the brain’s inhibitory system and a 
release of gamma-Aminobutyric acid. Wearing the device produces a gentle warming 
sensation and feelings of relaxation. This innovative technology galvanizes a potentially 
dangerous paradox; many individuals report using Mellow Melon in lieu of taking 
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medications for anxiety or depression. Others report using the helmet as a replacement 
for smoking marijuana or consuming opioids.  
Advertised on the QVC, Shed Head is a weight loss headband stimulating the 
release of epinephrine, a hormone essential to metabolism. Excess use of this product is 
associated with sleep problems, anxiety, and attention disorders. Nevertheless, the side 
effects fail to hinder sales of the headband; users report feeling mentally alert and focused 
while wearing it. Scientist Karla Kienlen, creator of Shed Head, claims empirical studies 
provide evidence that the headband successfully inhibits insulin excretion and raises 
levels of fatty acids in the blood. Double-blind placebo studies demonstrate that 
participants with a body mass index above 25 typically lose at least one pound per week 
while using Shed Head.241  
The pharmaceutical industry faces a need to pivot their business strategy, as 
neural interfacing technologies slowly eliminate the need to ingest biochemical 
substances. Last year, the FDA approved Ceresulin, a hair cap to control type II diabetes. 
Placed on the head, the cap directs the brain to stimulate the pancreas to release more 
insulin, a peptide hormone involved in the regulation of metabolism. Ceresulin replaces 
the need for an arsenal of injections and diabetes prescriptions—the number of minutes 
spent wearing the cap replaces the need for rapid release, short-acting, and long-acting 
insulin regulation drugs. Biofeedback technology links a patient’s insulin vitals directly 
to their smartphone in real-time with a medical consent option to give physicians access 
to insulin monitoring. A built-in safety feature turns the cap off if a patient’s insulin 
levels approach dangerously high levels.  
Combining neural stimulation devices with other substances and technologies 
amplifies their potential side effects. In 2030, synthetic drugs are highly prevalent with 
approximately 200 new substances arriving on the street each year. On college campuses 
across America, students experiment by combining neural stimulation devices like 
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HaiRave with synthetic drugs, as highlighted in Figure 11. Athletes test the limits of their 
physical endurance by coalescing Vitaglass eyeglasses and traditional forms of doping 
like steroids.  
Figure 11.  GNN: Collegiate Drug Use in a Digital Age 
In the healthcare field writ large, physicians worry about the potential for long-
term brain damage from excessive exposure to various neural stimulation devices. 
Underscoring their concern is a void in longitudinal data on the topic. On one hand, bio-
hackers creating neural interface devices are tinkering with brain chemistry in the same 
manner as a biochemist would. On the other, the interaction effect from combining 
multiple neural interfacing devices remains unknown. Pharmacists argue that as an 
increasing number of neural interfacing devices appear on the market, it is important that 
the various FDA-approved healthcare devices are able to integrate their platforms to 
avoid the effects of drug interactions. At the last annual meetings of the American 
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Pharmacists Association and the American Medical Association, multiple pharmacists 
and neurosurgeons led forum discussions on the possible brain damage and lasting 
medical implications that could arise as Americans continue to experiment with various 
neural interface devices on the market.  
However, not all physicians are against the use of neural interface technology. In 
the field of behavioral health, psychiatrists treating substance use disorders promote the 
use of interface technology as a replacement therapy for other biochemical recreational 
drugs, as illustrated in Figure 12. The use of interface replacement therapy is especially 
effective in treating patients addicted to such hallucinogenic drugs as ecstasy, psilocybin 
(“magic mushrooms”), LSD (or “acid”), and phencyclidine (PCP or “Angel Dust”). A 
clinic in San Francisco operates a clinical trial for substitution therapy wherein HaiRave 
technology works as a replacement for popular hallucinogenic club drugs. Behavioral 
health advocates and addiction counselors applaud this form of substitution therapy as an 
effective harm reduction approach.242 Preliminary data from a large pilot study reveals a 
30 percent improvement in the success of substitution therapy for treating addiction when 
compared with standard detox and outpatient treatment.  
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Figure 12.  HaiRave Rehab Advertisement  
This age of exponential technological growth and hyper-connectivity highlights 
the danger of trusting neural interface devices. When the IoT links everything, everything 
is vulnerable. Illustrated in Figure 13, the U.S. Department of Homeland Security (DHS) 
and the Federal Bureau of Investigation (FBI) publish bulletins alerting state fusion 
centers about the possibility that neural interface devices could be hacked. Operatives 
within the intelligence community regard neural interface technology with trepidation, 
especially in light of the cavalier attitudes of Americans as most citizens lack awareness 
of how this same technology has utility for nefarious purposes. Just last year, a lawmaker 
in Germany had his Ceresulin cap hacked on the morning of voting for a highly 
controversial piece of legislation. An unknown source was able to access the Ceresulin 
cap and order it to release excessive levels of insulin, bypassing the automatic shutoff 
safety feature and causing the lawmaker to fall unconscious.  
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Figure 13.  FBI/DHS Joint Intelligence Memo 
Critics of neural stimulation devices call for strict regulatory oversight. In 
response, advocates point to the fact that BCI devices are merely computers. How might 
the government create the regulatory infrastructure to govern their use—should the 
government even aim to do so? 
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B. WHERE ARE WE IN 2017?  
The previous section presented a plausible scenario for the year 2030. The 
fictional narrative highlighted the structural inter-relationships of the driving forces of 
neural stimulation, BCI, the IoT, a hyper-connected society, and exponential 
technological growth. In 2017, the fundamental driving forces that could make this 
scenario come to fruition are largely already in existence.  
1. Neural Stimulation and BCIs 
That psychiatrists can use both drugs and electricity to battle illness 
testifies to the fact that the brain is both a chemical and an electrical 
organ.243 
The concept of stimulating an individual’s nerves for therapeutic reasons is not 
new. In 46 A.D. Rome, a court physician to Emperor Claudius used electric rays to 
relieve headache pain.244 In the 1700s, Italian anatomist Luigi Galvani discovered that 
applying an electrical current to the muscles of dead frogs caused their limbs to twitch.245 
Nearly a century later, German physicians Fritsch and Hitzig laid the groundwork for 
understanding the motor cortex through their realization that by stimulating various parts 
of the brains of live dogs, they could produce predictable limb movements.246 Since the 
eighteenth century, the understanding of neural interfaces continues to evolve.  
A BCI allows an individual to communicate with a device using only the brain’s 
electrical conductivity.247 Previous research demonstrates BCI technology can already 
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detect, noninvasively, whether an individual is thinking “yes” or “no.”248 A company 
called BrainGate aims to turn thoughts literally into action by developing neural 
interfacing technology.249 In March 2017, this technology allowed a man with 
quadriplegia to gain mobility in his limbs following implantation of a brain-recording, 
muscle-stimulating device.250 Clinical trials for the BrainGate2 Neural Interface System 
are underway to allow individuals with tetraplegia to operate communications software 
by simply imagining the movement of their hands.251  
By using neural interfaces, scientists aim to connect an individual’s nervous 
system with the outside world. In this scenario, neural stimulation devices serve multiple 
functions and purposes to stimulate one’s brain to release specific neurotransmitters. In 
2017, physicians use neural stimulation technology to treat such neurological conditions 
as spinal cord injuries, neurological disorders, and sensory disorders.252 To stimulate 
human nerves, physicians already use electrical, mechanical, and/or light stimulation 
devices.253 Because of this technological innovation, individuals with sensory loss can 
use cochlear implants, retinal implants, and spinal cord stimulators to restore hearing, 
sight, and relieve pain, respectively.254 This technology supports cardiac pacemakers, 
implantable defibrillators, and even has potential for treating arthritis.255 The Bion 
microstimulator is a miniature wireless device that physicians inject into the body; 
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clinical trials are currently underway to appraise the utility of this device for treating a 
wide range of neurological conditions from urinary incontinence to sleep apnea or 
headaches.256 Neural stimulation is also a key component of BCI technology. 
Research on implantable “neural dust” shows promise for the future of brain 
monitoring. Neural dust refers to a technology involving thousands of free-floating, 
independent sensor nodes in the brain the size of dust particles.257 The particles identify 
extracellular electrophysiological data and communicate that information to a subcranial 
interrogator device.258 During in vivo testing led by the Defense Advanced Research 
Projects Agency (DARPA) in 2016, ultrasound wirelessly powered and communicated 
with tiny devices implanted into muscles and nerves.259 The use of ultrasound allows for 
the placement of tiny sensors deep within human bodies without interrupting the ability 
of the sensors to read neural signals. In the future, scientists aim to shrink neural dust to 
half the width of a single strand of human hair.260  
Most neural interface research focuses on outputs, but input research is slowly 
evolving. Input research allows scientists to record neural signals, an area where BCI 
technology is critical. For instance, by recording brain signals, researchers could decipher 
how individuals with paralysis intend to move their limbs. With a solid mapping of brain 
circuitry, researchers can understand neural coding, plasticity, disease origins, and the 
relationship between the brain and behavior.261 Understanding this foundational 
knowledge of the brain opens countless new avenues for utilizing neural stimulation.  
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The jump from invasive neural stimulation to wearable devices is not 
inconceivable. The products featured in this scenario profiled a hallucination-causing 
wig, norepinephrine-releasing sports eyeglasses, a relaxation-inducing helmet, a weight 
loss headband, and a hair cap for treating type II diabetes. Already in existence and sold 
in over 170 countries, people purchase HairMax, a wearable headband laser device to 
stimulate hair growth.262 In 2017, groundbreaking research is underway for using vagus 
nerve stimulation (VNS) to treat epilepsy and depression.263 Historically, treating severe 
depression using VNS has been invasive and involved neurosurgery to implant a 
stimulator device into the patient’s brain.264 In 2016, researchers successfully developed 
a noninvasive form of VNS for treating severe depression by merely clipping electrodes 
to a patient’s ear.265  
People already use electrical signals from their brains to interact with and 
influence their environments.266 This technology is in use in robotic devices, in visual 
spelling apparatuses, in prostheses, in certain wheelchairs, and in the disabled 
community.267 Some pacemaker devices interface with the Internet for remote cardiac 
monitoring.268 Wearable fitness trackers, such as Nike’s Fitbit, track body movement, 
heart rate, sleep, and calories. User data transmits in real time to a computer, tablet, or 
smartphone app.269 Doppel is a wearable technology that uses rhythmic pulses to induce 
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calmness and focus.270 Placed on the base of a user’s neck, Thync uses neurostimulation 
to lower stress and anxiety.271 
Emerging research also grounds the idea of using wearable neural stimulation for 
drug delivery, medical treatments, and health monitoring. Like the Ceresulin hair cap for 
treating diabetes in the scenario, evolving medical device research highlights how neural 
stimulation has value for drug delivery. For instance, a patent filed in 2001 outlines the 
use of neural stimulation devices to deliver drugs to patients in the treatment of 
cardiovascular disorders.272 In 2014, Google submitted a patent for digital multisensing 
contact lens that could help individuals with diabetes by monitoring glucose levels in 
their tears.273 Collaborating on this initiative, Novartis aims to link Google’s smart lens 
to smartphones or tablets to help diabetic patients monitor their blood glucose levels 
using real-time data from the contacts.274  
Also targeting the eyes, Sensimed is a Swiss startup developing FDA-approved 
contact lens for treating glaucoma by embedding microsensors for monitoring intraocular 
pressure into silicone lens.275 In collaboration with the Gates Foundation, Fuse Project is 
developing Kernel of Life, a diagnostic medical device necklace using cloud technology 
for health monitoring and diagnosis.276 Biosensing pads test blood, saliva, urine, and 
breath; results transmit by Bluetooth to mobile apps.277 The rapid adoption of wearable 
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fitness trackers provides evidence that wearable neural stimulation devices could be 
similarly embraced in the future.  
Not all innovative neural stimulation devices target medical conditions. In her 
book, Bonk: The Curious Coupling of Science and Sex, Mary Roach describes how neural 
stimulation can assist individuals in achieving orgasm.278 For instance, FertiCare creates 
a transcutaneous mechanical nerve stimulation device to help males with spinal cord 
injuries achieve orgasm.279 Separately, Dr. Stuart Meloy created the “Orgasmatron,” a 
modified spinal cord stimulator device wired to an individual’s spine to emit pleasure 
signals directly to the spinal cord.280 At Oxford University, researchers discovered that 
stimulating the orbitofrontal cortex produces pleasure; their goal is to create a “sex chip” 
using deep brain stimulation to target this area of the brain.281 In 2017, individuals 
heighten experiences by taking illicit drugs while experiencing virtual reality.282 
Capitalizing on the potential for combining technology with pleasure, other companies 
have built virtual reality pornography sites.283 Challenging the limits of how technology 
can impact human sexuality, sexual education expert Dr. Laura Berman argues that the 
future will include sex with robots, virtual reality, and the use of drugs.284                     
Outside of the private sector, BCI research is also taking place through 
government-sponsored initiatives. With a budget of over $100 million, DARPA is 
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working to develop an implantable neural interface through the BRAIN initiative.285 
Announced by the Obama Administration in 2013, the Brain Research through Advanced 
Innovative Neurotechnologies (BRAIN) project is a collaborative, public-private research 
enterprise.286 The project’s goal is to develop innovative technologies to provide insight 
into how the brain works as well as applications to enhance brain functioning.287 The 
creator of GPS and the Internet, DARPA has also created a new Biological Technologies 
Office in 2014 to “harness the power of biological systems.”288 The BRAIN initiative is 
only one of many ongoing projects within this office.  
Other projects underway in the Biological Technologies Office include memory 
improvement and human-machine symbiosis. One way DARPA is assisting with the 
BRAIN initiative is through its Electrical Prescriptions program. The goal of this effort is 
to “help the human body heal itself through neuromodulation of organ functions using 
ultraminiaturized devices, approximately the size of individual nerve fibers, which could 
be delivered through minimally invasive injection.”289 Its Hand Proprioception and 
Touch Interfaces and its Neural Engineering System Design programs are developing 
implantable devices that communicate with the brain directly and wirelessly with external 
modules.290 Another program, the Systems-Based Neurotechnology for Emerging 
Therapies program aims to create an implantable device for diagnosis and treatment of 
neuropsychological illnesses.291 These are only a few of the projects DARPA is focusing 
on as part of its role in the empirical BRAIN initiative.  
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At a time when the Pentagon is funding BCI research, private companies are also 
pouring funding into projects using the same technology. For example, Disney has 
created its own accelerator program to build a network of companies that “dream for the 
future” using technological innovation.292 The accelerator sponsors an annual portfolio of 
companies to merge the entertainment industry with such technologies as robotics, virtual 
reality, and mind control. Emotiv, a 2015 Disney accelerator finalist, produces 
electroencephalography headsets that noninvasively record brain activity and produce 
three-dimensional visualizations.293 Releasing new forms of “brainwear,” the company 
aims to measure brain fitness and harness this ability to control video games, among 
other activities.294 In 2016, the online payment company Braintree invested $100 million 
into Kernel, a startup company aiming to build a flexible platform for recording and 
stimulating neurons.295 This technology also has promise for treating Alzheimer’s or 
other diseases.  
With approximately two billion users, Facebook is working on the creation of 
“optical neuro-imaging systems” to allow users to type words from their brain directly 
into the Facebook platform. In pursuit of this lofty goal, Facebook spent $2 billion in 
2014 to acquire the virtual reality company Oculus.296 The company’s experimental 
technology division known as Building 8 claims that the goal of this telepathy is for users 
to type 100 words per minute, which is five times as fast as manual typing on a 
smartphone. Within seconds, people will be able to transcribe whole thoughts into texts 
or email without manual input. If successful, this consensual telepathy would remove 
language barriers.  
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In the future, electrical impulses may stimulate neurons for countless medical and 
recreational purposes. The field of healthcare could one day revolve around the use of 
neural stimulation targeting specific nerve fibers or areas in the brain.297 With a full map 
of the brain’s circuitry, physicians could intentionally target specific neural impulses to 
achieve a desired medical response, like controlling inflammation. Beyond medical uses, 
it is plausible that future iterations of this technology could allow people to bypass the 
consumption of biochemical drugs as society knows them today and directly stimulate 
targeted areas in the brain to achieve specific forms of altered consciousness.  
As of 2017, Americans have already merged with their phones, computers, and 
apps. Ambitious BCI technologies are not far from realization. It is now in the middle of 
an underdeveloped neurotechnology space that Americans should discuss the 
implications of BCI technology before intelligent dust particles can invade human brains. 
Inexorably, the existence of high performance BCI technologies places the onus on the 
government to decide how to regulate these devices. Is society willing to strike a Faustian 
bargain in its pursuit to augment human abilities?   
2. The Internet of Things 
Technology pioneer Kevin Ashton coined the term “Internet of things” in 1999 in 
reference to the growing web of Internet-connected devices.298 In 2017, devices as simple 
as coffee makers have now become “smart” and joined the IoT by connecting to the 
Internet; connecting to the IoT expands the device’s ability to produce coffee through 
remote activation or to analyze coffee consumption data.299 As the number of devices 
connected to the IoT continues to grow, the way that society operates will continue to 
transform. For example, as the online network of people and devices continues to grow, 
the job of collecting, organizing, and interpreting data will shift to machines, which have 
greater computing power in comparison to human capabilities. The accelerating speed of 
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development in the realms of information and communications technology propels the 
IoT forward.300 Expanded Internet access to rural and developing countries will further 
this acceleration toward connectivity. In 2017, the goal of Google’s Project Loon is build 
a network of balloons to send to the stratosphere; the project aims to extend Internet 
access across the globe with its aerial wireless network.301  
The IoT connects people to one another, people to machines, and machines to 
other machines. In the next evolution of connectedness, researchers believe that human 
brains could ultimately connect with one another on this same Internet-enabled web. In 
2012, an Israeli student connected his brain to a surrogate robotic avatar located 1,250 
miles away using a camera and functional magnetic resonance imaging.302 In 2013, 
scientists at Harvard University succeeded in noninvasively interfacing the brains of a 
human and a rat using brain-to-brain interface (BBI), an advancement beyond BCI 
technology.303 Connected by the BBI, human participants could control the rat’s tail 
through thought alone. As this technology continues to progress, it is conceivable that a 
BBI could exist between humans, allowing for the bidirectional transference of complex 
ideas.304 Furthering this research, neuroscientists at Duke University are creating a 
Brainet, networking multiple animal brains together into one super-brain, allowing for 
synchronous brain connection during activities.305 In the future, these preliminary 
archetypes could evolve into full brain-computer and BBI paradigms.  
Neural lace technology may be the next step in the progression to a human 
Brainet. Neural lace is a piece of ultra-thin mesh implanted in the skull to allow the brain 
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to connect to a machine.306 Once implanted, the wireless mesh molds to the brain. 
Scientists anticipate that neural lace will ultimately allow human brains to communicate 
bidirectionally with computers.  
With over $27 million in startup funding, Elon Musk created a project known as 
Neuralink that aims to advance humanity by essentially creating the equivalent of a 
human Brainet.307 In its simplest description, Musk is attempting to build an Internet-of-
brains, wherein human brains and the Internet coexist on one large networked web.308 
Intending to advance past neural lace, the project focuses on connecting human brains to 
the Internet and to one another, thus allowing for telepathy, among other changes, which 
could one day make language itself obsolete.309 If materialized, this technology would 
become intrinsically part of individuals, allowing mindless thought connection to cloud 
computing. Musk asserts that Neuralink is necessary to protect humanity from existential 
vulnerability in the face of AI.310 If the blueprint of whole-brain interface comes to 
fruition, society will need to usher in a new realm of brain security. Salient repercussions 
present themselves when criminals are able to access the biological core of human 
cognition.  
In 2017, more than 8.4 billion devices already comprise the IoT; that number 
continues to increase rapidly.311 Beyond robust connectivity, developments in digital 
connectedness provide a platform for the advancement of innovation. The growing IoT 
and emerging brain-computer research may one day converge to form the Neuralink as 
Elon Musk envisions. If neural stimulation devices like the ones depicted in this scenario 
come to fruition, it is likely they would follow the established path of technological 
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progression and join the IoT. As the United States continues to move toward an 
environment of ubiquitous digital technology—enhancing collective vulnerability—the 
need to secure this network grows.  
3. A Hyper-Connected Society and Exponential Technological Growth 
The existence of almost all Americans and their devices on one connected IoT 
creates a hyper-connected society. In a hyper-connected world, people live embedded in a 
landscape of invisible, networked computing, without which is nearly impossible to 
function. A hyper-connected digital society challenges such fundamental rights as 
freedom of expression and the notion of privacy. For instance, what might privacy of 
thought look like in a world immersing everyone in one connected digital labyrinth?  
Technology is growing exponentially, as described in several laws of exponential 
growth. In accordance with Moore’s law, technology is becoming smaller and more 
efficient as its cost decreases.312 Butters’s law of photonics claims that the cost for 
transmitting via optical fiber halves every nine months.313 This degree of technological 
advancement means that engineers can manufacture small, mobile devices that have the 
same performance capabilities of desktop computers. The laws of Reed and Metcalfe 
highlight how large networks, like social networks, scale exponentially with the number 
of people or devices in the network.314 In the realm of computation, Rose’s law for 
quantum computing describes exponential growth in computing power, a development 
that may allow people to solve humanity’s most complex problems.315 Together, these 
laws and others illustrate how the rapid pace of technological growth that the United 
States witnessed in the previous few decades will likely continue to grow exponentially.  
                                                 
312 Thomas N. Theis and H-S. Philip Wong, “The End of Moore’s Law: A New Beginning for 
Information Technology,” Computing in Science & Engineering 19, no. 2 (2017): 41–50.  
313 Thomas Butter, “Privacy-Preserving Framework for Context-Aware Mobile Applications” (PhD 
diss., Universität Mannheim, 2009), 9.  
314 Susan P. Crawford, “Who’s in Charge of Who I Am: Identity and Law Online,” New York Law 
School Law Review 49 (2004): 224.   
315 Matthew Griffin, “Quantum Computing Rose’s Law is Moore’s Law on Steroids,” Global Futurist 
Magazine, August 31, 2016, www.fanaticalfuturist.com/2016/08/quantum-computing-roses-law-is-moores-
law-on-steroids/.  
 85
Assessing the future of technology and innovation, the United Kingdom’s 
Government Office for Science succinctly described the implications for the interactions 
of emergent technologies and driving forces, “The greatest future opportunities lie in 
enabling existing and emerging technologies to interact with each other.”316 
Underscoring this notion is the idea that trends do not evolve in a vacuum. Rather, the 
convergence of technological innovation, interacting with other trends, combine together 
to affect profound change in the rapidly evolving future.  
One area highlighting the intersection of exponential technological growth and 
hyper-connectedness is in the realm of digital currency. Cryptocurrencies present a digital 
disruption to the standard notion of banking. The network of cryptocurrency known as 
bitcoin first came into existence in 2009.317 Bitcoin operates on a decentralized database 
known as block chain that records digital asset transfers in a distributed ledger.318 
Although bitcoin was the first cryptocurrency to achieve widespread adoption, there are 
several other operational alternative digital currencies, like Ethereum.319 Beyond 
currency, a hyper-connected society of exponential technological growth presents a litany 
of implications in the domain of drug policy. In October 2017, the peer-to-peer payment 
app Venmo announced its expansion to allow users to purchase items from two million 
online merchants.320 In pursuit of creating a modern digital wallet, Venmo ultimately 
aims to allow users to use the app in physical stores to pay for purchases.321  
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4. Drug Substitution Therapy  
In the field of drug addiction, medication-assisted treatment therapy (MAT) is a 
central component used in treating certain substance use disorders.322 MAT helps people 
transition from substance use addiction to sobriety in a step-down fashion that avoids 
life-threatening responses associated with sudden withdrawal. One popular example of 
MAT is the use of methadone for treating addiction to opioids like heroin or Oxycotin.323 
Patients on methadone typically visit a private or public methadone clinic daily for their 
dose of methadone and periodic counseling. Contingent on state laws, patients may 
receive a few days’ worth of methadone to take home, especially over the weekend.324 
Depending on the severity of addiction, patients may be on methadone for years or for 
their remainder of their life. Beyond methadone, a catalogue of other drugs also treat 
opioid addiction: buprenorphine, naltrexone, disulfiram, and others.  
In use since the 1960s, a large body of research provides evidence that methadone 
is effective in the treatment of opioid dependence.325 Notwithstanding its efficacy, this 
form of pharmacotherapy presents its own set of barriers and challenges. One significant 
barrier for patients is the fact that most methadone maintenance programs require patients 
to visit their MAT clinic daily for dosing.326 This presents an obvious hardship for 
patients as it logistically limits their ability to travel far from their dosing clinic. In 
response, pharmaceutical companies developed Vivitrol (naltrexone), a drug administered 
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intramuscularly once a month to improve treatment adherence.327 Vivitrol is 
approximately 10 times more expensive than methadone and is not appropriate for 
treating all types of opioid addiction.328  
Another challenge of MAT is that the pharmacotherapies are drugs themselves, 
creating an opportunity for diversion as well as abuse potential. For instance, methadone 
is an opioid drug; one major criticism of this treatment is that many patients move from 
an addiction to drugs like heroin to an addiction to methadone.329 A booming 
underground market exists for buying and selling MAT drugs.330 Aside from addiction 
potential, many MAT pharmacotherapies present a list of side effects for patients to deal 
with. For instance, common side effects, among others, of methadone include anxiety, 
insomnia, impotence, constipation, vomiting, and dry mouth.331  
Beyond the treatment of opioid addiction, other forms of substitution therapy 
show promise in treating addiction. MAT is the most popular and conventional form of 
replacement therapy used in treating substance use disorders. However, in 2017, 
emerging research draws attention to the use of marijuana as another form of substitution 
therapy. Along with state-level policy initiatives to legalize the medical and/or 
recreational use of cannabis during the past two decades, there is a growing social 
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acceptance of its use.332 According to the Center for Behavioral Health Statistics and 
Quality in, 2015 roughly 22.2 million Americans over the age of 12 self-reported 
marijuana use within the past month.333 Experimentation with cannabis also extends to 
physicians, whose patterns of drug prescriptions is decreased in states that legalized 
marijuana.334  
Although state-level medical marijuana regulations is in a legal purgatory outside 
of the federal CSA, people are self-administering cannabis to treat pain, anxiety, and 
other conditions.335 In May 2017, researchers in the state of Washington published 
evidence demonstrating that people are using marijuana as a substitute for prescription 
drugs.336 Another prospective study shed light on the use of cannabis to reduce opioid 
use for individuals with chronic pain.337 Promoting a harm reduction framework to 
reduce negative outcomes, Dr. Amanda Reiman promotes the use of marijuana as a form 
of substitution therapy for alcohol and other drugs.338 In the near future, marijuana could 
become a standard component of substitution therapy. While the use of marijuana for this 
purpose has utility for decreasing the negative consequences of more harmful drugs, 
cannabis itself is still a drug.  
In the more distant future, physicians may use neural stimulation technology as a 
form of substitution therapy for treating substance use disorder. Methadone and other 
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opioid analgesics treat addiction to such opiates as heroin, prescription painkillers, and 
morphine. In the future, marijuana could eventually become part of the standard protocol 
for treating other conditions and addictions. Complicating the field of addiction treatment 
is the fact that more and more novel synthetic drugs continue to appear on the streets, as 
discussed in the first scenario. For most of these novel drugs, substitution 
pharmacotherapy treatment options do not exist. With a more comprehensive 
understanding of brain circuitry and the capabilities of interfacing technology, could 
neural stimulation one day replace most forms of substitution therapy in treating the 
disease of addiction?  
5. A Cultural Context for Drug Use 
To reduce the harms associated with illicit drugs, society must understand both 
natural human impulses as well as the contemporary cultural context for taking drugs.339 
Abundant evidence establishes the human impulse to augment one’s reality; the history of 
humanity is full of examples of drug use for various purposes. This desire explains the 
decision by some people to deprive their bodies of oxygen during sex or to hack existing 
technologies in an effort to alter reality.340 One reason people attend raves is to heighten 
the experience of a drug through loud music and flashing lights.341 The contemporary 
cultural context of drug use in 2030 will most likely look different than it does in 2017. 
Technological influence and ubiquitous connectedness will likely change the landscape 
of drug use and the options for altering mental status.  
In 2017, one cultural context for illicit drug use revolves around the use of 
synthetic drugs. Synthetic drugs are a relatively new class of designer drugs promising 
potency, affordability, accessibility, and an inability for detection by drug screening.342 
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In 2017, there is already a strong demand for synthetic drugs. One reason these drugs are 
so popular is because of their perception as a “legal high.” For example, toxicologists 
point out that Salvia divinorum (salvia) and Mitragyna speciosa (kratom) are growing in 
reputation not only because of their hallucinogenic and morphine-like effects but also 
because the substances are unscheduled.343 As “legal” substances, they are available for 
purchase in convenience stores under a guise of such innocuous products as incense, bath 
salts, plant food, or potpourri. This emerging trend for legal highs is gaining traction; the 
dubious legality of these drugs allows them to evade toxicological monitoring.344 The 
American Association of Poison Control Centers illuminated an 80 percent increase in 
calls about synthetic cannabinoids from 2010 to 2012.345 Additionally, the DEA 
published a report revealing that in 2011, the number of emergency department 
admissions for this class of drugs had more than doubled.346 In 2017, the United States is 
combating an epidemic of heroin, pain relievers, and synthetic opiates such as fentanyl, a 
synthetic opioid analgesic 50–100 times more potent than morphine.347 
In 2017, the federal government is struggling to regulate synthetic cannabinoids. 
This class of drugs presents an oversight challenge due to a lack of standardization for 
testing as well as the seemingly endless number of variations. In 2010, the DEA passed 
an emergency one-year ban on five common synthetic cannabinoids, classifying them 
temporarily as Schedule 1 drugs.348 In 2012, President Obama signed the Synthetic Drug 
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Abuse Prevention Act of 2012, a law banning a non-exhaustive list of 15 chemical 
precursors found across many synthetic drug formulations.349 In 2013, former Attorney 
General Eric Holder permanently classified the psychoactive stimulant methylone as a 
Schedule 1 drug.350 Are these new laws effective in reducing supply, or are they merely 
pallid renditions of old bans for such substances as marijuana, cocaine, and heroin?  
Unfortunately, these laws often become obsolete almost immediately, and the list 
of chemicals used to create synthetics is ostensibly endless. Sentiment beclouds objective 
action, and too often, deviant innovation outpaces bureaucracy’s propensity for 
reactionary policy. Evading prohibitions of specific precursor chemicals, drug chemists 
easily recombine molecular structures to create even more potent drug strains. In the 
United States alone, the DEA identified approximately 300 new and discrete synthetic 
drugs between 2009 and 2014.351 Not surprisingly, there is little consistency in the range 
of reactions to various synthetic drugs—violence, hallucinations, death, paranoia, 
delirium, paralysis, psychosis, and irrational behavior are all reported side effects.352 The 
idea of banning analogues of existing controlled substances is a failed policy.353 
While most synthetic drugs in the United States originate in laboratories in China 
and Southeast Asia, the notion of homemade drug production is also conceivable.354 A 
quick YouTube search for “how to make drugs at home” generates over seven million 
videos; the same entry into Google reveals 28 million search results. In the future, lab-on-
a-chip (LOC) technology could make it even easier to synthesize drugs at home. LOC is 
an appliance that can integrate multiple laboratory functions into a single small chip to 
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automate high-quality screening or detection.355 In 2017, researchers have begun to study 
the use of LOC technology for toxicity screening.356 Furthermore, law enforcement 
agencies are in the process of developing mobile LOC devices to screen saliva for the 
presence of a wide range of intoxicants.357  
In 2017, LOC technology has permeated multiple disciplines. In particular, LOC 
devices hold promise for use in the field of global health. Tiny portable lab chips provide 
a means for mobile testing without a laboratory, a significant benefit for disease 
screening in resource-challenged countries. Moreover, LOCs are especially attractive 
because of low manufacturing costs.358 Many researchers view LOC technology as the 
solution to future diagnostic testing.359 Aside from testing, current research indicates an 
intention to use the technology for drug discovery.360  
In 2005, the United Kingdom’s Government Office for Science assessed how 
future scientific advances could ultimately affect illicit drug use. Its analysis 
hypothesized that in the future, LOC technology could be used to “produce one’s own 
drugs, or to download online instructions for synthesizing them from common raw 
materials straight onto a chip.”361 What happens when LOC technology moves from a 
nascent device to a low-cost, widely available item—will anyone be able to use these 
devices to create designer drugs at home?  
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C. POLICY IMPLICATIONS  
As the U.S. policymakers consider neural interfaces, what policy implications 
arise from its recreational use? Would this technology fit into the realm of drug policy 
concerned with controlling illicit biochemical substances? The scenario presented in this 
chapter highlights the regulatory challenges associated with this form of technology, as 
well as the dangerous human bias to trust technology instinctively. Furthermore, 
recreational use of neural stimulation in a world of hyper-connectivity challenges 
interdiction efforts. Finally, emergent technologies and global megatrends could 
inadvertently lead to the creation of digital and transhumanist divides.  
1. Regulating Neural Stimulation 
The crux of this scenario revolves around the issue of whether drug policy should 
be concerned about the development of non-biochemical devices that alter consciousness. 
Although it regulates U.S. drug policy at the federal level, the CSA does not govern 
technological devices. Although they could one day stimulate the release of specific 
neurotransmitters to mimic illicit biochemical drugs, neural interface devices are 
essentially nothing more than computers. This presents a challenge in trying to regulate a 
motherboard and its associated computer parts rather than specific chemical molecules, 
like methamphetamine. This regulatory challenge elicits a discussion on whether the 
government should try to govern the use of technological devices for brain stimulation.  
At its basic level, the purpose of U.S. drug policy is to protect citizens. If 
scientific advancements lead to the creation of a way to create pleasure in the brain 
noninvasively, society would possess a drug that could be very difficult to constrain. Lab 
studies provide evidence that animals can become compulsively addicted to neural 
stimulation. For example, in 1954, Olds and Milner discovered how rats would learn to 
work impulsively for direct electrical brain stimulation by pressing a lever.362 As 
neurological understanding of addiction progressed, scientists later discovered that 
monkeys would also compulsively self-administer pleasurable stimulants to the point of 
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sickness or death.363 Beyond evolving collective understanding of the science of 
addiction, these studies ground concern regarding the potential for humans to become 
addicted to neural stimulation devices.  
Knowing the addictive potential of neural stimulation devices, the government 
may not even have the option to govern these devices. What are the implications for the 
public once more advanced BCI technology comes to maturity? If the present is any 
indication of the future, it is likely that people will find ways to hack neural interface 
technology before commercial applications are even made available for purchase. Unlike 
FDA-tested drugs, recreational street drugs are not pure in quality. Individuals buying 
and selling illegal drugs generally chose to accept the risk accompanying an imprecise 
substance, even if that means the drugs could cause dangerous secondary effects. Rather 
than targeting a specific disease or condition, recreational drugs are illegal and largely 
operate as wide spectrum drugs. Applying this insight to neural stimulation, it is plausible 
that these same notions will hold true. Seeking an altered mental state, individuals may 
shrug at the notion that the technology is unsafe or not fully developed as long as it is 
effective in producing a high.  
If neural stimulation devices become a common form of technology, would the 
United States regulate them as it does medical devices through the FDA? A 2015 study 
by Harvard University demonstrated that FDA approval for innovative medical devices 
took, on average, 7.2 months longer than drug approvals.364 This difference in approval 
time means that the FDA could stifle innovation by blocking new disruptive technology 
from appearing on the market. On a pragmatic level, it will not be hard for individuals to 
avoid the FDA approval process once this technology is pervasive. Like the 2017 
marketing of synthetic drugs as potpourri or bath salts, neural stimulation manufacturers 
could attach similar packaging labels to indicate that the devices are not for medical use.  
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The regulatory challenges highlighted in this section largely focus on the 
recreational use of neural stimulation on the level of individual consumption. Considering 
this topic at large provokes a larger discussion of the implications for geopolitics, gangs, 
cartels, and militias.  
2. Digital Insecurity: In Technology We Trust  
Exponential technological growth positions the United States in an environment 
of staggering complexity, wherein accelerating change is networking everyday life 
through ephemeralization. In 2010, the chief executive officer of Google showed how 
every 48 hours, society generates as much information as it did from the beginning of 
humanity until 2003.365 As an increasing number of objects connect to the IoT, society 
generates even more data, allowing for complex analytics that produce new levels of 
efficiency. At the same time, this degree of connectedness means almost all things are 
becoming hackable. The country experienced this threat firsthand in 2013 when hackers 
stole personal and financial information from approximately 110 million customers of the 
retailer Target.366 The hackers were able to access this confidential information through 
poor security protocols of a third party heating, ventilation, and air conditioning 
contractor.367 As manufacturers attach sensors to more and more devices to allow them to 
communicate with one another, it is important to understand the data they generate. Risk 
increases as Americans entangle themselves further in the web of dependent 
connectedness: “when everything is connected, everyone is vulnerable.”368 
Research on “trust in screens” informs insight on how society may respond to 
neural stimulation and brain-computer devices of the future. For instance, abundant 
research establishes the human propensity to trust automated decision-making systems 
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over their own cognitive knowledge, a concept referred to as automation bias.369 Because 
of automation bias, there are countless examples of people ignoring their intuition and 
driving their vehicles into ponds and lakes as directed by GPS technology.370 When 
programmers design new technologies, they program ethics and decision making into the 
operating systems. Decisions arising from big data analytics are prone to reinforce 
negative biases.371 Consumers are generally unaware of which calculations go into 
programming ethics and black-box algorithms. For instance, programmers developing 
self-driving cars must program calculated ethics into the operation system of the cars. In 
confronting an unavoidable collision, should the car aim to save as many human lives as 
possible, or should it primarily protect the passengers in its vehicle?372 These examples 
demonstrate the fallacy of math neutrality and the danger of placing full trust in screens.  
Applied to neural stimulation and BCI devices, trust in screens may one day 
extend to trust in neural devices. Connected to the Internet, implanted and/or external 
technology becomes vulnerable to hacking. In 2016, National Public Radio profiled 
“body hacking,” a movement among individuals who experiment with intentionally 
augmenting themselves with technology to enhance the human body.373 As society 
grapples with the implications of the IoT, policymakers must also take into consideration 
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possible future threats emanating from accelerated digital convergence. In an age of deep 
digital insecurity, it may one day be possible to hijack someone’s mind.  
Is it possible to hack neural stimulation devices? In 2017, hacker culture refers to 
a subculture of people who intentionally conquer software limitations.374 The cultural 
movement has led to the formation of more specific subgroups, such as black hat hackers 
(people who hack for malicious purposes) and white hat hackers (those who hack for 
good). The biohacker movement challenges the status quo by championing the open 
democratization of science. The hacker ethic generally promotes societal improvement, 
open sharing, and decentralized technology.375 While the hacker ethic of 2017 is 
generally positive, nefarious actors still present a threat to the security of the country. For 
instance, China hires a large number of fulltime hackers to target the United States, 
among other actors.376 As growing connectedness enhances society’s collective 
vulnerability, the government must implement strategic cybersecurity prophylaxis before 
brain-computer devices come to fruition.  
3. Challenging Interdiction 
The ubiquity of neural and BCI technology could bring a sea change to how the 
government prosecutes a new realm of drug crimes. How might the government enforce 
interdiction efforts against a computer?  
A shift toward the use of neural stimulation in place of illicit drugs could have 
profound geopolitical ramifications. Drug trafficking is one of the most ubiquitous forms 
                                                 
374 “Hacking” refers to the act of engaging in activities (like programming) in a spirit of playfulness 
and exploration. Verna V. Gehring, The Internet in Public Life (Lanham, MD: Rowman and Littlefield 
Publishers, 2004), 43–56.  
375 Steven Levy, Hackers: Heroes of the Computer Revolution, Vol. 14 (Garden City, NY: Anchor 
Press/Doubleday, 1984).  
376 Edward Wong, “Hackers Find China is Land of Opportunity,” New York Times, May 22, 2013, 
http://www.nytimes.com/2013/05/23/world/asia/in-china-hacking-has-widespread-acceptance. 
html?mcubz=3; David E. Sanger, David Barboza, and Nicole Perlroth, “Chinese Army Unit Is Seen as Tied 
to Hacking against U.S.,” New York Times, February 18, 2013, http://www.nytimes.com/2013/ 
02/19/technology/chinas-army-is-seen-as-tied-to-hacking-against-us.html?pagewanted=all&amp;_r=0.  
 98
of transnational crime across the world.377 Trafficking illicit drugs comprises five parts: 
cultivation, production, trafficking, distribution, and consumption.378 The use of neural 
stimulation devices in lieu of biochemical drugs would upend this global system of 
supply and distribution. Manufacturers could produce neural stimulation devices in the 
United States (cultivation, production, trafficking) and sell the gadgets in retail markets 
(distribution) for consumers to purchase (consumption).  
Global connectedness also presents a challenge in the ability to track drug crimes. 
In a hyper-connected society, it is difficult to track communication. As an example, the 
Telegram Messenger is a messaging platform that allows anyone to communicate 
anonymously with high speed and security encryption. Largely owing to this security, 
Telegram is the messaging app of choice of the Islamic State of Iraq and the Levant and 
its affiliates.379  
Beyond messaging, Internet-based monetary platforms present a further host of 
regulatory challenges in the effort to prosecute drug crimes. Digital cryptocurrencies, like 
bitcoin, are decentralized and pose competition to central bank fiat currency.380 
Cryptocurrencies face issues of price volatility, hacking, theft, and the avoidance of 
government taxation. Nevertheless, their sovereign nature and anonymous platforms 
allow individuals to obfuscate their transaction histories. This benefit essentially creates a 
black market currency providing full amnesty—an issue with obvious implications in the 
realm of drug interdiction.381  
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The digital underground of the dark web further complicates the notion of drug 
interdiction. In 2013, the Federal Bureau of Investigation shut down the Silk Road, the 
largest international purveyor of contraband.382 Bypassing geopolitical borders and 
challenging prosecution, this site connected drug dealers anywhere directly with 
individuals on a quest to purchase drugs.383 The site operated as a Tor hidden service, 
allowing consumers to use browse and shop with anonymity.384 Tor is a protocol for 
asynchronous, loosely federated overlay network designed to anonymize major Internet 
applications.385 One month after the Federal Bureau of Investigation terminated Silk 
Road, a substitution site, Silk Road 2.0, was already operational.386 Although Silk Road 
2.0 also shut down, countless other equivalent sites have opened. The massive economic 
success and global dimension of the original Silk Road indicates that illicit drug vendors 
are content with buyer demand.387 Cyber drug marketers are innovative in finding 
avenues for creating an online retail market for illicit products.388 Should law 
enforcement agencies continue to shut down an endless string of online clandestine 
marketplaces, or is this endeavor a failing game of whack-a-mole? 
The U.S. government is aware of the prevalence of synthetic drugs as well as the 
challenges inherent in regulating these substances. In 2016, the Congressional Research 
Service released a report providing an overview of synthetic drugs in the United States as 
well as related issues for Congress.389 The report provides a synopsis of the increasing 
                                                 
382 Goodman, Future Crimes, 245–246.  
383 Nicole Lee, “Anonymity is Dead and other Lessons from the Silk Road Trial,” Engadget, February 
8, 2015, www.engadget.com/2015/02/08/silk-road-trial-lessons/.  
384 Nicolas Christin, “Traveling the Silk Road: A Measurement Analysis of a Large Anonymous 
Online Marketplace,” in Proceedings of the 22nd International Conference on World Wide Web (Rio: 
Association for Computing Machinery, 2013), 213–224.  
385 Roger Dingledine, Nick Mathewson, and Paul Syverson, Tor: The Second-Generation Onion 
Router (Washington, DC: U.S. Naval Research Lab, 2004), www.dtic.mil/docs/citations/ADA465464.  
386 Joe Van Buskirk et al., “The Closure of the Silk Road: What Has This Meant for Online Drug 
Trading?” Addiction 109, no. 4 (2014): 517–518.  
387 Marie Claire Van Hout and Tim Bingham, “Responsible Vendors, Intelligent Consumers: Silk 
Road, the Online Revolution in Drug Trading,” International Journal of Drug Policy 25, no. 2 (2014): 
183–189.  
388 Alasdair J. M. Forsyth, “Virtually a Drug Scare: Mephedrone and the Impact of the Internet on 
Drug News Transmission,” International Journal of Drug Policy 23, no. 3 (2012): 198–209.  
389 Sacco and Finklea, Synthetic Drugs, 1.  
 100
prevalence of synthetic drugs as well as the resulting encumbrance on the nation’s public 
health system. The report further presents a list of issues for Congress to consider, 
including but not limited to: implications on the criminal justice system when scheduling 
synthetic drugs within the CSA, hindering future medical research by enumerating 
additional synthetic drugs as Schedule 1, and the idea of amending the CSA to facilitate 
easier enforcement against synthetic drugs. Articulating its role in scheduling drugs, the 
FDA testified before the Senate Committee on the Judiciary in 2016, cautioning, “New 
illicit synthetic drugs are flooding the U.S. market, and many pose significant health 
risks.” 
The issue of how to regulate synthetic drugs overlaps with the issue of how to 
regulate do-it-yourself biology (DIYbio). DIYbio is an emerging global phenomenon of 
transversal collaborations promoting an open source ethos and access to resources for 
tinkering with biology.390 This movement of more than tens of thousands of amateur 
biologists challenges institutionalized biology, promising cheaper and simpler 
solutions.391 Although global governance of this movement is complicated, the DIYbio 
community has created its own safety and ethical framework of guidelines. Sophia 
Roosth, a cultural anthropologist with expertise in DIYbio, claimed, “Hobbyist tinkering 
and industrialized manufacture are two modes of production that are not dialectically 
opposed in the twinned cultures of synthetic biology and DIY biology.”392 Does this 
mentality of accepting the coexistence of divergent epistemic profiles have any utility in 
how policymakers view designer drugs? 
Synthetic drugs create unique interdiction challenges due to a lack of means of 
drug testing, an endless catalogue of potential chemical configurations, pervasive 
availability for purchase online, and the ability to synthesize new drugs at home. Drug 
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markets are perpetually resilient in the face of environmental changes.393 U.S. drug 
policy must be similarly adaptable so as to stay relevant in a changing world.  
4. Digital and Transhumanist Divides  
Serendipity fades with everything we hand over to algorithms.394 
What does it mean to be human in a hyper-connected world? The IoT’s capacity 
to affect the country profoundly is genuine and should not be underestimated.395 As 
Americans accumulate vast quantities of personal data, the ability of an individual to 
control their own data continually decreases. For example, an individual may choose not 
to create accounts on any social media platforms. Nonetheless, that individual will likely 
appear in pictures uploaded by friends, family, and colleagues—even if only peripherally. 
With the advent of biometric scanning and facial recognition software, sites like 
Facebook have the ability to compile a catalogue of images of that individual, despite the 
fact that she or he is not a registered user on the site. This level of deep-rooted 
connectivity raises policy implications regarding privacy, security, and human autonomy.  
The acceptable limit of hyper-connectivity is a societal—rather than personal—
philosophy. With the rate of objects joining the IoT and the exponential growth of 
technology, Americans may not have freedom of choice in their participation in a hyper-
connected society. In the 1970s, social psychologist Henri Tajfel and John Turner 
theorized about the social selves of humans through their formation of social identity 
theory.396 Focusing on intergroup behaviors, Tajfel described one’s social identity as the 
piece of a person’s self-concept originating from perceived membership in various social 
groupings.397 For example, a person may identify herself as a woman, sister, daughter, 
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graduate student, professional, personal trainer, and crayon enthusiast. Within each of 
these self-selected categorizations, there are different sets of norms and behaviors that 
define the in-group.398 Social identity theory arose in a time before the Internet. As 
society becomes more connected, people may experience increased multidimensional 
framing of their social identity as digital privacy fades away.  
Besides privacy implications, a hyper-connected digital society elicits ethical 
discussions on issues related to fairness, access, and equality. Because of exponential 
technological growth, the price of new technology decreases over time, as innovative 
disruption refines and challenges existing prototypes. Nevertheless, the rate of 
technological growth is striking. In 2007, Apple released the first iPhone, a revolutionary 
smart phone.399 Rivalling Blackberry, the first iPhone was a groundbreaking touchscreen 
handset fusing a mobile phone with Internet access, a camera, a calendar, email, and 
music/video streaming capabilities.400 Only a decade later, Apple has released the 
iPhoneX, featuring an intelligent personal assistant, augmented reality, a bionic chip, 
facial recognition technology, and two high-definition cameras.401  
The phrase “digital divide” refers to “the unequal access and utility of Internet 
communications technologies and explores how it has the potential to replicate existing 
social inequalities, as well as create new forms of stratification.”402 In a highly digitized 
world, those without economic means to access the same technologies are likely to be at a 
disadvantage. In a world of neural stimulation and BCI technologies, this same digital 
divide may transfer to a transhumanist divide, creating a deeper divide between those 
with and without access.  
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Merging man with machine is the prospect of using technology to augment human 
capability positive or negative for humanity? On one hand, a breadth of emerging BCI 
research promises to improve quality of life and cure medical conditions. Human brains 
have extraordinary cortical plasticity, the ability to self-reorganize by forming new neural 
connections in response to mental experiences.403 Because of this neuroplasticity, brain 
circuitry reflects individual habits and behaviors. Largely reliant on computers and 
mobile phones, Americans are already in the process of becoming digitally superhuman. 
According to writer Tim Urban, “the digital age has made us a dual entity—a physical 
creature who interacts with its physical environment using its biological parts and a 
digital creature whose digital devices—whose digital parts—allow it to interact with the 
digital world.”404  
On the other hand, it remains unknown how the use of BCI technologies in people 
beginning at birth could change the nature of how brains operate. Similarly, it remains 
unknown what could happen when BCI devices interface with AI. In future iterations, 
society may decide to employ BCI devices for perpetual health monitoring, and BCIs 
could transmit hourly biometric data into permanent electronic medical health records.405 
This would revolutionize public health but also usher in privacy concerns regarding data 
protection. In the future, could BCI technology track or investigate citizens?  
Used in the wrong hands, BCI technologies are also vulnerable to weaponization. 
Neuroethicist James Giordano states, “It’s not a question of if non-state actors will use 
some form of neuroscientific techniques or technologies, but when, and which ones 
they’ll use.”406 DARPA is currently in the process of creating neural implants that can 
detect and suppress urges in people. The proliferation of this type of device could treat 
addiction or anxiety, but it also generates a new vulnerability for mental hacking. In the 
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future, will the United States even need a drug policy, or will neural implants block 
Americans from temptation to try illicit substances?  
5. A Path Forward 
Facing growth projections for the IoT and continued exponential technological 
growth, the United States stands on the early moments of a seismic shift. Society will not 
see the boundary separating the everyday from hysteresis until past the point where 
technological progress is irreversible.407 As a country, the United States must decide 
whether citizens should be able to purchase objects to alter perception through 
cybernetics. After this is decided, policymakers must develop adaptable policies that can 
handle shape-shifting forms of drug use. Dexterous policy execution is critical for 
allowing the nation’s regulatory process to stay abreast in a complex, rapidly-evolving 
world.  
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V. FINDINGS, CONCLUSIONS, AND RECOMMENDATIONS 
Whatever happens, it’s important that we begin the conversation about the 
society we want to create, and the role that drugs will play in that.408 
A. INTRODUCTION  
This thesis asks the question of which megatrends and emerging technologies are 
influencing the future of U.S. drug policy. Through the presentation of two scenarios, 
fictional “worlds” established and exposed flaws in the conventional wisdom driving 
modern day drug policy. Furthermore, the scenarios highlight broader umbrella 
implication of technological innovation when considering the future of drug regulation.  
There is no effective panacea for banning all the other new illicit creations 
coming onto the street. Continuing along a longitudinal ascendant trend line over the past 
four decades, the use of recreational drugs has increased.409 As new technology continues 
to emerge, manufacturing synthetic drugs will only become easier. 
Neuropsychopharmacologist David Nutt summarizes the difficulty in regulating novel 
drugs, stating, “This is the designer drug problem: as fast as government can legislate 
against known drugs, chemists around the world design new compounds specifically to 
get around the law.”410 
The value of fictional scenarios is in their creation of heuristic tools to emphasize 
hypotheses and insights.411 The future of the United States may not appear as a linear 
extrapolation of the present. The scenarios described in this thesis are not predictions of 
how the world will look in the future. Rather, they depict plausible alternative futures. In 
each of the two scenarios, megatrends and emerging technological variables intersected 
to highlight how people might use drugs in the future outside of the current regulatory 
frameworks.  
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B. FINDINGS  
Being willing to change our minds in the light of new evidence is essential 
to rational policy-making.412 
All trends represent linear projections of the status quo, but black swan events 
could change forecasts. Black swan events refer to major, unforeseen events that could 
disrupt the megatrends discussed in this thesis. For example, nuclear war could have 
massive implications on Internet usage and/or reliance on technology.  
Each scenario presented its own list of policy implications that arose from the 
fictional narrative. More broadly, patterns in these implications highlight three recurring 
themes present across all scenarios. First, underscoring each scenario is a challenge for 
how society decides to define a “drug.” Second, each scenario challenged the feasibility 
of regulating emergent forms of drug use. Finally, the scenarios drew attention to ethical 
issues resulting from these nascent technologies.  
1. What is a Drug? 
The word “drug” itself is polysemic in nature.413 Title 21 §802 of the U.S. Code 
outlines definitions pertaining to the CSA. In item 12, the legal definition for “drug” 
references back to §321(g) (1) of the same title, as Title 21 of the U.S. Code governs all 
food and drugs: 
The term “drug” means (A) articles recognized in the official United 
States Pharmacopeia, official Homeopathic Pharmacopoeia of the United 
States, or official National Formulary, or any supplement to any of them; 
and (B) articles intended for use in the diagnosis, cure, mitigation, 
treatment, or prevention of disease in man or animals; and (C) articles 
(other than food) intended to affect the structure or any function of the 
body of man or other animals; and (D) articles intended for use as a 
component of any article specified in clause (A), (B), or (C).414  
Under this regulatory framework, it is unclear how the federal government might 
define the products described in the two scenarios presented in this thesis. In light of 
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various emerging technologies with the potential to alter one’s mental status, the federal 
definition for a drug appears open to interpretation. For instance, the federal government 
may consider neural stimulation devices as drugs under clause (B), as its use in the 
context of drug substitution therapy would function in the mitigation and treatment of 
substance use disorders. Furthermore, neural stimulation also fits into clause (C), as it is a 
non-food item intended to affect the mental functioning of the body. Inconsistently, 
coffee and green tea—nootropics altering the mind by stimulating alertness—are not 
included within this same regulatory framework.  
Within the Controlled Substance Act, actual classification schedules are 
undefined and largely based on the abuse potential for each drug. According to the U.S. 
DEA, “If a drug does not have a potential for abuse, it cannot be controlled.”415 
Paradoxically, by law, U.S. Code does not consider alcohol or tobacco to be controlled 
substances.416 While the DEA does not define “potential for abuse,” the administration 
outlines four indicators in its Drugs of Abuse: A DEA Resource Guide, 2017 edition: 
(1) There is evidence that individuals are taking the drug or other 
substance in amounts sufficient to create a hazard to their health or to the 
safety of other individuals or to the community. (2) There is significant 
diversion of the drug or other substance from legitimate drug channels. (3) 
Individuals are taking the drug or other substance on their own initiative 
rather than on the basis of medical advice from a practitioner. (4) The drug 
is a new drug so related in its action to a drug or other substance already 
listed as having a potential for abuse to make it likely that the drug will 
have the same potential for abuse as such drugs, thus making it reasonable 
to assume that there may be significant diversions from legitimate 
channels, significant use contrary to or without medical advice, or that it 
has a substantial capability of creating hazards to the health of the user or 
to the safety of the community. Of course, evidence of actual abuse of a 
substance is indicative that a drug has a potential for abuse.417 
Using the abuse potential criteria outlined above, it is not clear how the DEA 
might consider the use of emerging technologies to augment mental functioning. The 
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FDA does not regulate vitamins or supplements. Would a recreational pharmaceutical 
like the fictional Motus, described in scenario one, fall under the vitamin/supplement 
category, or would the federal government determine that it should fall within the CSA 
due to its potential for abuse? Neuroprosthetics, like retinal implants, supplant or 
supplement the nervous system’s inputs and outputs.418 What happens when it becomes 
effortless to use these same devices to hack one’s own nervous system, especially for 
recreational purposes? As new intelligence augmentation devices continue to amplify 
human cognitive abilities, it will become increasingly difficult to discern what qualifies 
as a “drug,” and where to draw the line in ascribing abuse potential.  
2. Regulatory Challenges  
If the federal government does decide to regulate emerging technologies as 
drugs—pursuant to the regulations outlined above—regulation provides the next 
logistical challenge. The history of illicit drug use in the United States is one of resilient 
adaptation and deviant innovation. In 2017, traffickers are already bypassing federal drug 
laws by creating novel synthetic drugs and using packaging with labels indicating that 
products are not for human consumption. The United States is losing its whack-a-mole 
effort to control synthetics as producers rapidly innovate using new chemical 
formulations to create drugs outside of the law as written. This same approach may 
continue into the future with new mind-altering technologies. For example, a 
manufacturer might produce a neural stimulating sleep aid with the publicized knowledge 
that individuals could easily reconfigure the device to produce feelings of sedation akin 
to taking opiates. Can the government pragmatically regulate technology 
misappropriation?  
Developing technologies may ultimately make drug regulation feasibly 
impossible as it is known today. In 2017, the CSA describes drugs in the context of such 
distinct biochemical substances as marijuana, heroin, or amphetamines. Law enforcement 
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officers can test substances to ascertain their chemical composition, definitively 
categorizing whether a white pill is ecstasy, oxycodone, or simply acetaminophen. On the 
other hand, a BCI is essentially a piece of hardware containing computer code. 
Individuals can hack 3D printers to produce drugs, but the physical device itself is merely 
a modern day printer.  
Further compounding the feasibility of drug regulation, global connectedness 
makes interdiction more taxing. For instance, the decisions by Canada and Mexico to 
legalize marijuana will exacerbate interdiction efforts in the United States. As of 2017, 
the federal-state chasm in marijuana regulation continues to grow as new states legalize 
the drug in certain forms. In addition, globalization continues to make the world more 
connected than ever before. Digital currency, the rapidly growing IoT, and the ability to 
create drugs in one’s own home make drug prosecution efforts even more complicated. 
Perpetual shifting toward a dynamic socio-technical system presents vulnerabilities in 
this high level of connectedness.419 According to technology policy expert Alec Ross, 
“The layout of the Internet scrambles the traditional idea that both sovereign countries 
and warfare are tied to geography and physical place.”420 Unless the legislative or 
executive branches drastically modify the CSA to take into account new technologies for 
altering mental status, prosecutors will eventually face the limitation of outdated drug 
laws.  
When it comes to drug policy, is society asking the right questions? Policymakers 
focusing only on the implementation of regulations pertaining to the present will find 
themselves unprepared for the rapidly evolving future. Testing drivers for marijuana 
intoxication provides an example of this notion. As states legalize the use of marijuana in 
defiance of federal law, they suddenly find themselves faced with the need to regulate its 
use. Without the technology to test for marijuana intoxication, for instance, policymakers 
must decide how to enforce policies for driving while under the influence. As lawmakers 
scramble to govern marijuana use, and researchers rush to engineer a breathalyzer for 
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cannabis to detect driving while under the influence, the advent of autonomous vehicles 
looms in the near future. Decades of research establish evidence that the war on drugs is 
an ongoing policy failure; the addition of new technologies for altering the mind will only 
exacerbate this defeat.421  
3. Ethical Considerations  
Beyond regulatory implications, emerging technologies and global megatrends 
may intersect to create a future of digital and/or transhumanist divides. The scenarios 
highlighted this idea in the context of such realms as the neuroethics of intentional 
cognitive enhancement and through digital insecurity. As humanity slowly merges with 
technology, society will continue to wrestle with what it means to be human.  
One major realm in the field of biotechnical ethics pertains to the creation of 
economic divides. For instance, if nootropics become ubiquitous, it will create a 
monetary rift between individuals who can afford them and individuals who cannot.422 
Novel forms of cognitive amplification and a progressive embodiment of augmentation 
technologies could lead to identity-based conflict.423 If humans stop sharing a common 
umwelt—a shared way of experiencing the world—the resulting alterity conflict could 
result in civil conflict based on transhumanist advantage.424  
C. CONCLUSIONS 
This thesis distills a broad arsenal of concepts and research pertaining to global 
megatrends, emerging technologies, and illicit drug use. Fictional scenarios underscore 
the challenges in defining a drug, governing its use, and incorporating ethical 
considerations into regulatory frameworks. The “Where Are We in 2017?” sections 
marshaled evidence to demonstrate plausibility. From these scenarios and ensuing 
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findings, three general conclusions emerge: 1) people use drugs, 2) innovation is 
outpacing drug policy, and 3) the United States must rethink its approach to drug policy.  
1. People Use Drugs 
Humans are natural pleasure seekers.425 
Humans have a long history of using drugs to alter their consciousness, physical 
functioning, and/or mental status. Historians of drug culture highlight how drugs are “an 
important part of our evolutionary history.”426 Policymakers cannot frame the use and 
acceptance of these substances through a purely mechanistic way as context and 
environment are integral components in understanding usage.427 Drugs already surround 
most Americans on a daily basis in the socially acceptable forms of coffee, nicotine, 
ibuprofen, or wine. 
It is plausible to assume that humans will continue to use drugs—both legal and 
illegal—in various forms. This decade’s popularity with synthetic and emergent 
nootropics drugs indicate a societal desire for a legal high, and throughout history, people 
have tinkered with technologies to produce pleasurable results. It is reasonable, therefore, 
to presume that individuals will find ways to hack new technologies creatively for 
enjoyment. As new technologies continue to emerge, their potential for misappropriation 
only grows exponentially. The fact that scientists have discovered how to engineer 
baker’s yeast into LSD and opiates, for example, means that it likely will not be long 
before people figure out how to replicate this process in their homes.  
Aside from misappropriation, pioneering ingenuity will continue to fuel society 
with characteristic American moxie. In the future, cultivators may adopt genetic 
technologies to splice the cannabis genome to produce different strains for different 
moods like calmness or creativity.428 Researchers may create a hangover cure in a pill 
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using dihydromyricetin, derived from certain Asian trees.429 The hangover-free pleasure 
drug soma, envisioned in Aldous Huxley’s Brave New World, may finally come to 
fruition.430 In the future, society may no longer view drugs just as molecular 
combinations of carbon, hydrogen, and other elements on the periodic table. Replaced by 
interfacing neural stimulation devices, biochemical drugs may be an antediluvian notion. 
Over time, hidden fringe subcultures will become mainstream with a normalization of 
experiences once considered taboo.  
2. Innovation Is Outpacing Drug Policy 
There really isn’t any way to shut down the Silk Road unless multiple 
governments synchronize a worldwide jam of the entire Internet.431 
Innovation is slowly making U.S. drug policy irrelevant. Dealers peddling drugs 
will continue to fuel the supply of illicit drugs, and novel digital technologies will only 
make sales easier. As the country is already starting to witness in 2017, the CSA will not 
be able to enumerate a never-ending lineup of newer and more potent synthetic drugs.  
The scenarios presented in this thesis highlight countless interdiction challenges 
as the Internet has revolutionized a lucrative transnational drug trade. The global drug 
trade is experiencing the same forces that revolutionized other industries: Netflix 
replaced Blockbuster, Airbnb is supplanting the hotel industry, and Uber is displacing 
taxis. Sales of drugs on the dark web are already entering the mainstream, with “Cyber 
Monday” sales offering discounts on drugs, such as 50 percent off of LSD.432 In a global 
landscape of hyper-connectivity, it is not feasible to oversee the online sale of illicit drugs 
in a comprehensive, sustainable way.  
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Whereas the war on drugs represents failed policy, the future of unchanged 
prohibitionist drug policies will be a futile abomination. The failure of U.S. drug policy 
was transparent, for example, in the country’s effort to ban the stimulant plant khat. 
Operating under a false premise that banning drugs reduces its use, the federal 
government banned khat in 1993.433 Predictably, there were subsequent increases in its 
price and related criminal activity and no advances in public health.434 As the United 
States already learned from Prohibition in the 1930s, this is the tradeoff, the danger in 
getting drug policy wrong.  
The two scenarios presented in this thesis touched on only a few in a long list of 
emerging technologies. Countless innovations, like 3D printing, also threaten to influence 
the realm of illicit drug use. The disruptive technology of 3D printing may signal a third 
industrial revolution in the future, ultimately simplifying supply chain and distribution.435 
Also known as additive manufacturing, 3D printing refers to a computerized process of 
stacking thin layers of material to create objects. Using a similar process, bioprinting 
allows scientists to manipulate cell structures and artificially construct living tissue. 
Layers of living cells are stacked on top of each other systematically to print tissues and 
organs. In March 2016, the FDA approved Spritam, the first 3D-printed drug for use in 
the treatment of seizures and epilepsy.436 3D printing also has utility for printing guns or 
opioid pharmaceutical drugs on demand, creating vulnerabilities for this technology to be 
hacked to print illicit drugs.437  
According to technology policy expert Alec Ross, “Innovation brings both 
promise and peril.”438 Radical nascent technologies, like 3D printing, are mixing with 
drug use to form emergent social phenomena to produce concepts like “chemputers” for 
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printing drugs.439 In 2017, self-proclaimed “psychonauts” are tripping on hallucinogenic 
drugs while experiencing full immersion in virtual reality.440 How will the government 
protect citizens when drug regulation is obsolete? The United States is living through an 
era of exponential technological growth. The speed at which neoteric technologies 
emerge is unprecedented and beyond the ability of regulators to govern under current 
policy frameworks.  
3. The United States Must Rethink its Approach to Drug Policy  
The biggest wins from technology will go to the societies and firms that 
don’t just double down on the past but that can adapt and direct their 
citizens toward industries that are growing.441 
The United States needs a new social framework for conceptualizing drug policy. 
A zero-tolerance policy approach of prohibition is not only myopic but soon to be 
unenforceable as well. A drug policy framework for the twenty-first century should 
actively incorporate ethics and new technological innovation. Instead of clinging to a 
failed policy agenda, the United States should take a clearheaded look at where the 
country is heading. The United States must have a drug policy grounded in solid evidence 
rather than a product of radical subjectivity and bitter partisanship.  
The mission of the U.S. Office of National Drug Control Policy is to “lead the 
Nation’s counternarcotics efforts by developing policies and coordinating, promoting, 
and implementing initiatives to successfully reduce the supply, the use, and the social 
acceptance of Drugs in the United States.”442 With flexibility of purpose, the federal 
government can up-frame this mission statement to make it more relevant to current and 
emerging societal norms. For instance, a sociotechinical systems approach to drug policy 
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would recognize the interaction between human behavior, drugs, and technology.443 
Moreover, the cultural context of an illicit drug influences perceptions of how dangerous 
it is.444 Regulatory drug policy structures should be antifragile—not only resilient to 
shocks but also strengthened by them.445 
An evolution in thinking requires adaptability in this face-paced world. With the 
creation of augmented reality applications and other novel approaches, the field of 
healthcare is already embracing emergent technologies.446 This type of intellectual 
flexibility requires lawmakers to challenge the status quo before it is too late. An adaptive 
mindset means being willing to accept that the federalist approach to drug enforcement 
may not be the most effective. In a global economy, transforming drug policy requires 
international support to discuss multijurisdictional interdiction responsibility. How 
countries adapt in the digital era will directly impact how competitive and stable they are 
in the future.447 The United States cannot afford to lack urgency or succumb to 
bureaucratic paralysis in this realm.  
D. RECOMMENDATIONS 
Our Nation cannot arrest its way out of the drug problem…the 
Administration has made it a priority to identify and expand promising, 
evidence-based practices that increase public safety, promote public 
health, and correct injustice.448 
What does the United States imagine for its preferred future? The country 
currently has an ineffective drug policy not based on evidence, thus producing no real 
benefit to Americans. As an example, there is a strong correlation between large anti-
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drug promotions—like “this is your brain on drugs”—and increases in first-time drug 
use, as youth actually become more curious about drugs.449 Nevertheless, the same 
ineffective mass messaging campaigns continue to dominate prevention efforts.450 Before 
the United States makes decisions about reforming its drug policy framework, it needs to 
decide on the purpose of drug policy reform. Is our intention to treat or punish those 
addicted to illicit drugs?  
What might the preferred future of this country look like? Policymakers should 
proactively envision a drug policy for the twenty-first century, rather than retrospectively 
looking back to the nineteenth. In contextualizing a modern drug policy framework, 
regulators must manage a balance between exploration (obtaining new knowledge about 
emergent drug use) and exploitation (using that knowledge to improve policy 
frameworks).451 A balance between these two behaviors will produce an optimal result 
for framing the future of U.S. drug policy.  
The burden of illicit drug use is a real and significant policy problem. As the 
United States continues to increase spending on drug control programs, it is important to 
continually monitor and evaluate what policies are working and which are failing. It is 
imperative to analyze the issue of illicit drug use within a contextual framework assessing 
threats, laws, agencies, governance, culture, emergent trends, and mentality. The 
following four recommendations discussed below will create a resilient, adaptable drug 
policy prepared for the future.  
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1. Decriminalization  
Is criminalization ever an effective or appropriate moral response to drug 
use?452 
In public discussions on the topic of drug policy, American politicians frequently 
take a position of tough on enforcement on laws regarding drugs and crime. In the fields 
of healthcare, criminal justice, and behavioral health, leaders call for harm reduction 
approaches that do not penalize addicts for suffering from the disease of addiction. While 
often portrayed in this juxtaposed way, the two views are not inherently mutually 
exclusive.453 It is important to flag the false dichotomy between total drug prohibition 
and full legalization. It is a tragic paradox when policies designed to make the country 
safer end up making the world more perilous.454  
To operate a modern drug policy for this century, the federal government should 
eliminate the CSA and the war on drugs. This policy recommendation joins an exhaustive 
collection of decades of research suggesting that the United States is not winning the 
“war,” and it is causing more harm than positive outcomes.455 This conclusion is not 
surprising; literature on the field of drug policy repeatedly concludes that as a 
mechanism, criminalizing drugs fails to deter use.456 
As of 2017, states want to circumvent federal drug policy, as evidenced by the 
growing number of state-level marijuana laws. Another domain highlighting the state-
directed shift toward drug policy reform is in the use of drug treatment courts. Beginning 
in the 1990s, some states created drug treatment courts to divert users out of the criminal 
justice system and into treatment, thus limiting criminal sanctions for personal drug 
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use.457 The creation of this innovative approach indicated a paradigm shift toward 
treatment and restoration instead of punishment.458  
A decriminalization framework should replace the elimination of the failed war 
on drugs policies. There are various definitions for describing decriminalization; for the 
purpose of this policy recommendation, the term refers to a policy wherein use of drugs is 
not a criminal offense.459 A transnational threat requires a global response via 
international cooperation. In assessing the efficacy of decriminalization, the United States 
should look to Portugal.  
In July 2001, Portugal decriminalized possession and use of all drugs for personal 
use.460 This innovative policy arose following a public health crisis, as morbidity and 
mortality from illicit drug use was rapidly increasing. Before 2001, Portugal’s drug 
policy, similar to that of the United States, centered on a criminal approach to dealing 
with illicit drug use.461 In the late 1990s, the country recognized that its strategy was not 
working. A drug use report produced by Portugal’s Counsel of Ministers in 1999 stated 
that 95.4 percent of drug addicts undergoing addiction treatment the previous few years 
were heroin users, of which 11.6 percent tested positive for HIV.462 At this same time, 
deaths from overdose and drug-related arrests were steadily increasing; 57.5 percent of 
arrests at that time were related to illicit drug use.463 In 1997, drug related convictions 
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were rising in Portugal, with individual users (52.2 percent) being sentenced more than 
traffickers (43.6 percent).464  
Portugal’s Law 30/2000 decriminalized the use, possession, and acquisition of all 
drugs for personal use, defined as possessing up to a 10-day supply.465 While it removed 
penal sanctions for drug crimes, this policy did not make drug use legal in Portugal. 
Rather, Portugal now treats drug use as an administrative violation, and the violator has 
the potential to receive punishment by either fines or community service. The penalty for 
citizens rests at the discretion of the Commissions for the Dissuasion of Drug Addiction, 
a panel comprising health, social work, and legal professionals.466 Despite the existence 
of this panel, most individuals do not receive penalties as Portugal aims to have citizens 
enter into rehabilitation treatment voluntarily.467 It is important to note that under 
decriminalization, it is still a criminal offense to traffic and distribute drugs. Even so, 
Portugal is an ideal case study for assessing total drug decriminalization because 16 years 
of data help determine whether this policy was a failure or a success.  
Contextually before 2001, cultural perceptions of drug use in Portugal favored a 
harm-reduction mentality in light of the illicit drug use crisis.468 Grounded in public 
health theory, harm reduction in this context refers to pragmatic policies, such as syringe 
exchange programs, intended to reduce the harmful consequences of drug use 
behaviors.469 Most Portuguese citizens favored decriminalization in principle, despite 
concern over how this notion would work in practice.470 Decriminalization policies 
accompanied fear that the rates of illicit drug use would sharply increase, that Portugal 
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could become a destination for drug tourism, and that a decriminalization policy would 
connote federal acceptance of drug use.471 As part of its overarching strategy to 
decriminalize drug use, Portugal expanded available resources for drug use prevention, 
treatment, and recovery.472 In addition, broad social and health reforms played a crucial 
role in expanding the welfare state for citizens.473 This is not surprising; previous 
research has demonstrated how low socioeconomic status positively correlates with 
morbidity and mortality from drug use.474  
From a public health standpoint, the policy was a success; incidence of HIV 
infections, hepatitis B, hepatitis C, and overall drug related deaths decreased.475 Since 
2001, Portugal has one of the lowest prevalence rates of drug overdose deaths in the 
European Union. Drug use decreased among 15–24 year olds, a group at higher risk for 
drug experimentation.476 Moreover, the rate of individuals experimenting with a drug(s) 
and continuing to use it dropped from approximately 45 percent in 2001 to 28 percent by 
2012.477 Overall, drug use among minors also decreased.478 At 10 percent, Portugal has a 
low rate of lifetime marijuana use in individuals over age 15 (the rate is around 39.8 
percent in the United States); Americans also surpass the Portuguese in rates of cocaine 
                                                 
471 Jordan Blair Woods, “A Decade After Drug Decriminalization: What Can the United States Learn 
from the Portuguese Model,” University of the District of Columbia Law Review 15, no. 1 (2011): 11.   
472 Caitlin Elizabeth Hughes and Alex Stevens, “What Can We Learn from the Portuguese 
Decriminalization of Illicit Drugs?” British Journal of Criminology 50, no. 6 (2010): 1016, doi: 
10.1093/bjc/azq038.  
473 Alex Stevens, “Portuguese Drug Policy Shows that Decriminalisation Can Work, But Only 
Alongside Improvements in Health and Social Policies,” European Politics and Policy at LSE (December 
2012): 1.  
474 Jake M. Najman, Ghasem Toloo, and Gail M. Williams, “Increasing Socio-Economic Inequalities 
in Drug-Induced Deaths in Australia: 1981–2002,” Drugs and Alcohol Review 27, no. 6 (2008): 615, doi: 
1080/09595230801956108.  
475 “Drug Decriminalisation in Portugal: Setting the Record Straight,” Transform [blog], June 11, 
2017, /www.tdpf.org.uk/blog/drug-decriminalisation-portugal-setting-record-straight.  
476 Hughes and Stevens, “A Resounding Success,” 103.  
477 “The Success of Portugal’s Decriminalisation Policy—In Seven Charts,” Transform [blog], July 
14, 2014, www.tdpf.org.uk/blog/success-portugal%E2%80%99s-decriminalisation-policy-%E2%80%93-
seven-charts.  
478 Ibid.  
 121
usage.479 From a criminal justice and law enforcement perspective, the policy was a 
success as it led to a decrease in crime.480 Finally, the prevalence of synthetic drug use in 
Portugal is now lower than in any country possessing reliable data on usage rates. 
Overall, drug use has decreased, even while usage across most other countries in Europe 
has continued to rise.481 According to drug policy expert Alex Kreit, criminal justice 
system savings following decriminalization in Portugal allowed for an increase in 
treatment capacity, leading to a 147 percent rise in the number of people seeking 
treatment from 1999 to 2003.482 In Portugal, decriminalization also led to a reduction in 
federal costs. 
Portugal’s fears accompanying a policy of decriminalization never materialized. 
Before decriminalization, there was a fear that such a policy would lead to a dramatic rise 
in illicit drug use, yet this anticipated fear did not come to fruition.483 Rather, there was a 
significant increase in the number of individuals seeking treatment for addiction, and the 
number of individuals on medication-assisted treatment therapy more than doubled 
following decriminalization.484 The significant decreases in deaths from drug overdose, 
coupled with a decrease in transmitted diseases, provide compelling evidence that this 
policy is a success. 
The structure of Portugal’s government is as a semi-presidential representative 
democratic republic, a government structure providing utility for using Portugal for a 
comparative analysis.485 Both Portugal and the United States claim to take a public health 
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rather than criminal approach toward illicit drug use. However, American policies do not 
reflect a public health approach, or what is referred to as the “public health smoke-screen 
in drug policy.”486 Rather than actually following a public health approach to drug use, 
the United States concentrates most effort on law enforcement and incarcerating 
nonviolent offenders.487 More than 80 percent of drug arrests are for personal possession, 
rather than drug distribution.488 The majority of arrests for personal possession are 
among nonviolent offenders.489 Illicit drug use remains highly criminalized with laws 
such as mandatory minimum sentencing and “three strikes” shifting sentencing power 
from judges to attorneys.490 Because of these strict sentencing laws, first time nonviolent 
offenders can easily receive de facto life sentences if the court prosecutes multiple 
trafficking convictions together.491 Rather than continuing to promote a façade, the 
Office of National Drug Control Policy should center the national drug control strategy 
on public health. 
Availability is not the only basis for decisions to use illicit drugs. Rather, cultural 
and social trends strongly influence norms surrounding use. Portugal’s policy shift away 
from criminalizing drug use reflects a cultural trend happening around the world.492 
Currently, more than 25 countries have shifted toward removing criminal sanctions for 
personal use of illicit drugs.493 For example, the Netherlands, Uruguay, and certain states 
within Australia removed criminal sanctions for the recreational use of marijuana.494 
Joining Portugal, social attitudes in the United States currently favor deregulation, and 
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citizens are widely calling for reform of drug policy at the national level. In 2011, the 
Global Commission on Drug Policy concluded that the United States should spend less 
on law enforcement and more on prevention, education, and treatment.495 
Drug decriminalization in Portugal led to a decrease in drug use, decrease in 
certain diseases, and an upsurge in the number of people pursuing addiction treatment. It 
is plausible to infer that decriminalization in the United States will likely lead to similar 
outcomes. Considering Portugal’s decriminalization policy in the context of U.S. drug 
policy would necessitate a full restructuring of existing drug laws. If the United States 
decides to implement a decriminalization policy akin to the one in place in Portugal, it 
would need to replace the CSA. The Office of National Drug Control Policy would shift 
toward a public health-centric mission focused on prevention, treatment, and recovery. 
From a federal standpoint of drug decriminalization, states and local governments could 
decide how to operationalize the process of adjudicating administrative penalties.  
When assessing its own implementation fidelity, the United States could 
collaborate with Portugal. RAND Europe created a guide to help other countries 
implement Portugal’s drug strategy. It includes a breakdown of implementation priorities, 
tasks, and objectives under the realms of prevention, treatment, rehabilitation, harm 
reduction, prisons, justice, police, and research.496 In itself, decriminalization is neither a 
policy nor an action. Rather, within a legal framework of decriminalization, Portugal’s 
drug policy contains a number of overarching policies.  
United States drug policy remains unmatched among developed nations due to its 
scale and the degree of criminal penalties for illicit drug use. According to a 
comprehensive systemic review of Portugal’s decriminalization policy, policymakers in 
Portugal are “virtually unanimous in their belief that decriminalization has enabled a far 
more effective approach to managing Portugal’s addiction problems and other drug-
related afflictions.”497 Portugal provides a 16-year case study for assessing the utility of 
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broad drug decriminalization. Analyses of results following Portugal’s decriminalization 
framework depict positive outcomes. In 2001, Portugal decided to fight the disease of 
addiction instead of addicted individuals themselves. Rather than continuing current 
outdated and draconian policies, the United States can and should pursue drug policy 
reform centered on decriminalization. Aiming for the evidence-based policy described in 
the nation’s 2016 Drug Control Strategy, the United States should allow Portugal’s 
decriminalization data set to change this nation’s drug policy mindset.498  
2. National Biotech Ethics Committee and Strategy 
Society is trusting our lawmakers, political appointees, and agency heads 
to apply those instruments to biological technologies that could literally 
change the future of humanity.499 
In a world of globalization and rapidly emerging technological innovation, the 
United States needs a strategy and a committee on national biotech ethics new biological 
and technological developments are intended to enhance human life, but simultaneously 
they pose an existential threat to humanity. With cutting-edge discoveries like gene-
editing, biology is one of the most critical technology platforms of this century.500 
Though the implications arising from their existence will ultimately affect illicit drug use 
as highlighted in the thesis scenarios, emergent biotech advancements transcend drug 
policy.  
Existential risk is not a new concept: humanity has always coexisted with the risk 
of asteroids, volcanic eruptions, pandemics, earthquakes, and other natural disasters. 
Compounding these risks, society is now introducing transformative technologies that 
pose a new kind of peril, the likes of which the human species has never experienced 
before.501 According to physicist Stephen Hawking, AI threatens to trigger unstoppable 
growth until society experiences singularity—the point where human civilization is 
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irreversibly changed, ushering in a new human era.502 Researchers at Cornell University 
developed a programmable synthetic skin that could change the entire appearance of 
robots and wearable consumer technologies.503 Elon Musk’s company SpaceX claims it 
will send a manned rocket to Mars before the year 2024.504 CRISPR technology allows 
scientists to alter the human genome permanently, an ability that could revolutionize 
fields like healthcare or lead to human augmentation and extensive geopolitical 
destabilization.505 In the near future, these separate technologies will converge with the 
ability to change drastically medicine, agriculture, and human life at an incomprehensible 
rate.  
Policymakers lack the technical understanding and domain expertise to apprehend 
how most of these contemporary technologies work. As of 2017, there is only one PhD 
scientist in Congress, and the country has no coordinated biology or technology 
strategy.506 This is critical because emerging technologies are advancing faster than the 
government is able to understand and regulate them. Without preparation for emerging 
trends and technologies, it may be too late before an issue, like genetic privacy, leads to 
profound consequences.507 Without a national biology platform, the country leaves 
private companies alone to toy with technologies that have the potential to reshape the 
human species.508  
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The federal government needs to form a separate committee with the authority to 
develop a science-oriented biotech strategy outside of the realm of political or religious 
bias. The National Biotech Ethics Committee must comprise nonpartisan researchers, 
policy experts, futurists, scientists, ethicists, and individuals with domain expertise. Led 
by a chief ethics officer, this group should develop a common lexicon for discussing 
these topics and work directly to educate the executive branch on the implications of 
accelerating change. This committee should not be part of the national institutes of 
health, science, or technology. Rather, the Biotech Ethics Committee should act as a 
conduit between the executive branch of government and the scientific community. In 
understanding the potential consequences of emergent sociobiological and technical 
developments, the committee should take into consideration economics, behavioral 
theories, the environment, population demographics, cultural implications, and 
megatrends using a multi-faceted analytical approach. According to futurist Jim Dator, 
“once certain values, processes, and institutions have been enabled by technologies, they 
begin to have a life of their own.”509 
3. An Office of the Future 
Institutionalized forward thinking proactively strengthens homeland 
security capabilities and delays the time it takes the government to react to 
change.510 
In a landscape of exponential technological growth and a rapidly expanding IoT, 
it is imperative for the United States government to create the Office of the Future. This 
office should develop a sophisticated toolset to prepare the country for emergent 
phenomena on the horizon. It is important to balance adaptation and planning. Where 
bureaucracy is reactive, the Office of the Future would proactively anticipate upcoming 
issues and technologies still in their embryonic stages. According to technology policy 
expert Alec Ross, security is supposed to be “a public good administered by government, 
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not a private good purchased in the marketplace.”511 Has the U.S. government fully 
addressed the need for digital security in a new era of cybersecurity and conflict?  
To avoid bureaucratic paralysis, the Office of the Future should operate 
independently under an Auftragstaktik (decentralized) command philosophy. Under this 
broad concept, the executive branch oversight should provide the cabinet-level director of 
the Office of the Future with a general direction to develop strategic foresight, allowing 
the office the freedom to determine how to accomplish their mission.512 For example, the 
office could utilize forward-thinking solutions such as crowdsourcing to solve problems. 
Prospective thinking must occur on a continual forecasting basis, as technological 
innovation and digital disruption changes constantly. According to scenario planning 
expert Kees Van der Heijden, it is crucial to institutionalize the ability to interpret 
signals.513 What could the DEA have done 5–10 years ago to better prepare for the 
changing ecosystem of illicit drug use in 2017? 
The creation of an Office of the Future would be evolutionary, though not without 
precedent. In Silicon Valley, the Institute for the Future and the Foresight Institute 
research revolutionary technologies and their fundamental importance to the human 
future.514 The Foresight Factory conducts similar research on behalf of Fortune 500 
companies.515 An institutionalized approach to anticipating trends on the horizon does 
not belong solely in the private sector domain. In the United Kingdom’s Government 
Office for Science, teams work on year-long foresight projects focused on areas where 
emerging science informs policy.516 In Australia, the government funds a futures project 
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focused on migration of skilled labor.517 Within the U.S. Department of Homeland 
Security, Federal Emergency Management Agency conducts its own strategic foresight 
initiative focusing on future disasters.518 To provide the most benefit to Americans, a 
dedicated office should collaborate with the private sector to focus on all areas of 
strategic foresight systematically.  
4. Health and Behavioral Healthcare System Transformation  
The success or failure of any government in the final analysis must be 
measured by the well-being of its citizens. Nothing can be more important 
to a state than its public health; the state’s paramount concern should be 
the health of its people.519 
Franklin Delano Roosevelt  
a. Move Drug Policy from the Realm of Law Enforcement to Public Health  
The U.S. government should transition the domain of drug policy from law 
enforcement to public health. This realignment falls in line with the frequently repeated 
conclusion that the country’s drug problem “needs radical thinking as a public-health 
crisis rather than a moral crusade.”520 Researchers have established that a zero-tolerance 
drug policy impedes public health approaches, subsequently marginalizing and 
stigmatizing those who suffer from addiction.521 Moreover, experts in healthcare fields 
claim that zero tolerance dismisses evidence-based harm reduction strategies, such as 
syringe exchange programs.522  
Part of the public health success seen in the case study of Portugal was due to a 
general shift to treating drug use using a medical model rather than a criminal one that 
bestows criminal sanctions. With a policy of decriminalization in place, there would no 
                                                 
517 For more information, see (for example) http://australianfutures.co.uk/faqs.html.  
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longer be a reason for law enforcement to enforce a strict penal code related to the 
consumption of illicit substances. Moreover, this system transformation would better 
prepare the nation for a future in which people use drugs other than biochemical 
substances to get high. Homeland security and public health have a shared mission to 
maintain social and economic stability as well as government functioning; a drug policy 
realignment from law enforcement to public health will help further this mission.523  
b. Expand Access to Healthcare and Behavioral Health Services 
In Portugal, decriminalization has reduced stigma related to drug addiction. 
Citizens are no longer afraid of criminal involvement for seeking treatment. Instead of 
being prosecuted, individuals caught using drugs receive a non-enforceable invitation to 
seek treatment. As a result, the number of individuals seeking treatment for substance use 
disorders nearly doubled in the years following implementation.524 Formalizing the 
expectation that treatment is available, Portugal’s model hinges on the existence of a 
highly functioning drug treatment system.525 The United States is the only industrialized 
nation without government-sponsored universal healthcare.526 If the United States 
intends to decriminalize drug use, it must complement this action with a move to 
strengthen the existing drug treatment system.  
The best way to strengthen the existing drug treatment system is to implement a 
universal healthcare system like the socialized health system found in Portugal or almost 
all other developed nations. In the United States, a mélange of for-profit, nonprofit, and 
government-provided funding at privately and publicly funded facilities provide 
healthcare. Although the United States spends more on healthcare per capita than any 
other nation, it drastically underperforms and continually ranks as one of the worst 
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performing systems among developed countries.527 A universal public health system 
would provide complete access to behavioral health services to all citizens.  
Health is the cornerstone of ensuring a population is safe, secure, and resilient in 
the face of threats.528 Universal healthcare represents a preferred homeland security 
practice. According to Fremont Police Captain Kimberly Petersen, “Our ability to obtain 
health care is part of the homeland security preparedness puzzle.”529 With a fractured 
healthcare system, the United States limits its ability to be resilient and fails to achieve 
full preparedness. Universal health coverage is indispensable to achieving individual 
health security.530 Security threats are not static. As the United States faces surges and 
innovative forms of drug epidemics, it is imperative that the homeland security enterprise 
remain adaptable. Adopting universal healthcare will systematically strengthen the 
nation’s homeland security and ability to be resilient. Ability to obtain healthcare, 
including behavioral health treatment, is vital to Americans and reinforces an all-hazards 
framework to security.531  
E. LOOKING FORWARD 
We need policymakers and thinkers who have that intuitive revolutionary 
feel for the inescapable demands of innovation.532 
Society changes to keep up with technological innovation. Pacemakers, organ 
transplantation, and Lasik eye surgery were wild, fringe innovations when they first 
appeared in in the public but are now accepted by the mainstream. The next industrial 
convergence will likely be a collision between the biological and computer sciences. In 
the future, policymakers will likely merge subjective judgment with computer-based 
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forecasting.533 According to futurist Rodrigo Nieto-Gómez, “upcoming trends are visibly 
influencing the homeland security environment in a way that should not be 
surprising.”534 To prepare for the arrival of new trends, it is important to value divergent 
views and emergent thinking. Scenario thinking is one method for harmonizing the 
spectrum from imagination to pragmatism. Fictional scenarios challenge assumptions and 
show how moving parts could intersect to produce counter-intuitive outcomes. With a 
phenomenal instinct to pioneer new policy approaches, the United States will thrive as a 
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